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Abstract 
The recent reports into standards in the NHS (Francis, 2013) and quality in pathology (Barnes, 
2014) have focused scrutiny on the way in which we work in pathology and how we can provide 
assurance that this is of a sufficiently high standard. There are a number of external quality 
assurance schemes covering pathology generally and histopathology specifically (UKNEQAS), 
however, there is no scheme of any kind covering the process of histological surgical dissection. 
This is an area undergoing development currently, as it changes from an area which is the sole 
preserve of medically qualified pathologists, to an area utilising a number of highly trained 
biomedical scientists.  
The concept of biomedical scientist led dissection has been around for some years, being 
codified into a document of best practice in 2005 (IBMS, 2005). This document placed the 
responsibility for the work of the BMS in the hands of the pathologist, without structured 
oversight or a quality assurance programme. Ten years on and specimen dissection, including 
the developing area of BMS led dissection, remains without any formal structured form of 
quality assurance. 
This work builds on the points made by Barnes (2014), taking the guidance of the Royal College 
of Pathologists (RCPath) and Institute of Biomedical Science (IBMS) to form a series of key 
performance indicators (KPI) in relation to specimen dissection. These KPI can be used as an 
indicator of individual practice, highlighting areas of variation, weakness or strength. Once these 
are identified, a tailored feedback and training event provides an opportunity to address these 
errors & omissions, or to enable areas of strength to be shared. The results of this thesis show 
that introducing training events serves to drastically reduce variation by, and between, 
dissectors, driving up standards in the department.  
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Introduction 
Few could fail to be aware of how badly Mid Staffordshire NHS Trust failed their patients. The 
Francis Report (Francis, 2013) examined in detail the practices of the Trust and found that the 
patient was not placed at the heart of the service, that targets were prioritised over good 
practice and that there were no effective sanctions to deal with poor performance. This was 
more than a decade after the Kennedy Report (2001), which looked into unnecessary deaths 
during paediatric heart surgery in Bristol. Kennedy noted that the mortality rate was double that 
in similar centres elsewhere. He also noted that the patients here were again not placed at the 
heart of the service. In his conclusions he stated that learning from errors is vital, and that 
openness and transparency are considered vital. Beyond this, he went on to consider the 
attitude of healthcare professionals to patients.  
Kennedy speaks about the importance of a partnership between healthcare professionals and 
patients, one including respect and honesty. He is keen to move away from the traditional 
attitudes of “doctor in charge” and encourages an open collaborative approach. This is keenly 
echoed in the Francis Report, and, Secretary of State for Health, Jeremy Hunt’s statement in 
response to the report clearly criticised the attitudes encountered. The Secretary of State went 
on to call for accountability and transparency (Hunt, 2013). 
In this newly emerging culture of openness and transparent quality data, a report into possible 
misdiagnosis at Sherwood Forrest NHS Trust was commissioned (RCPath, 2013). Ultimately no 
misdiagnosis was found, however, a number of serious concerns were identified into the funding 
and organisation of the laboratory, attitude of the trust management to the pathology 
department, training and equipment; the most significant concern was in regard to the EQA 
scheme which gave rise to the original concern. The EQA scheme did not adequately consider 
the sample size and the statistical safety of extrapolating from the data, nor were the results 
sufficiently meaningful as to provide direction and specificity to their concerns. The report also 
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detailed concerns regarding the methods used by an external agency appointed to investigate 
the issue; their apparent identification of “weak positivity” of oestrogen receptor (ER) staining, 
which they claimed had erroneously been reported as negative, were in fact false positives. The 
original report of ER negative was correct. This gave rise to another investigation, this time by 
Dr Barnes. The Barnes Report (2014) covered quality control in pathology and was quite 
exhaustive in nature. Barnes noted the reports from Francis and Sherwood Forrest, and echoed 
a number of their findings, particularly calling for open, transparent individual quality data and 
standardisation of practice in pathology. Currently there is some quality data available for 
pathology, however, it is obscure in nature and nonspecific. The national EQA scheme in 
histopathology is run by UKNEQAS (ukneqas.org.uk), the results generated by this scheme are 
fed back to the individual laboratory along with regional average rates. It is not possible to draw 
direct parallels between laboratories, nor is it possible for non-members of the scheme to view 
the data. Where a laboratory fails to meet the minimum standard, a letter is sent to the 
nominated “technical head” (UKNEQAS, 2015). This clearly does not fit within the framework of 
openness, accountability and transparency. 
This work aims to go some way to addressing this failing. Barnes (2014) noted that quality 
procedures in pathology were no longer fit for purpose and called for individually identifiable, 
evidence based, key performance indicators. This work examines the evidence base for practices 
in surgical dissection in diagnostic histopathology, and establishes the premise of using key 
performance indicators to identify deviations in practice. It looks at how to feedback this data 
to the personnel involved, with methods of encouraging a collaborative team approach to 
determining best practice and optimising performance. Further, as Biomedical Scientist (BMS) 
led specimen dissection is an emerging field, this work looks to establish an objective standard 
of practice, by providing comparison with the current practice, performed by consultant 
Histopathologists.  
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Research Aims and Objectives 
This research aims to investigate the feasibility of developing Key Performance Indicators that 
can be applied to the process of histopathological surgical dissection. The aim of this is to enable 
the use of KPI data to demonstrate variation in practice by and between individuals; 
demonstration of this variation then allows a form of remedial and preventative action to be 
introduced, to reduce variation and increase standards.  
The objectives of the research are to: 
 Create a set of histopathological dissection KPIs based on the best available professional 
and scientific guidance 
 Collect performance data in relation to the KPIs from a number of dissectors 
 Develop a mechanism for correcting errors or weak / poor practice 
 Devise a team led system of training, education and feedback, based on the KPI data 
Thesis Overview 
Chapter One 
Chapter one is a review of the current literature. Beginning with a consideration of histological 
dissection and its position within a framework of evidence based practice, the literature 
covering the emerging area of BMS led dissection and the devolution of responsibility this 
requires is reviewed. The evidence around the lack of current quality standards and why such 
are needed is examined. Along with this, the concept of, and evidence for, key performance 
indicators is considered. The literature review will then examine in detail the evidence regarding 
the need for standardisation of dissection practice, looking particularly at the literature 
published on lymph node sampling as its exemplar and will consider the findings with reference 
to current laboratory practices. The review continues and considers the evidence surrounding 
the use of checklists in practice, to reduce error; following the evidence from the aviation sector 
and its translation into a medical context. Finally, the literature review examines how best this 
performance data may be used to improve performance, considering change management and 
teaching & learning theories.  
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Chapter Two 
Chapter two presents the findings of the first study which reviewed current practice in the 
laboratory. The reports were reviewed, examining a number of criteria, selected as KPIs. These 
criteria were selected as examples, exploring the concept of KPI reporting in surgical dissection, 
and the difference in practice between pathologists and BMS. The KPI were selected, based on 
the recommendations from the RCPath for macroscopic description and sampling.  This is used 
to establish a picture of current practice for pathologists and BMS. The difference between the 
two groups are considered and the significance of the difference is investigated. Discovery of 
the variance in practice between individuals and groups allowed a consideration of how quality 
might be assured by monitoring key performance indicators. It goes on to provide an initial 
consideration of the results and how to develop the investigation further. 
Chapter Three  
Chapter three presents study two, the development and delivery of a training intervention 
employing a face-to-face training event, the use of a practice checklist and diagrammatic 
representations of dissection. Study two was an eight part trial which first created the checklists 
and collected baseline data then introduced the training event, checklists and guide diagrams in 
different combinations to assess the individual effectiveness of each. The results are presented 
for each stage in the appendices and then brought together and presented by different 
dissection types at the end of this chapter. 
Chapter Four 
Chapter four presents study three, where a series of interviews are performed. In these 
interviews a number of the dissectors who have been involved in study two, parts one to eight, 
are questioned regarding their experience of the study, what effect they thought the study had 
and their opinions were sought in regard to what further developments might be made. The 
transcripts of the interviews were reviewed and a thematic analysis performed  
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Chapter Five  
Chapter five is a detailed discussion of the investigations in context. Here the variations are 
considered in their context and the significance of the variations in practice are discussed. The 
effect of the interventions is also discussed along with reflection upon individual practice and 
the methods that might be used to improved performance.  
Chapter Six 
Chapter six presents the conclusions of this work, where the new information gained in the study 
is presented in the context of a changing medical, social and political environment.  The work is 
placed into the context of the changing NHS, with drives for identifiable, transparent quality 
performance data, with sanctions and rewards for poor or good performance.  
The list of references is available on page 191 and the appendices start on page 203.  
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Chapter One - Literature Review 
Histological Dissection 
The specimens received by the histology laboratory range from a single fragment of tissue, such 
as an endoscopic biopsy, to a large multi organ resection, such as a pelvic exenteration; these 
specimens must then be handled in such a way as to enable microscopic analysis.  
There are many terms employed in laboratories to cover the process of transforming specimens 
of all types into samples suitable for chemical treatment and subsequent sectioning. In the 
experience of the author, “Cut up”, “Trimming” and “Dissection” are three of the more common. 
The term “dissection” will be used here, as this is the terminology used by the Royal College of 
Pathologists (RCPath) and the Institute of Biomedical Science (IBMS) in their co-authored 
documents (IBMS, 2009; IBMS, 2010a; IBMS, 2010b).  
The process of dissection takes organs, or portions of organs, and selectively samples the 
specimen. This process is of paramount importance in providing an accurate diagnosis, staging 
of disease and prognosis for the patient. Histopathological dissection is a highly skilled 
procedure, performed in order to enable the microscopic analysis of the tissue. There is 
substantial guidance available for this process, the Royal College of Pathologists have issued a 
number of guidance documents on how to handle and report these specimens (Williams et al., 
2007; RCPath, 2009; Appendix One – Tissue Pathways and Minimum Datasets, on page 203). 
This process has traditionally been performed by medically qualified pathologists, according to 
their own preferred method. In recent years the process has been delegated to Biomedical 
Scientists and the RCPath best practice guidelines have been incorporated into standard 
operating procedures (SOPs), which BMS are expected to follow. The extent to which these SOPs 
are followed, by both the BMS and pathologist, is a debated topic; as are the relative standards 
of performance displayed by both groups (Sanders, 2009; Simmonds, 2011; Duthie, 2004). 
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Evidence Based Medicine 
Standardisation in medical practice has been increasingly linked to improved patient outcomes 
(ACOG, 2012; Dhingra, 2010; Coombs, 2009; Ferran, 2008) and is an integral part of the current 
drive for Evidence Based Medicine (EBM). EBM may be thought to have originated with Dr Archie 
Cochrane with his book Effectiveness and Efficiency: Random Reflections on Health Services in 
1972 (Shah, 2009). EBM seeks to base the practice of medicine on the best available evidence, 
rather than the individual preferences of the practitioner. As research indicates better methods, 
the guidance is updated. As such, the practice of medicine should follow the available guidance, 
based on the current evidence, and all practitioners should be working in very much the same 
way. The logical extension of this is that variation in practice, either within or between 
individuals, should be eliminated where possible.   
EBM is not without its detractors. Croft (2011) provides a balanced review of EBM, covering both 
the positive and negative aspects. One of the criticisms levelled at EBM is that in some cases 
there is no evidence. Whilst this may be true, it does not preclude working to what evidence is 
available and being open to changing practice when research provides new evidence. Also, 
where no evidence is currently available, if practitioners note this lack and document their 
practice and outcomes, this forms the beginning of an evidence base for this area. Another 
criticism sometimes made is that EBM stifles innovation. Research is always ongoing in 
medicine, the newly emerging evidence is collated and evaluated by the appropriate 
professional body, who will issue best practice guidelines amended, or not, in light of the new 
findings. EBM does counsel a more rigorous approach to adopting new innovations; however, 
as EBM is by definition based on evidence gained from research, a culture of EBM encourages 
research and innovation. EBM only restricts the implementation of new practice, requiring that 
the change be evidence based (Glasziou et al., 2011).  
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The concept of EBM, or rather evidence based practice (EPB), is not new to pathology. Within 
pathology the staging, diagnosis and reporting practices are based on evidence; even guidance 
on appropriate staffing is given, which is also evidence based (Lowe, 2014; Thorpe et al., 2012; 
Ellis et al., 2005). The practice of histopathological dissection is based on variable amounts of 
evidence and in considered in detail within the “Standardisation of Dissection” section.  
Devolution of Responsibility 
Another emerging trend within pathology, and within the wider medical community, is the 
devolving of tasks and responsibilities traditionally undertaken by medically qualified doctors to 
appropriately qualified paramedical professionals. This has occurred extensively within nursing, 
with a great deal of traditional nursing roles being undertaken by Healthcare Assistants (Bosley, 
2008; Daykin & Clark, 2000). This is also occurring in pathology, whereby the process of surgical 
dissection, which was traditionally the preserve of medically qualified pathologists, has been 
passed to suitably trained biomedical scientists. The concept of pathological dissection being 
performed by non-medically qualified staff (specifically, qualified Biomedical Scientists) has 
been present for some time. There has been considerable variation in range and scope of 
practice, which until recently has been uncoordinated and left to local agreement. In recent 
years there have been steps to formalise and standardise the range of specimens and personnel 
that are authorised to work with them (IBMS, 2009; IBMS, 2010a; IBMS, 2010b; RCPath, 2004). 
However, there are no protocols in place to ensure the standard of this work; the quality must 
be monitored locally, there are some suggestions made on how to perform this (IBMS, 2009, 
RCPath, 2007), but no structured or formal systems have yet been developed.  
As might be expected, there is variation in attitudes to this change. Simmonds (2011) reported 
the results of a survey carried out on all the consultant pathologists registered with the RCPath, 
for whom they could obtain an email address, 463 individuals responded out of 1320 contacted 
(response rate of 35%). Those who responded showed a largely positive attitude towards BMS 
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led dissection, with 98.9% of respondents being either fully in favour of BMS dissection or in 
favour with some reservations. There remains some controversy and arguments regarding 
exactly how BMS led dissection should progress and be monitored, but the prevailing attitudes 
expressed are positive.  
The responsibility for histological dissection still, currently, remains with the consultant 
pathologist (IBMS, 2005). Consequently, it is easy to see where the hierarchical attitudes stem 
from, these are also noted in surgery (Bosk et al., 2009). Medicine has traditionally been self-
regulating, at least for the last 150 years since the 1858 Medical Act. This has changed, and 
continues to change; the General Medical Council, until very recently, took very little interest in 
the standard of work performed by their members, only censuring for occurrences of Serious 
Professional Misconduct (Dixon-Woods et al., 2011). Dixon-Woods et al. (2011) relate a series 
of scandals that came to prominence through the 1990s, which had been occurring for decades, 
and where concerns had been raised previously, with no action taken. There is clearly a 
responsibility here, that of oversight and management. Dixon-Woods et al. claim that the 
scandals they discuss represent a failure of not only oversight, but also of the responsibilities of 
doctors towards their peers. However, the fundamental flaw was that the GMC set their 
threshold for involvement at the level of serious professional misconduct, with no lesser claims 
being entertained, also, their standard for conviction was akin to the criminal court standard of 
“beyond reasonable doubt”. The institutional structure encouraged a lack of candour, 
something also seen in other professional arena, where “whistleblowing” can be at the cost of 
a career. Fortunately, things have changed. The GMC was restructured in 2009, after the Council 
for Healthcare Regulatory Excellence (now the Professional Standards Authority) was formed in 
2003. The restructuring primarily ensured that the members of the GMC council would be 
equally registrant and laity.  
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The importance of noting these historical circumstances and their subsequent changes is to 
place the devolution of responsibility and attitudes to assessment in a proper context. Being a 
medical doctor has long held a social weight, a certain cachet; this came with certain 
responsibilities as a part of the social contract. The fabric of this social contract, the trust with 
which the public hold their doctors, has been successively damaged over the years, in no small 
part by these scandals. The consequence of this is a move to what Dixon-Woods et al. (2011) 
call a “confidence” system, whereby individuals (the patients) put their faith in the system of 
assurance and regulation around the individual, rather than in the individual themselves. This 
means that we must be able to demonstrate our quality within that system in order to promote 
this confidence in us. With the current political environment and the drive for ever increasing 
competition, any commissioning group will also be looking for evidence for putting their 
confidence in any particular hospital, department, or individual. Demonstrating appropriate 
team behaviours, attitudes and quality is going to be a necessity.  
Quality in Pathology 
Following the serious failings in standards of care, personal performance, oversight and 
leadership identified in the Frances Report (2013), the Secretary of State for Health published 
an initial response, committing the government to fully implementing 204 of the 290 
recommendations (Hunt, 2013). In this response, Berwick (2013) was tasked with building on 
the work of Frances and finding a way forward. His prime recommendation was to place the 
quality and safety of patient care above all else. In this newly emerging environment of 
prioritising quality, concerns noted at Sherwood Forest Hospitals NHS Trust (RCPath, 2013) gave 
rise to an in depth review into quality control in pathology (Barnes, 2013). The Sherwood Forest 
Report makes a number of key findings, although the publication most relevant to pathology is 
the Barnes Report, which relates to quality in pathology. Both make a number of 
recommendations and are considered in some depth later in the literature review.  
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One of the methods used to ensure quality is External Quality Assurance (EQA). The value of 
EQA has been proven repeatedly (Hastings and Howell, 2010, Sciacovelli et al., 2010), over many 
years (Barr & Williams, 1982). EQA is a method whereby an external agency provides 
independent feedback on performance, against an agreed standard. Within UK pathology the 
main sources of EQA are UKNEQAS and the Royal College of Pathologists, where substandard 
performance is identified, this is reported back to the laboratory. EQA has been used across all 
areas of histopathology, with the sole exception of pathological dissection. There are schemes 
covering the microscopic analysis of tissue sections (NHSBSP, 2003; RCPath, 2007), routine and 
special staining (UKNEQAS, 2011a), immunocytochemistry and in situ hybridisation (UKNEQAS, 
2011b). Duthie et al. (2004) specifically highlight the lack of published literature regarding the 
quality of specimen handling. When considering how quality assurance of histopathological 
dissection might be performed, whether BMS or pathologist led, it is significant that dissection 
involves compromising and damaging the sample. The training process suggested by the IBMS 
(2009) suggests preview prior to dissection, moving on to review after dissection, progressing 
to dissection with regular audit. The concept of regular audit is, however, not further defined; 
nor are any recommendations made regarding EQA. Additionally, one of the drivers for BMS led 
dissection is the time saved by consultants, it is not practicable for each specimen to be viewed 
before, during and/or after dissection, beyond an initial training stage. This gap in knowledge 
and oversight is something we seek to address here. Whilst EQA clearly has much to offer, it 
lacks a robust framework in which poor performance of individuals can be identified, or whereby 
poor performance can be managed.  
However, one of the recent outcomes of EQA has had far reaching consequences. An audit by 
East Midlands Breast Screening Programme Quality Assurance Reference Centre into aspects of 
the histopathology service at Sherwood Forest NHS Trust revealed concerns about the quality 
of the work performed. The Care Quality Commission, along with the Royal College of 
Pathologists, investigated the issue. Whilst they found that the concerns were unfounded, 
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indeed criticisms were made of the external agency appointed to investigate the alleged 
discrepancies, they identified a number of further issues within the EQA system (RCPath, 2013).  
The review undertaken was extensive, involving rescreening a great many slides and 
determining the Oestrogen Receptor (ER) status of breast tumours. This highlighted a number 
of areas of variation, both within this centre and between centres. However, the main problem 
noted was related to the EQA scheme. As Sherwood Forest Trust was handling a small number 
of cases, a small amount of variation was sufficient to create the appearance that this trust was 
an outlier. The subsequent investigation into the matter was further compounded the issue by 
the use of the antibody clone 6F11. 6F11 is now know to show false positive staining (Ibrahim, 
2012; Rakha, 2012). This is something which was picked up by the EQA scheme, however, there 
is clearly a significant time lag in identifying and reporting these issues. The Sherwood Forest 
Report also highlighted a number of systematic faults with the statistical aspects of the EQA 
service. It also recommended that statistical monitoring of individual performance be 
introduced, using radiology or cervical screening methods as a starting point (RCPath, 2013).  
As a consequence of this investigation, and the background of the Francis report, the NHS 
Medical Director, Sir Bruce Keogh, appointed the National Clinical Director for Pathology, Dr Ian 
Barnes, to review pathology quality assurance. Barnes (2014) states “the current systems of 
quality assurance in pathology are no longer able to meet the needs of modern healthcare” and 
“we cannot say the best interests of the patients are being served”. This could not be stated 
more clearly. He based this assertion on a number of factors, including the lack of key assurance 
indicators (KAIs) and the inability of the pathology service to provide evidence of quality to the 
Care Quality Commission (CQC).  
This was published in January 2014 (Barnes, 2014). Barnes felt that pathology services must be 
visible to patients; accountable to boards and commissioners; reliable, robust, and responsive; 
rewarded when they make improvements in quality, patient safety, and in the contribution they 
16 
 
make to patient experience; held to account when they fail to offer the level of service patients 
expect.  
Barnes noted that there were a number of failings in pathology practices, particularly in relation 
to KAI and demonstrating quality data (Table 1 below).  
Table 1 - Recommendations from Barnes, 2014 
1.7.1 The broad assurance framework has a lack of KAIs to evidence quality and safety 
of pathology services, and to enable effective contract management both within 
organisations and by commissioners. 
1.7.2 Pathology assurance and governance is not consistently embedded in provider 
governance and assurance frameworks. 
1.7.3 Pathology is unable to provide evidence to the Care Quality Commission 
(CQC)/Hospital Inspectorate of the overall quality of pathology services.  
1.7.4 Pathology needs to respond to changing and additional requirements from 
commissioners and the public for information and assurance around consistency 
of provision and reporting.  
1.7.5 The impact of new technology and processes (genomics, point of care testing 
(POCT), digitalisation, molecular techniques, informatics) on delivering pathology 
services, and the impact on a rapidly changing workforce, require a strengthened 
quality assurance framework.  
1.7.6 There is too much variation between pathology services, and a lack of 
harmonisation and standards, which is unacceptable to patients and users. 
1.7.7 The current system was fit for the purpose for which it was designed, but it is not 
fit for the future, nor does it meet the emerging requirement for transparency 
and well-evidenced quality assurance. Therefore, the Review and the 
recommendations it makes will attempt to bring these features of the system into 
sharper focus, strengthening existing structures to ensure these gaps are filled. 
 
One of the recommendations made by Barnes is: 
“Further consideration must be given to the ways in which individual performance can be 
assessed, monitored and competence-assured. The National Medical Director will ask the 
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professional bodies, led by RCPath, to review these issues and report back within twelve months 
on their findings.” 
This clearly echoes the comments made in the Sherwood Forest investigation (RCPath, 2013), 
showing that these calls for individualised quality data are growing.  
The RCPath, IBMS and Association of Clinical Biochemists (ACB) welcomed the publication of the 
report (Jayaram, 2014). They acknowledge that the report presents an opportunity for 
professionals in pathology to form a rationally based quality system. This work attempts to 
address some of the gaps identified by Barnes, by identifying KAIs / KPIs, demonstrating their 
evidence base, and investigating how poor performance or change in expectation can be 
addressed.  
Foy et al. (2002) discuss how to best implement changes in professional practice. They 
performed an audit and regression analysis of the work done in the Gynaecology Audit Project 
in Scotland, and categorised the existing recommendations as having any of the following 
features: 
 Addresses common issue 
 Precisely described 
 Compatible with values  
 Key feature to a set of wider recommendations  
 Based upon sound evidence 
 Fits patient expectations 
 Observable benefits 
 Requires organizational change 
 Requires changed routines 
 High profile 
 Complex 
 Trialable 
They assessed the degree to which each recommendation possessed each of these features, and 
the degree to which each recommendation was being followed. They then looked at the 
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correlation between these and noted that there were four features that most correlated with 
change. Two showed a positive correlation and two showed a negative correlation. Those 
recommendations compatible with the views and values already held by practitioners relating 
to the performance of their duties and those recommendations that were termed “key 
features”, which is to say they formed part of a larger set of recommendations key to wider 
goals were seen to show a positive correlation to recommendation uptake. A negative 
correlation was seen to those recommendations that required organisational change or a 
change in routine. Foy also noted that although only 3% of recommendations could be classified 
as being trialable, that is, they could be adopted as a temporary measure and discarded if 
needed, these showed a higher level of uptake.  
As a change in guidelines is likely to involve change in routine practice, and may well relate to 
practices where there is some disagreement over what is appropriate practice, this presents 
something of an obstacle to change. Since Foy noted measures that could be adopted on a 
temporary basis showed a greater and more sustained uptake, this is something that has been 
considered in the development of this study.  
From this we can see that simply publishing new guidelines and expecting everyone to pick up 
on these and change practice is not an effective method, which may come as no surprise. As 
with other findings reported above, concordance was higher when the reasons behind the 
changes were explained, something which the paper by Pronovost (2006) (discussed extensively 
in the change management section) also commented on. Foy et al. (2002) found that 
disseminating new guidelines resulted in very little change in behaviour, the greatest change 
was reported after interactive implementation strategies, whereby steps were taken to engage 
practitioners in the guidelines, explaining the benefits to the changes. This tallies with the results 
reported by Ho et al. (2010) which are discussed in detail below, in the section on change 
management. Briefly, Ho et al. (2010) looked at episiotomy procedures, concluding that many 
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unnecessary interventions were being made. They worked with a number of practitioners, 
explaining the research and the evidence for the recommendations, this enabled the 
practitioners to form their own opinion regarding the evidence and the recommendations, 
rather than simply responding to instruction, or ignoring the guidelines. This enabled the 
practitioners to preserve their autonomy and develop their knowledge and skills in light of new 
evidence. Ho et al. combined this with recommendations that could be adopted on a trial basis, 
as with the conclusions from Foy (2010), this showed the greatest change in practice. These 
papers have been considered in relation to the work currently being undertaken, whereby the 
training interventions are to involve as many people as possible, and are to be guided, 
interactive and initiated on a trial basis. This is considered in more depth later in the literature 
review, under the heading of “Change Management” on page 33.  
Key Performance Indicators 
The process of dissection is by its nature a destructive one, therefore, it is not possible to revisit 
the specimen and assess the adequacy of examination with complete certainty. Some review of 
cases after dissection is recommended as part of the training process. However, this is labour 
intensive, time consuming, and as the specimen has been dissected and partially sampled, such 
a review is of an altered state. The scenario has many parallels with surgery. It is clearly not 
feasible to re-open an apparently well patient to examine the quality of the surgery they have 
received, but some form of quality review is necessary. There is abundant evidence to show how 
standards slip in the absence of such monitoring, the Francis Report (Francis, 2013) being one 
of the more recent high profile examples; the Kennedy Report in 2001 shows that this is not a 
modern problem and the Barnes Report (2014) demonstrates clearly how such standards can 
be monitored. Francis and Kennedy both detail serious examples of substandard practice and 
care. In both cases, appropriate oversight and monitoring was missing. In the case of Francis, 
the Mid Staffordshire Trust had a great many targets to meet, but a lack of appropriate 
standards and monitoring led to the scandalous situation that arose. Barnes (2014) responded 
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to the findings of the Francis and Sherwood Forrest reports, examining in great depth the quality 
assurance (QA) processes in pathology. He concludes that QA has worked well up to now, but in 
the expanded and more complex role pathology plays, QA in pathology needs to be 
fundamentally re-assessed as it is no longer fit for purpose. This is discussed in more depth later, 
however, one of the recommendations he makes is developing Key Performance Indicators 
(KPIs).  
The use and importance of KPIs in a medical setting is well demonstrated by the reports of 
surgical site infections (SSIs). Public Health England (2014) reports on the number of SSIs in 
English NHS hospitals (2013/2014). This is one of the KPIs used by Care Commissioning Groups 
(CCGs) when determining which trust to award contracts to. NHS England have recently 
determined that mortality statistics for NHS surgery should be published on-line 
(nhs.uk/consultantdata), adding to the pool of performance data available. Bridgewater et al. 
(2007) looked at over 25,000 patients undergoing first time cardiac surgery, between 1997 and 
2005. He reported how the recent introduction of the publication of surgical outcome reports 
has reduced both the observed and risk adjusted mortality rates. The ratio between the 
observed mortality and expected mortality before and after the public disclosure of outcome 
data was 0.71 and 0.53 respectively (p<0.05). Hannan et al. (2012) noted a drop in the risk 
adjusted mortality following cardiac surgery of 41% (from 4.17% in 1989 to 2.45%) in New York 
in 1992. The Hannan study examined over 57,000 patients undergoing surgery between 1989 
and 1992, when New York State began to collate, compile and disseminate quality data relating 
to the risk factors, mortality, and complications of this type of surgery. There is much research 
into the use of KPIs within surgery, one area where this bridges into pathology is the use of a 
scoring system for total mesorectal excisions (TMEs). When a TME is submitted for 
histopathology the quality of the surgical specimen is assessed by the dissector and given a 
numerical score (Williams, 2007). This score reflects the quality of the surgery performed and is 
an important prognostic indicator (Quirke, 2009). Furthermore, Quirke discovered that giving 
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feedback on these scores to the surgeons led to an improvement in the quality of the submitted 
specimen during the period of their study. 
KPIs are not, of course, unique to healthcare, Gonzalez-Gil (2014) details the use of KPI in 
managing the energy use of a railway system, and Cai (2009) discussed their use in improving 
supply chain management. The unifying principle of KPIs and the inherent benefit of their 
incorporation into practice is that they are based on the best available evidence, and are 
amended in the light of new research. Here we identify KPIs relating to histological dissection 
and demonstrate how they can be used to demonstrate quality, how to improve quality and 
how to monitor quality. 
Standardisation of Dissection 
Duthie et al. (2004) introduced BMS led dissection in their lab in 1999, and wished to assess the 
quantitative and qualitative effects of this. They examined 672 specimens dissected by six 
consultants and 660 specimens dissected by two BMS. The specimens were limited to those in 
category B (Appendix Two – IBMS & RCPath Dissection Categories, page 204), they indicated 
that they found a higher concordance with Standard Operating Procedure (SOP) by BMS than 
pathologists. The authors noted that an increased number of blocks and levels was seen in BMS 
dissected specimens, but determined that the additional work of the increased number of blocks 
was more than offset by the time saved by pathologists. Whilst no investigation into the costs 
associated with this were performed, it is probable that a cost saving was made, as BMS time is 
substantially cheaper than pathologist time. Duthie et al, concluded that the quality of 
dissection performed by BMS was not reduced when compared with pathologists, suggesting 
this is potentially an area for further investigation, which would allow an evidence based 
approach to staff structuring and budgeting in this area. Additionally, the authors reported an 
increase in lymph node yield when dissection was performed by BMS when compared to the 
pathologists. This finding was supported by Shaw et al. (2008), showing BMS (median 15, range 
22 
 
12–20) identified more lymph nodes than consultant pathologists (median 10, range 7–13), 
confirming the findings of Thomas (2006).  
When considering the differences between BMS led dissection and pathologist led dissection 
one must be aware of the different training backgrounds. Pathologists are medically trained, 
whilst BMSs have followed a scientific pathway, which clearly leads to a very different sphere of 
knowledge. Simmons (2011) investigated attitudes to BMS led dissection, they surveyed over 
1300 consultant histopathologists, 25% of respondents expressed concern at the potential lack 
of knowledge and increased supervision required by the BMS. One of the concerns held by 
consultant pathologists, reported by Simmons was whether the BMS is aware of important and 
unusual clinical features, and when specimens might be best dealt with by a non-standard 
approach. This is a judicious concern, Chandra et al. (2010) published a review of best practice 
in bladder pathology specimens; they indicate the importance of being aware of the significant 
aspects of clinical information and the previous history.  However, this is specifically addressed 
in the IBMS document (2005) relating to good practice in dissection – they explicitly recommend 
that BMS dissectors should seek advice on unusual or complex cases. The IBMS good practice 
document should be read in conjunction with the protocols recommended in the RCPath 
minimum datasets and tissue pathways (RCPath, 2014a; RCPath, 2009). These are evidence 
based, Flemming & Griffiths (2005) detail in their best practice article much of the reasoning 
behind the protocols and minimum dataset points. Whilst this is essential information, the 
knowledge, awareness and comprehension of these points is not monitored in either BMS or 
pathologists once they have passed their exams as currently there is no requirement for a 
periodic or on-going skills test or CPD in dissection. 
When considering specimen dissection and the guidance available, Ludeman & Shepherd (2006) 
provide an excellent treatise on the macroscopic assessment of colorectal specimens. Perhaps 
unsurprisingly, they make no mention of competency assessment either as a gateway to practice 
23 
 
or of an ongoing nature. The paper is an excellent reference indicating how various colorectal 
resection specimens should be handled according to current state, although they make no 
recommendations for further development or how to asses or ensure quality. However, they 
raise an interesting point regarding the RCPath minimum requirements. For example, the 
minimum dataset requires at least 12 lymph nodes to be sampled – they suggest that for some 
dissectors this minimum number becomes a target, this is something which has been echoed 
during personal communication with other pathologists. There is no incentive to obtain more 
than the baseline minimum number of lymph nodes, or indeed to do anything more than meet 
any minimum standard. The authors indicate that despite audits on lymph node numbers 
retrieved, the numbers of retrieved nodes remains low in some centres. Within Shepherd’s 
laboratory there is an informal “leader board” with the number of nodes retrieved and the 
dissector noted, this, they state, has created a culture of ensuring high lymph node counts. 
Ludeman & Shepherd published their paper nine years ago, some eight years after the initial 
RCPath recommendation that a minimum of 12 nodes be obtained (Quirke and Williams, 1998) 
and with no on-going standardised framework to monitor this or to provide training / feedback, 
the authors consider this is unlikely to change. There is extensive evidence and evidence based 
guidance regarding lymph node retrieval, clearly though, the actual approach to lymph node 
retrieval is not meeting this guidance. Verrill (2004) highlighted the importance of sampling 
lymph nodes fully, detailing the prognostic relevance of tumour involvement in lymph nodes. 
Thus ensuring that minimum standards are consistently reached is critical. 
Despite this clear evidence based guidance, Shia et al. (2012) reported that the number of 
hospitals meeting the 12 lymph node minimum standard increased from 15% in 1995/6 to only 
38% in 2004/5. This was amongst hospitals in the USA; Bilimoria et al. (2008) reported that the 
increase was most notable among those hospitals which had been designated as 
“Comprehensive Cancer Centers” by the National Cancer Institute.  The criteria for being 
designated a “Comprehensive Cancer Center” (CCC) include mandatory multidisciplinary team 
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(MDT) meetings, meeting specific designated care standards etc., in such an environment it may 
come as no surprise that these hospitals showed more improvement. There was, however, little 
change reported amongst other hospitals. The CCC designation is made above and beyond the 
standard criteria required for status as a Cancer Centre. This is primarily made on the depth and 
extent of the research performed and the education provided by the institution (NIH, 2012). 
Those with CCC designation have demonstrated an integrated programme of research and 
education; it is perhaps therefore no surprise that they out-perform other centres. The UK 
designation of “Cancer Centre” requires many of the same criteria, e.g. MDT meetings, specific 
care standards, however, there is no requirement for research or any specific requirement for 
what form the on-going education should take. Linking education to continued practice is not 
new (Continuous Professional Development / Continuing Medical Education), and is a 
requirement for practice both as a BMS or pathologist (HPC, 2012; RCPath, 2010). Thus, 
developing and incorporating a structured method for determining how close to best practice 
an individual is working, and providing feedback, would fit within both EQA and CPD/CME. BMS 
are registered and governed by the Health and Care Professions Council (HCPC (previously the 
Health Professions Council, HPC)), who state that registrants must undertake CPD to maintain 
their registration. The IBMS provide a CPD scheme, enabling BMS to meet this requirement. The 
IBMS CPD guide encourages “professional activities with recognisable outcomes and benefits,” 
(IBMS, 2014a) the use of KPIs to demonstrate and maintain quality clearly has recognisable 
outcomes and benefits. Pathologists are licensed and governed by the GMC, who stipulate that 
doctors registered with them must “keep [their] professional knowledge and skills up to date” 
and recommends that CPD is an appropriate way of doing this (GMC, 2012; GMC, 2013), the 
Royal College of Pathologists runs its own CPD scheme, enabling pathologists to meet this 
requirement. The RCPath CPD scheme makes specific note of the need for “maintenance of the 
reputation of the profession and assurance to the public”, along with the recommendations 
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from the Barnes report (detailed later), this clearly highlights a need for KPIs to be collated and 
actioned.   
The literature supporting the notion of standardisation of dissection practise in this thesis is 
presented primarily from the perspective of lymph node sampling as the decision made on the 
number of lymph nodes required by the RCPath is possibly the most evidence based. The notion 
of stipulating a minimum number of lymph nodes began when Scott and Grace (1989) 
demonstrated a method of ensuring all the lymph nodes were recovered and examined. Scott 
and Grace collected data from 103 colorectal carcinoma specimens, traditional dissection 
methods yielded a mean 6.2 nodes whereas further sampling gained a further 12.4 nodes. These 
additional nodes showed tumour positivity in 5% of the cases which were initially reported as 
lymph node negative. Their data showed that when significantly more nodes, and more involved 
nodes, were found for each resection this resulted in upstaging of the tumours in 5% of the 
cases. The data analysis resulted in the recommendation that a minimum of 13 lymph nodes be 
sampled, forming a foundation for the later minimum number (12) given by the RCPath. Kim et 
al. (2007) determined that there was minimal added value to the extensive search for nodes, 
once 12 nodes had been found. Their conclusions suggested taking additional samples if no 
positive nodes were found, but if at least 12 nodes had already been found and at least one was 
positive, no further sampling was required. However, this recommendation of further sampling 
in the absence any positive nodes failed to make it into the RCPath guidelines (Quirke and 
Williams, 1998).  
Therefore, we can see that the recommendations for sampling of lymph nodes is clearly 
evidence based, the standard of a minimum of 12 being based on a wide and rigorously tested 
set of published data. The other standards, relating to TME score, the size of the tumour, 
perforation of tumour, the distance of the tumour to the nearest surgical margin etc. are built 
on a similar foundation, although the RCPath do accept that evidence base is not as extensive 
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(RCPath, 2014a). The numerical data standards (number of lymph nodes) are easily assessed; 
other standards, such as adequacy of tumour sampling, are less easily judged. The distribution 
of tumour staging for different types of tumour is not available in any published format, an 
omission noted in the RCPath minimum dataset (RCPath, 2009). However, some data has been 
obtained in this area though freedom of information (FOI) requests and local data (Figure 1, 
below). This is currently unpublished, but does indicate that there is a broad concordance of 
stage at presentation.  
 
Figure 1 - Graph showing stage of colorectal tumour at presentation (Duke’s staging). 2009 data, from 18 different 
cancer networks – data obtained via Freedom of Information Requests from the North Yorkshire Cancer Network.  
Whilst some variation is apparent, it is evident from the data presented in Figure 1 (above) that 
there is a broad constancy across cancer networks. Some variation in staging would be expected 
nationally, as there is in the incidence of various cancers across England, Wales & Scotland 
(Cancer Research UK, 2012). Using the microscopic staging of the tumour allows another 
possible quality measure, as the accuracy of the diagnosis relies on the quality of the dissection 
(Ludeman & Shepherd, 2006).  Comparison of staging between individual dissectors should 
show broadly similar proportions, as each is working with a similar pool of samples. If any 
individual within a group of dissectors, who are all working with the same pool of samples, shows 
a staging profile that differs from that of their peers, this would demonstrate a variation in 
practice worth investigating.  
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Using a rolling mean of tumour staging of resections begins to provide a dissection practice 
profile. Adding further evidence based data points to this would allow a clearer picture of 
individual practice to be seen. Another measure detailed in the RCPath minimum dataset is the 
frequency of extramural venous invasion; again, no published data is available in regard to this. 
A comparative analysis between individuals would allow some discussion as to quality of 
practice. There are a number of studies which indicate the importance of accurate assessment 
of vascular invasion, and its prognostic significance. Stefansson et al. (2004) examined 237 
endometrial cancers and were able to report that vascular invasion is a strong prognostic factor, 
independent to the stage or grade of the tumour. Westenend et al. (2004) investigated 50 cases 
of breast cancer, they reported that tumour size and vascular invasion were the most important 
prognostic factors. Whilst there is a recommendation that pathologists audit the number of 
cases which they report as showing vascular invasion, there is no suggestion that dissectors 
should do similar. Personal experience and anecdotal evidence shows that poor practice can 
lead to the appearance of vascular invasion; therefore, this is another possible area for 
comparison.  
Building on the clear and extensively published area of lymph node clearance, it should be 
possible to create similar clear guidelines regarding other quality standards for pathological 
dissection noted above. However, as Shia et al. (2012) reviewed the current state of practice 
and guidelines in relation to lymph nodes in colorectal cancer. They noted that whilst the lymph 
node yield showed little variation based on surgeon, there was notable variation based on the 
pathologist; this was echoed by Shaw et al. (2008) who correlated a higher standard of colorectal 
surgery with specialist colorectal surgeons than general surgeons and a higher lymph node yield 
with BMS than pathologists. They note that although the College of American Pathologists 
recommends resampling the resection if less than 12 lymph nodes are found, this seldom 
happens. Bilimoria et al. (2008) examined reports for 156789 colorectal cancer resections across 
the USA. They reported that 60% of hospitals failed to achieve a benchmark of 12 lymph nodes. 
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Shaw (2008) reports that less than 12 lymph nodes were found in 54% of the 1,194 cases they 
examined. Clearly, having guidelines in place does not mean that people will follow them or 
reach the standards detailed in them. There are a number of ways in which poor performance, 
or a change in expectations, can be managed. Mesmer-Magnus and Viswesvaran (2010) detail 
an extensive review of training methodologies, concluding that what they refer to as the “Why?” 
method is a particularly effective method. This methods causes the individual to move their 
attention from the details to the underlying process and back in a fluid manner. They detail a 
method of training primarily aimed at untrained individuals in which the trainee is encouraged 
to ask why certain things are done, or not done, in order to fully understand the process and 
their part in it.  This is certainly something that is targeted to those in training; however, those 
who are already trained, but who take part in on-going training, CPD or reflective learning would 
also stand to benefit.  
When considering the assessment of ongoing competency and performance it is worth 
considering the current state of initial training. The process currently in place for training BMS 
and pathologists in dissection is based entirely on local protocol. In a wider medical context one 
of the strongest assessment tools currently in place is the Objective Structured Clinical 
Examination (OSCE), this is used in several aspects of medical training. Newble (2004) goes in to 
some depth regarding the strengths of this method. The OSCE is becoming increasingly popular 
with time; however, it is used as an assessment during or at the end of training and has not been 
evaluated as an on-going tool. Whilst it could certainly be employed in such a role, the time 
involved in making such an examination would render it likely to be only done infrequently and 
a pronounced “observer effect” might be expected. Beard et al. (2005) indicate how such 
procedures may be used to identify when failings are due to a lack in technical knowledge, but 
note that poor performance on a routine basis would not be identified. Currently no suitable 
tool for on-going assessment / monitoring has been published, a lack that this work goes some 
way to address.  
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West (2005) and Syred (2005) provide an excellent breakdown of some of the problems faced 
by medical trainees in pathology. West published a mini symposium on training in 
histopathology where he discusses the demands placed on trainee histopathologists, and on the 
departments training them. The article by Syred should be read in concert as it is written across 
much the same topic, although from the point of view of the trainee. Many of the same 
problems are now being faced by BMS staff in their histology training; since much of the work 
has already been done, it would be foolish not to take advantage of this. The challenge we now 
face is in convincing an already pressured consultant pathologist workforce to take on a 
structured programme, rather than the ad hoc system currently employed in most places. Cross 
(2005) has written a good exposition on some of the more important qualities and character 
traits one may need as a histopathologist, as a BMS dissector many of the same will apply. His 
work may be very useful when considering how to structure training and feedback. He also 
considers the assessment methods used, some of which may be modified for the BMS role. He 
considers many possible methods of aptitude testing and draws comparisons with other 
professions, most of these comparisons have been made in surgical research literature. He 
considered skills such as manual dexterity, intelligence, visuospatial ability and personality traits, 
concluding that these specific traits, and combinations of traits, showed no specific association 
with performance or aptitude to surgical procedures. This data is gathered from a pool of skilled 
individuals, therefore their skills and aptitude may be considered to be greater than that in the 
general population; his work was considering aptitude testing and noted that there was no 
specific method that was able to accurately identity a particularly high aptitude for surgical skills, 
beyond the baseline demonstrated by the cohort. He determines there are currently no 
appropriate aptitude tests for histology and that the development of these would be of benefit 
to histology. The areas that Cross identifies as important for a practicing histologist are 
knowledge base, report generation, communication, clinical governance, audit, continuing 
professional development, laboratory management and macroscopy. He also states the 
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objective assessment is the “holy grail” of assessment. Cross notes a number of areas where 
performance needs to be assessed (Table 2, below). 
Table 2 - Performance assessment areas (from Cross, 2005) 
Diagnosis by light microscopy Not applicable to BMS, pathologists assessed by review, 
examination and EQA. 
Diagnosis by other modalities This would include macroscopy, specimen dissection, and 
has no form of assessment beyond gateway 
examinations. 
Knowledge base Assessed well by the appropriate pathological 
qualifications for both the BMS and pathologist. 
Report generation and checking These are reviewed by the reporting consultant, and by 
the requesting clinician. For the BMS the report is limited 
to a report of the macroscopic appearance, which may 
show characteristic features giving an indication of the 
diagnosis. 
Communication with colleagues Historically undervalued, but these are now being 
assessed as part of performance reviews in many centres. 
Learning Theory 
When considering performance, performance assessment, performance management and 
training interventions, it is useful to be aware of current learning theory. Torre et al. (2006) cover 
the main learning theories, in a context of medical education. They postulate that different goals 
require different theoretical approaches Within the area of surgical pathology dissection 
training we have three main goals; learning a new skill, developing critical thinking and clinical 
problem solving skills, initiating best practice in a clinical setting. Torre et al. suggest that these 
goals are best met by a behaviourist approach, a cognitive approach and a social learning 
approach, respectively.  
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Behaviourist learning focuses on the satisfactory performance of pre-requisite steps, prior to 
advancing on to subsequent tasks. This requires reinforcement from the teacher / trainer, who 
is central to this process. The learner models the behaviour demonstrated by the teacher, who 
is able to provide assessment of competency. The cognitivist approach uses the teacher to help 
the learner to develop the skills needed to develop their own learning. Enabling the learner to 
develop their knowledge and apply this to what they already know allows for meaningful applied 
learning. This integrates with the work of Mesmer-Magnus and Viswesvaran (2010), discussed 
above. Mesmer-Magnus and Viswesvaran detailed an approach whereby learners were 
encouraged to question why things were, or were not, done in certain ways. This questioning 
and investigation into theory and process clearly fits into a cognitivist model. This critical and 
reflective thinking is crucial to specimen dissection, moving beyond a simple stepwise process 
and applying critical judgement to a specimen is a necessary aspect of training in more complex 
work. The initial training in dissection can easily sit within the behaviourist approach, where 
training follows a pattern of “watch and repeat”. However, moving away from simple specimens 
where the handling is very similar each time, to complex cases which much be closely assessed 
on its own merit, requires the application of clinical judgement, extensive knowledge of 
pathology and surgery. In order for this to be possible the learner must have a much greater 
depth of knowledge and skill base than would be possible with just a behaviourist approach. The 
social learning model seems largely to be an expansion of the behaviourist theory. The 
difference is that with social learning the observation is seen as the key learning feature, without 
a necessary step of repeating what has been observed. The learner is able to reproduce the 
learned behaviour / technique because they have evaluated and gained a cognitive insight into 
what they have observed, and is not merely copying what is highlighted as “good” behaviour. 
However, this does require a baseline of knowledge and practice in order to provide a 
framework in which this knowledge can sit.  
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A fourth area which Torre et al. (2006) discuss is constructivist learning. Constructivist learning 
is facilitated by the educator, who fosters critical reflection and helps to develop meaning from 
experience. The IBMS strongly promotes reflective learning in their dissection portfolios (IBMS, 
2009; IBMS, 2010a; IBMS 2010b) and their CPD scheme (IBMS, 2014b). Colliver (2002) publishes 
what amounts to a wholesale dismissal of constructivism as anything other than a philosophic 
stand point. He concludes that constructivism “offer[s] little of value to medical education”. 
However, Cobb (2002) rebuts all of Colliver’s points, expanding on the meaning and application 
of constructivism and highlights Colliver’s lack of questioning of assumptions. Cobb concludes 
that “constructivism might be of greatest relevance to educators”, this appears to be a more 
widespread opinion. 
Torre et al. (2006; 2007) provide an explanation of how reflective practice may be performed in 
a medical context, in a way which is easily applicable to specimen dissection, and details what 
may be gained from such an approach. They also note that their method of documenting their 
reflective learning leads well into group work. Bennett et al. (2002) provide a review of small 
group teaching, where they note that explaining material to another party is one of the most 
effective means of cognitive elaboration. Their review is comprehensive, covering aspects such 
as the composition of the group in terms of gender and ethnic mix (which appears to make little 
difference) ability (mixed ability shows most improvement for most people) and group size (6 
learners and a facilitator appears to be the optimum number).  
Bennett goes on to consider the practical considerations of group work, being in a circle, 
encouraging participation, supporting those that do not feel comfortable to speak up, ensuring 
a safe space, rewards and the perils of “social loafing”, They note that well-functioning group 
work enable participants to “make overt their private speech”. This enables those operating at 
a lower cognitive level to understand the thought process of those operating at a higher level 
and allow them to apply this model to their own thinking.  
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The research above clearly shows that there are many evidence based standards of practice, 
and that many people are failing to meet these standards. Having identified the veracity of the 
evidence base for and need for these standards, and having identified the failure to meet these 
standards, how do we then address this? The evidence in the area of learning theory provides 
us with an insight into how we might best approach the educational deficits in our practitioners. 
However, what is needed is not just education, there needs to be a change in practice. Creating 
and sustaining a change is a multifactorial process, which comes under the heading of change 
management.  
Change Management  
Change management is an extremely large area, one that forms its own subspecialty within 
project management (Crawford and Nahmias, 2010). We only need look at how much resistance 
there was to Semmelweis and his ideas about infection control (Scholl, 2013; Persson, 2009) to 
see how a badly handled attempt at change can backfire. Semmelweis noted a correlation; the 
knowledge of germ theory, infection and hygiene at that time was insufficient for Semmelweis 
to present a cogent argument behind why hand washing reduced infection. This, coupled with 
his somewhat dictatic style, led to a great deal of resistance. Very few were prepared to even 
try Semmelweis’s idea of washing, this was a greatly wasted opportunity, and many more 
patients went on to die because of this lack of team approach to change. Organisational change 
and shifts in attitude/culture are needed to effect lasting change (Crawford and Nahmias, 2010).  
Ho et al. (2010) examined episiotomy procedures in 11,016 women, with the aim of decreasing 
unnecessary surgery. They described how after concluding their research they realised that a 
change in practice was needed. They go on to explain how they attempted to bring this change 
about and some of the difficulties they encountered. Most of the resistance was related to a 
reluctance to change from their current method, despite evidence to show this was not best 
practice. Being able to demonstrate the evidence to those who they wished to change was 
critical. Demonstrating how they came to their conclusions, discussing the reasons for the 
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suggested change and listening to the concerns of those involved was critical. The most 
successful method of change reported by Ho et al. (2010) was in cases where the staff had been 
part of research projects that investigated the change proposed. Active engagement of staff, 
allowing them to evaluate the evidence were key aspects. This is echoed by the comments made 
around the research of Pronovost (2006) detailed later in the literature review. The training 
intervention which is to follow this literature review will be structured with these concerns in 
mind, drawing on research in medical practice, change management, and behaviour 
management.  
Lim et al. (2012) discuss an interesting study based in the area of mental health workers and 
evidence based practice (EBP). They ran a series of workshops during which they examined a 
number of methods and practices, went through with participants (n=238) whether or not these 
were evidence based and explained the implications of these aspects. The participants were 
found to have a more positive attitude towards EBP at the end of the workshops. With this and 
the preceding paragraph in mind, the proposed method will be developed in conversation and 
negotiation with active staff members. Attempting to impose a quality system on reluctant 
subjects is unlikely to result in long term success.  
Chisholm et al. (2012) investigate why some medical professionals (of varying experience levels) 
are less likely to engage in “behaviour change” discussions with patients. A similar attitude may 
be seen when it comes to behaviour change discussions with colleagues.  The three primary 
reasons were listed as personal challenges, “someone else’s responsibility” and prioritising the 
doctor – patient relationship. The first two clearly apply across a wide range of situations, the 
third is less relevant outside the clinical situation, although parallels may be drawn in prioritising 
professional relationships. Addressing these requires providing the right environment; if people 
feel valued for their work and contribution they are more likely to feel positively in regard to 
personal and professional development. If there are particular interpersonal difficulties 
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regarding communication or addressing performance issues, these should be addressed 
regardless of any training or feedback event, however these issues are frequently pushed aside 
as it is often easier to work around these issues than to address them. Fostering this supportive 
and collaborative environment will go a long way towards addressing these issues.  
There are key lessons to be learnt from Chisholm, if we are to engage in changing attitudes and 
behaviours. The most important thing she reports is that people are more likely to engage in 
such discussion if they have had some form of formal training in the theory behind behaviour 
change techniques. Drawing on this may help with the current work, finding key personnel and 
enabling them to undergo such training could help with engagement and dissemination of 
findings and recommendations.  If we are able to demonstrate a robust quality monitoring and 
feedback system, we shall be reliant on others to deliver it elsewhere. As such, we must also 
provide some form of instruction on how to implement these changes.  
One intervention making use of KPIs and dealing with behaviour change demonstrated startling 
effectiveness. Pronovost et al. (2006) set out to determine whether central line related blood 
stream infections in Intensive Care Units (ICU) could be reduced. They developed a Team 
Checklist, centred on five evidence based infection control procedures. This was a multicentre 
trial, where hospital participation was optional. When a hospital opted in, the use of the 
checklist within the ICU was mandatory for all staff involved in the placing of central lines. A 
number of training and educational interventions were planned, training staff in the science of 
the safety measures. If the individual placing the central line was not following the approved 
procedure, any team member was authorised to stop the procedure (in non-emergency 
situations). 
The removal of lines was discussed at daily rounds, the number and rates of infections were 
regularly reported back to the team. The final version of which contained 20 items and is 
36 
 
credited with a reduction in the rate of catheter-related bloodstream infection of up 66% 
sustained over the course of the 18 month study.  
Checklists have been widely used in safety critical environments, notably aviation – the first 
published instance being in Life magazine (Anon, 1942). Since then there have been a number 
of attempts to bring checklists as a safety feature into the realm of healthcare. These continue 
to the current day, Ornato and Peberdy (2014) note the need for healthcare practitioners to 
respond in a consistent, high quality manner. Whilst they are talking in relation to emergency 
situations, this is clearly relatable to routine practice. They note the 2000 fold reduction in 
fatalities per million flight miles since 1929, and attribute this to the insistence on standardised 
procedures regardless of who is on the team. Kao and Thomas (2008) also strive to apply lessons 
from aviation into healthcare, specifically surgery. They note an intervention that reduced the 
incidence of wrong site surgery to 0, they also refer to a number of studies that state such 
interventions improve the safety climate and clinical outcomes. Pugel (2015) notes the number 
of errors in the operating room, and relates that communication errors are a common form of 
error. Dhingra (2010) backs this up, stating that 70% of serious events reported by the Joint 
Commission are due to communication errors. Pugel (2015) also discusses some of the 
drawbacks to checklists. Pugel notes that previous safety checks may be dropped and that the 
checklist can interrupt the performance of other safety tasks. She also states that without a firm 
commitment to the checklist it may become a routine activity of checking off boxes without 
actually driving behaviour change or improvement and that checklists may give staff a false 
sense of security that issues have truly been resolved when in fact they have not 
However, they note that the checklist is in fact part of a much larger intervention. They 
characterise the checklist as the scaffolding on which teamwork and attitudes can be improved 
and managed. This is something that is often overlooked. One extremely powerful intervention 
was that mentioned above by Provonost et al. (2006). The ten-day line-infection rate went from 
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11% to zero. The reporting around this focused extensively on the checklist (Gawande, 2007; 
Lawrence, 2009; Seifert, 2009; Kingsbury, 2008). Whilst each of these reports makes some effort 
to explain the intervention around the checklist, it is clear that the checklist is given centre stage. 
This was noted by the authors, who published an update, giving greater emphasis on the 
surrounding parts of the intervention (Bosk et al., 2009).  
Whilst the checklist was not the only factor in the intervention detailed by Pronovost et al., it is 
the central point around which the other factors revolve. Checklists have received considerable 
interest in medicine since their paper. After discussing the applications of aviation lessons to 
surgery, Kao and Thomas (2008) go on to discuss some of the differences. They note that when 
compared to pilots, surgeons tended to downplay the effect of stress and fatigue on decision 
making. Senior surgeons tended to prefer a rigid hierarchical structure, where junior members 
of the team do as instructed without question. Ornato and Peberdy (2013) support this 
conclusion, highlighting a difference in attitude between pilots and surgeons. They note that 
pilots recognise that permission to fly is a privilege, not a right and that this permission can be 
easily withdrawn. They also note that with pilots their own lives and safety are dependent upon 
the function of the team, whereas in surgery the only life at risk is likely to be that of the patient 
and the surgeon will take the majority of responsibility for the success, or not, of the surgery.  
Sexton et al. (2000) reported that out of consultant surgeons, consultant anaesthetists and pilots 
there was a wide difference in who would acknowledge the effect of fatigue on performance 
(30%, 53% and 74%, respectively). Additionally, only 55% of consultant surgeons recommended 
a flat hierarchy in contrast to 94% of cockpit staff. Kao and Thomas (2008) suggest that 
approximately 25% of errors may not be admitted in morbidity and mortality. 
Further investigating the attitude of surgeons, particularly in relation to checklists, Bosk et al. 
(2009) state that some feel that the checklists undermine their claims to expertise, are 
infantilising and impede their decision making. There is a clear difference here between the 
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attitude of the pilots, who accept the need to satisfy requirements to prove their competence 
whereas many of the surgeons resent and resist attempts to introduce similar requirements. 
Within the Keystone intervention reported by Pronovost et al. (2006) and further expounded 
upon by Bosk et al. (2009), there was a large social aspect to the intervention, with the 
implementation phase lasting 9 months. Additionally, a member of the senior executive within 
each hospital had to agree to work with their ICU; a senior physician and senior nurse were also 
identified, along with team leaders who were tasked with explaining the principles of safety, the 
specifics of the investigation and the evidence base. The explanation of the evidence base is 
something that Ho et al. (2010) identified as a key factor in driving behaviour change. 
Clearly this was an investigation far greater in scope than the introduction of a checklist, indeed 
it was not one single checklist. There were in fact over 100 different checklists. Each ICU was 
encouraged to take the template checklist and adapt it according to their own needs, but 
keeping within the needs of the investigation and the demands of the evidence (Bosk et al., 
2009).  
There is an extensive body of evidence indicating the rationale behind the practices undertaken 
in diagnostic pathology, there is also a large body of evidence indicating the need for and 
importance of EQA. This review establishes both the need and the basis for a quality system, 
which would ideally integrate with the training programme for Biomedical Scientists and 
Pathologists involved in specimen dissection. It may be hoped that validation of such a scheme 
in one area might form the basis for further work within Histopathology and the wider Pathology 
field as is clearly needed.  
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Chapter Two – Study 1 – Review of Recent Practice 
 
 
 
 
  
Study 2 – The Training Intervention  
Part One – The creation of the checklists and collecting baseline data 
Part Two – Checklist Introduction (BMS N=5, Pathologist, N=7) 
Part Three – Training Event and Checklists (BMS N=5, Pathologist, N=7) 
Part Four – Training Event only (BMS N=5, Pathologist, N=7) 
Part Five – Guide Diagrams (BMS N=5, Pathologist, N=7) 
Part Six – Training Event and Guide Diagrams (BMS N=5, Pathologist, N=5) 
Part Seven – Checklists only ((BMS N=5, Pathologist, N=0) 
Part Eight – Training Event and Checklists (BMS N=6, Pathologist, N=8) 
Study 1 – Archival Review 
100 appendix, 100 gallbladder, 100 colon, 100 uterus reports reviewed 
Unknown number of participants 
Study 3 – Participant Interviews 
The dissectors were interviewed 
BMS n=6, Pathologist n=4 
 
40 
 
Introduction 
In order to investigate the level of variation in practice within the Royal Derby Hospital 
Histopathology Department, a retrospective review of practice was undertaken. A number of 
points were addressed, noted below in the procedure section, and these were completed 
against authorised reports from the preceding year.  
This allowed a picture to form, regarding how frequently different features were noted or 
criteria met, at this stage only BMS or pathologist was noted, to investigate any differences 
between the two groups. The aim at this initial point was to explore the possibility of identifying 
data in the reports that could be mapped to good or bad practice. The Royal College of 
Pathologists minimum dataset and tissue pathway documents, along with the dissection SOPs 
in the department were reviewed, in order to identify the important points that ought to be 
mentioned in the description. Also, a number of macroscopic features of pathological conditions 
were considered. This was to enable some measurement of how frequently individuals were 
identifying these features, with the idea that this might enable some assessment of how 
accurate the description was.  
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Method  
Design 
An audit into the dissection processes performed in 2009 – 2010 was performed.  
Participants 
Individual participants were not personally identified at this stage, however, there were 18 
practicing dissectors at this time (10 pathologists and 8 BMS). As the individual reports were 
examined, the dissector of that specimen was noted as either BMS or pathologist only.  
Materials 
Four data collection sheets were created (  
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Appendix Three – Baseline Data Collection Sheets, page 206), to capture data specific to the 
specimen type being considered. The specimens examined were appendix, gallbladder, uterus 
and colon. These were chosen as they represent an increasing level of complexity, whilst being 
within the scope of BMS dissection. Appendix and gallbladder are relatively straightforward 
specimens, with a limited range of presentations. The uterus and colon are of varying complexity 
and have a wide range of presentations, making dissection a more complex and multilevel 
activity.  
Procedure 
Ethical approval was granted by the University of the West of England Ethics Committee 
(UWEEC). The National Research Ethics Committee (NRES) determined that this investigation 
did not require ethical approval under their scheme. The Derby Teaching Hospitals NHS 
Foundation Trust (formerly the Derby Hospitals Foundation Trust) were satisfied with the ethical 
approval granted by UWEEC and the statement from NRES and gave their approval for this 
investigation to proceed, having registered the investigation with the trust R&D department. 
This covered study 1 and 2; study 3 required separate approval which is detailed in Chapter 4.  
The pathology Laboratory Information Management System (LIMS) archive was searched, 
identifying 100 appendix, gallbladder, uterus and colon specimens from 2009 – 2010. The 
pathology report for each was checked against the data collection sheet and the sheets were 
structured as follows. 
 All specimens 
 Time from receipt to dissection (working days) 
 Need for extra investigations (e.g. levels, Immunocytochemistry) 
 The status of dissector (e.g. Pathologist or BMS) 
 The number of blocks 
 Pathological staging under the TNM classification (for cancer cases) 
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 The need for and number of extra blocks 
 A record of any errors in the macroscopic description 
 Whether the manner of dissection and macroscopic description allows the 
minimum dataset to be completed. 
 If there is agreement between the macroscopic description and the microscopic 
report. 
Additionally, the macroscopic description was reviewed and more specific data was logged for 
each specimen type. These data points are all mandated by the Standard Operating Procedure 
(SOP), some are specifically required by the relevant minimum dataset. As such, if a feature is 
present it should be recorded; there is no requirement to record the absence of such features. 
The criteria marked in bold should return at 100% for all cases, as this mandatory information 
required by the SOP for that specimen. There is no expectation that the other criteria should 
return a specific value, simply that as all the dissectors are drawing their specimens from the 
same pool, theoretically working in the same manner, a similar value should be seen for each 
criteria for each group.  
 Appendix 
o Length 
o Diameter  
o Serosa, exudate, perforation, mucin, fibrosis, faecolith, pus 
o Appearance suggestive of carcinoid / neuroendocrine tumour 
o Normal / unremarkable appendix 
 Gall Bladder 
o Length x width x breadth (or diameter) 
o Whether the specimen was received open or unopened 
o Serosal surface, the contents of the lumen, the presence or absence of 
choleliths (gall stones) and their type, the presence of an exudate, the presence 
of a perforation 
o Fibrosis, mucin, the thickness of the gall bladder wall, mucosal polyps, mucosal 
cholesterolosis, empyema, Rokitansky-Aschoff sinuses, cystic duct lymph node, 
the mucosa 
o Any suspicion of a more serious underlying pathology 
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 Hysterectomies 
o The presence of fibroids, the appearance of the serosal surface 
o The thickness of the endometrium 
o The appearance of the myometrium 
o The presence of adenomyosis, the presence of endometriosis 
 Colorectal 
o Full measurements 
o Background mucosa described 
o Polyps, diverticulae, ulceration, fissuring, loss of mucosal fold pattern 
o Thickening / thinning of wall, oedema, congestion, exudate, perforation 
A sample of the data sheets were reviewed by an independent third party to check for accuracy. 
The data was transcribed on to an excel workbook, and the sheets shredded. Confidentially and 
data protection was maintained by following NHS Information Security Policy (NHS England, 
2014a). All electronic records were kept within the NHS computer system within a password 
protected system, any paper copies were kept within a locked cabinet within a locked office, 
prior to shredding. No identifying characteristics for either staff or patients were carried over on 
to the data collection form, only a record of BMS or pathologist was made.  
Results 
The tables below show differences in practice between the two groups, whilst the true value for 
any category is not known, it is reasonable to suppose that both groups of dissectors are likely 
to encounter the same range of specimens, with the same pathological distribution, and 
therefore ought to return similar values for each category. Certainly each of the criteria marked 
in bold above ought to the noted at 100% for each group. For example, the RCPath tissue 
pathway for Gastrointestinal pathology (RCPath, 2009) indicates that the length and diameter 
of the appendix should be stated, also that the external surface, cut surface and luminal contents 
should be described. As the laboratory SOPs are based on the guidance from the college, and 
the dissection training is based on the SOPs, all of these things should be described, where 
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present. Therefore the criteria in bold should be at 100% for both groups, and the other criteria 
should be at a similar level for both groups.  
As was noted extensively in the literature review, variation in practice reflects poor patient 
outcomes (ACOG, 2012; Dhingra, 2010; Coombs, 2009; Ferran, 2008). As such, methods of 
identifying this variation, assessing the root cause, and providing an opportunity to reduce this 
variation, must be developed. This initial review provides an opportunity to assess practice and 
identify what, if any, variation is occurring. 
t – test  
The results were analysed with a t-test. As the data is in matched sets, each of the variables 
applying to both groups, the two columns were paired and a t-test run to consider the 
differences. As it is the differences in practice between each group, for each variable that is 
important, the standard deviation between the variables is calculated and this is used for the t-
test. As these are small data pools, using the small areas of change are powerful, as such it would 
be unwise to make too many firm conclusions from the initial exploration, however, this basic 
statistical assessment allows for some initial impressions to be formed. Using a 95% confidence 
interval to assess significance, the results are then discussed below each table.  
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Table 3 - Recent practice in appendix dissection 
 BMS 
(n=61) 
Pathologist 
(N=39) 
% 
difference 
Time from receipt to dissection (working days, 
mean) 
0 0 0 
Need for extra investigations (e.g. levels, ICC) 0% 0% 0 
The number of blocks (mean) 1 1 0 
The need for and number of extra blocks 8.2% 5% -3.2 
A record of any errors in the macroscopic 
description 
0 0 0 
Whether the manner of dissection and macroscopic 
description allows the minimum dataset to be 
completed. 
NA NA 0 
Whether the following are described in the macro:    
Length 100% 100% 0 
Diameter 91.5% 69.0% -22.5 
Serosa 59.1% 51.7% -7.4 
Exudate 30.9% 13.8% -17.1 
Perforation 12.7% 6.9% -5.8 
Mucin 0% 0% 0 
Fibrosis 1.4% 3.4% +2 
Appearance suggestive of malignancy 0% 0% 0 
Faecolith 4.2% 10.3% +6.1 
Pus 1.4% 0% -1.4 
Diverticula 1.4% 3.4% +2 
Normal / unremarkable appendix 9.9% 34.5% +24.6 
If there is agreement between the 
macroscopic description and the 
microscopic report. 
100% 100% 0 
t = 0.579, df =17, p = 0.012  
 
Whilst it would be unwise to place too much significance on data from such a limited pool, the 
data above does demonstrate noticeable variation between BMS and pathologists. Several 
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discrepancies are identified, most notable are the discrepancies regarding the description of the 
appendix as normal and the provision of the measurement of the diameter. These will be 
considered in the discussion section 
As all data is pulled from the same pool, a paired two tailed t-test is most appropriate. 
Performing a paired two tailed t-test shows a statistically significant difference in the % 
differences between the two groups (p=<0.05) overall. There is a clear difference in some areas 
of practice, which indicates that this is an area requiring further investigation. Whilst the 
dissectors are human, and humans are individuals, these simple straightforward specimens 
ought to be handled in a near identical fashion. The fact that so much low level variation is noted 
is a cause for concern, and certainly makes the case for further work.  
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Table 4 - Recent practice in gallbladder dissection 
 BMS 
(n=69) 
Pathologist 
(N=31) 
% 
difference 
Time from receipt to dissection (working days, mean) 0 0 0 
Need for extra investigations (e.g. levels, ICC) 1.4% 0% 1.4 
The number of blocks (mean) 1 1 1 
The need for and number of extra blocks 0% 3.2% -3.2 
A record of any errors in the macroscopic description 0 0 0 
Whether the manner of dissection and macroscopic 
description allows the minimum dataset to be 
completed. 
NA NA  
Whether the following are described in the macro:    
Length 100% 100% 0 
Width 98.5% 80.6% 17.9 
Depth 56.5% 29.0% 27.5 
Received open / unopened 29.4% 19.4% 10 
Serosal surface 14.7% 3.2% 11.5 
Luminal contents 94.1% 87.0% 7.1 
Presence or absence of stones 97.1% 93.5% 3.6 
Type of stones (if present) 5.1% 0% 5.1 
Exudate 0% 0% 0 
Perforation / incision 7.4% 3.2% 4.2 
Fibrosis 4.4% 0% 4.4 
Mucin 2.9% 0% 2.9 
Wall thickness 100% 12.9% 87.1 
Polyps 2.9% 0% 2.9 
Appearance suggestive of cholesterolosis  13% 9.7% 3.3 
Empyema 0% 0% 0 
Rokitansky-Aschoff sinuses 0% 0% 0 
Cystic duct lymph node 3.1% 0% 3.1 
Suspicious of malignancy 0% 0% 0 
Mucosa 97.1% 25.8% 71.3 
If there is agreement between the macroscopic 
description and the microscopic report. 
100% 100% 0 
t = 0.026, df=25, p = 0.021  
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As with the data from the appendix, this is a small pool. However, two large discrepancies are 
seen; the mucosal appearance and the wall thickness show a very large disparity. This will be 
further considered in the discussion section. A significant difference is noted in overall practice, 
as are several substantial individual differences, provision of a description of the mucosa being 
the more notable (97.1% vs 25.8%).  
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Table 5 - Recent practice in colon dissection 
 BMS 
(n=46) 
Pathologist 
(n=54) 
% 
difference 
Time from receipt to dissection (working days, mean) 1 2 -100 
Need for extra investigations (e.g. levels, ICC) 1% 1.5% -0.5 
The number of blocks 18 18 0 
Pathological T staging under the TNM classification 2.81 2.7 0.11 
The number of lymph nodes recovered 16.1 9.5 170 
The incidence of requests for extra blocks 3 1 300 
A record of any errors in the macroscopic description 0 0 0 
Whether the manner of dissection and macroscopic 
description allows the minimum dataset to be 
completed. 
100% 100% 0 
Whether the following are described in the macro: 
   
Full measurements  37.5% 27.0% 10.5 
Background mucosa 46.3% 30.4% -15.9 
Polyps 8.7% 7.4% 1.3 
Diverticula  15.2% 20.4% -5.2 
Ulceration 4.3% 22.2% -17.9 
Fissuring  4.3% 1.9% 2.4 
Loss of fold pattern 4.3% 13.0% -8.7 
Thickening / thinning of wall 6.5% 11.1% -4.6 
Oedema  2.2% 13.0% -10.8 
Perforation 0% 7.4% -7.4 
Serosal puckering 0% 9.3% -9.3 
Exudate 2.2% 5.6% -3.4 
Agreement between the macroscopic description and 
the microscopic report 100% 100% 0 
t = 0.327, df = 20, p = 0.116 
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The review of the colorectal specimens shows conformity between BMS and pathologists in all 
areas, with the exception of lymph node yield. As previous studies have already demonstrated 
a higher lymph node yield with BMS dissection, this does not come as a surprise. The majority 
of the items in Table 5 on page 50) relates directly to the visual macroscopic features or 
numerical data (number of lymph nodes, number of blocks); however, one feature of the 
microscopic report is also correlated here – the T stage of the TMN classification. This has been 
done to assess distribution of mean staging. Acting on the premise that all dissectors are taking 
specimens from the same pool, they can be expected to encounter a similar distributions of 
tumours at different stages. Therefore, if sampling is being performed adequately and 
appropriately, the mean T stage for each group (BMS and pathologist) would be expected to be 
similar. A further development might be to plot out the individual TNM profile for each dissector, 
and compare the rolling plot for each dissector. A dissector with a persistently low N score may 
correlate with a low lymph node yield, or one with a high T score might correlate with poor 
dissection technique causing carryover or may be performing more through or more accurate 
sampling than others.  
More interesting than the differences, however, are the similarities. A number of discrepancies 
are noted in the comparison of macroscopic description, however, no notable discrepancies are 
seen between the BMS cases and pathologist cases. Although the average BMS lymph node yield 
is 170% that of the pathologists.  
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Table 6 - Recent practice in uterus dissection 
 BMS 
(n=86) 
Pathologist 
(n=14) 
% 
difference 
Time from receipt to dissection (working days, mean) 1 2 -100 
Need for extra investigations (e.g. levels, ICC) 1% 0 1 
The number of blocks 9 9 0 
The need for and number of extra blocks 2% 0 2 
A record of any errors in the macroscopic description 0 0 0 
Whether the manner of dissection and macroscopic 
description allows the minimum dataset to be 
completed. 
100% 100% 0 
Whether the following are described in the macro:    
The presence of fibroids 39.5% 33.3% 6.2 
The appearance of the serosal surface 8.1% 7.7% 0.4 
The thickness of the endometrium 85.1% 66.6% 18.5 
The appearance of the myometrium 95.3% 93.3% 2 
The presence of adenomyosis 22.1% 6.6% 15.5 
The presence of endometriosis 0% 0% 0 
If there is agreement between the macroscopic 
description and the microscopic report. 
100% 100% 0 
t = 0.310, df = 12, p = 0.034  
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Review of the hysterectomy specimens does show a number of discrepancies. The need for extra 
investigations and extra blocks was minimally increased for cases dissected by BMS. This was an 
extremly small increase and has a minimal impact in terms of additional work performed. This 
correlates with the work published by Duthie, 2004; they performed an examination in to the 
quality of impact of BMS dissection. They noted that a larger proportion of cases required extra 
blocks and levels when the dissection was performed by BMS than by consultant pathologists. 
They highlighted other studies with lower rates of additional sampling, and suggested that their 
higher rates may be as they were comparing BMS early in dissection training with experienced 
consultant pathologists. They suggest that their resampling rates may fall with time, as their 
BMS become more experienced. This could well account for the lower rates seen in this study, 
as although there is a mix of experienced and more inexperienced BMS dissectors, it would 
appear that the BMS dissectors at Derby at the stage of this study were more experienced than 
those that Duthie assessed, at the time of publication. The larger discrepancies were in the area 
of endometrial thickness (18.5% lower) and the presence of adenomyosis (15.5% lower); in both 
cases the provision of data was far lower by pathologists than by BMS; supported by the t-test 
result.  
Discussion 
The review of the completed reports enabled an overview of dissection practice to be formed, 
and how quality measures might be introduced could be considered. As each of the dissectors 
is randomly drawing their work from the same sample pool, it is reasonable to suppose that they 
are each likely to encounter a similar range and distribution of pathologies. In this study a 
number of discrepancies have been identified. The pathologists described the appendix as 
“normal” or “unremarkable” in 34.5% of cases, in comparison to the BMS who stated this in 
9.9% of cases. Whilst it is not particularly uncommon to encounter a macroscopically 
unremarkable appendix at dissection, it is unlikely that the BMS and pathologists would 
encounter them with such differing frequencies. Either the BMS are overcalling normal 
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appendix, failing to recognise the normal appearance; or the pathologists are failing to recognise 
abnormal macroscopic appearances.  Or both of these things may be happening, either way, 
identifying this variation allows the discrepancy to be investigated and for a more accurate 
description. Another area of variation for the appendix is in stating the diameter of the organ. 
Clearly there is a difference between an appendix which is 75 mm in length and 5 mm in 
diameter and one which is 75 mm in length and 25 mm in diameter. The diameter is a 
measurement called for by the RCPath tissue pathway, and there is no good reason for not 
including it. The data for study one indicates that the BMS recorded this measurement in 91.5% 
of cases, whilst the pathologists only in 69% of cases. Similarly, in the gallbladder data the 
mucosa of the gallbladder was described in 97.1% of cases by the BMS, but only in 25.8% of 
cases by the pathologist. It is possible that some cholecystectomy specimens may lack visible 
mucosa, although a statement to the effect ought to be made in the macroscopic description. 
There is, then, no accounting for those cases where there is no comment in relation to the 
mucosa. The gallbladder mucosa may show features of cholesterolosis, polyps (either 
cholesterol or adenomatous) or features indicating a more severe pathology such as dysplasia; 
or they may appear unremarkable. It is worth noting that whilst dysplasia is clearly a microscopic 
feature, there are macroscopic signs that ought to be recognised. This can be seen in other areas 
of the GI tract also, being aware of the features of a Dysplasia Associated Lesion or Mass (DALM) 
is important even when handling apparently benign material. DALM can show a number of 
features, including single or multiple polyps, bumps, plaques and velvety patches (Kitis and 
Maris, 2005). Given the possibility of abnormal appearance, it is customary to make a statement 
in relation to the mucosa, even if it only to state its apparent normalcy. This variation continues 
in the colon, although with a smaller gap between the BMS and pathologist groups. The 
background mucosa of the colon also ought to be described, as a number of pathologies, 
secondary to the main pathology, may be co-existent and recognisable macroscopically. The 
pathologists made a description in only 30% of cases and the BMS in only 46.3% of cases. Whilst 
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there is not a significant difference between the two groups, there is no obvious reason why this 
is not at 100% for both groups, clearly both groups are varying from the recommend procedure. 
The uterus data also shows some variation between groups. The thickness of the endometrium 
should be recorded on the macroscopic description, yet the pathologist record this in only 66.6% 
of cases, and the BMS in only 85.1% of cases. Again, this should be at 100%. There is a normal 
range of thickness for pre- and post-menopausal women, measurements outside this range are 
an indication of possible benign or malignant conditions. The presence of adenomyosis in the 
myometrium should also be stated, this is not mandated by the RCPath, but is part of local 
protocol, this is noted in 6.6% of cases by the pathologists, and 22.1% of cases by the BMS. 
Whilst adenomyosis can be detected microscopically, a comment indicating macroscopic signs 
of adenomyosis would suggest a level of severity beyond that which can only be detected 
microscopically. Beyond this, the agreed protocol calls for the comment to be made, if the 
pathologists are not commenting because they feel it is unnecessary, then the same ought to 
hold for the BMS and the SOP should be amended. It may be that the pathologists are under 
calling adenomyosis, or that the BMS are over calling, or both; in any case, identifying this 
variation allows for the discrepancy to be investigated. 
Many surgical KPIs are based on patient outcomes (surgical margins, re-operation rates, 
anastomotic dehiscence, 30 day mortality following surgical resection (Scottish Cancer Task 
Force, 2014)), these are clearly going to vary greatly depending upon the patients. However, the 
rates are translatable between surgeons operating within the same pool of patients. A similar 
principle is applied here, to histopathological surgical specimens – whilst it is not feasible to 
apply patient outcomes, it is feasible to use the frequency with which anatomical and 
pathological features are noted as a guide to performance. As there is no managed 
randomisation of specimens some variation, however, may be expected. In order to help 
standardise this, the NHS Consultant Outcome Data use Case Mix Adjustment (Radford et al., 
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2015). As this is an initial work, there is no way to use existing data to model case mix correction 
into the current work, however, this is something that could become useful in the future.  
Derby Hospitals Histopathology laboratory has been, and remains at, the forefront of BMS led 
dissection. The laboratory and its staff have an international reputation for their skills and 
knowledge, with some of the most advanced qualifications and practices in the country. Even 
so, the data above shows a great deal of variation in practice, which is a cause for concern as 
variation in practice leads to poorer patient outcomes and higher error rates (ACOG, 2012; 
Dhingra, 2010; Coombs, 2009; Ferran, 2008, Bridgewater et al., 2007). A further study was 
devised, whereby selected KPIs could be used to monitor and feedback variations in practice.  
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Study 2 – The Training Intervention  
Part One – The creation of the checklists and collecting baseline data 
Part Two – Checklist Introduction (BMS N=5, Pathologist, N=7) 
Part Three – Training Event and Checklists (BMS N=5, Pathologist, N=7) 
Part Four – Training Event only (BMS N=5, Pathologist, N=7) 
Part Five – Guide Diagrams (BMS N=5, Pathologist, N=7) 
Part Six – Training Event and Guide Diagrams (BMS N=5, Pathologist, N=5) 
Part Seven – Checklists only ((BMS N=5, Pathologist, N=0) 
Part Eight – Training Event and Checklists (BMS N=6, Pathologist, N=8) 
Study 1 – Archival Review 
100 appendix, 100 gallbladder, 100 colon, 100 uterus reports reviewed 
Unknown number of participants 
Study 3 – Participant Interviews 
The dissectors were interviewed 
BMS n=6, Pathologist n=4 
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Introduction  
Chapter three begins study 2. After analysis of study 1, the results demonstrated that there was 
considerable variation in practice. As this investigation is predicated on the assertion that 
variation in practice is undesirable, and leads to worse patient outcomes, study 2 was designed 
to investigate and attempt to correct this variation.  
Study 2 consists of eight parts. Study two, part one expands on the work done in study one by 
creating checklists to be used at the dissection bench (Appendix Four – Dissection Checklists on 
page 210). In part one, the checklists are used to analyse recent reports, similar to study 1, in 
order to establish the feasibility of using these for data collection.  
In part two, the dissection checklists are introduced at the dissection bench for the first time. 
The dissectors, and their assistants, complete the checklists at the point of dissection. The 
checklists are returned and the data is analysed. From this analysis, there is clear variation in 
practice between individuals, as seen in the preceding investigation; this leads in to part three, 
where methods to correct this variation are considered.  
Part three introduces a training intervention. This intervention is aimed at highlighting the 
variation to the dissectors and enabling a group conversation between the BMS dissectors and 
the pathologists. The checklists remain in place at this point, the training event highlighting their 
use and utility as a memory prompt and guide. The results from the checklists in this part 
demonstrated a reduction in variation, but some variation remained. 
In part four, the training intervention remained, whilst the checklists were removed. The aim 
here was to demonstrate the effect of the training event in isolation. In order to identify the 
factors that were most effective, the training event was run without the checklists, and the 
checklists were used to analyse the reports of specimens dissected during this period, much as 
in study two, part one.  
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Part five marks the introduction of the guide diagrams. An alternative approach to the training 
event was taken, whereby indicative guide diagrams where introduced to the dissection rooms. 
The aim here was that the diagrams indicated the key features that they ought to be aware of, 
and what information was required in the macroscopic report, therefore, both the training event 
and checklists were removed. The checklists were used to perform a retrospective analysis of 
the completed reports of specimens dissected during this period. 
In part six, the training events are reintroduced. The training events were much missed by the 
dissectors, whilst the diagrams were not well received by any of the dissectors. The diagrams 
remained in place for a further round of data collection, along with the re-introduced training 
event. Once again, the checklists were used to analyse the completed report from this period. 
Part seven shows data gained with the checklists only. There have been many changes up to this 
point, and so a round of data collection using on the checklists was undertaken, to assess any 
changes since this was last done in study two, part 2. 
In each of the preceding rounds, a reduction in variation had been seen, most notably with the 
use of the checklists and the training event. Therefore, a final round of data collection was 
undertaken using both of these interventions, to assess how this effected variance in contrast 
to the last time this combination was run in study two part three.  
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Study Two Part One – The creation of the checklists and collecting baseline data 
Introduction 
The checklists were created with reference to the RCPath minimum datasets and tissue 
pathways (Appendix One – Tissue Pathways and Minimum Datasets, page 203) and local SOPs. 
For example, as noted above, the tissue pathway for appendix states that the length and 
diameter of the appendix ought to be recorded, but there were a large percentage of cases 
where the diameter was not recorded, this was stated as a point on the checklist. Whilst there 
is no requirement in the RCPath guidelines for a measurement or description of the cervix, it is 
called for in the SOP based on a local requirement; also the RCPath tissue pathways call for a 
description of the endometrium, this can be in prose or a measurement of thickness, the local 
protocol calls for the thickness of the endometrium to be recorded. Both of these criteria were 
added to the checklists. The checklists were designed to act as a prompt to good practice, as 
well as a method of data recording.  
The checklists were then used to assess current practice by completing the checklists against 
reports authorised in the previous month.  
Method  
Design 
The analysis of the data sheets allowed a baseline of practice to be established for both groups 
for the variables stated in study 1. Building on the work of Pronovost (2006), this data collection 
was followed by the creation of a checklist, based on the discrepancies, minimum datasets, 
tissue pathways and best practice guidelines issued by the RCPath and IBMS (Appendix One – 
Tissue Pathways and Minimum Datasets, on page 203). Reports for the preceding month were 
analysed and checklists retrospectively completed against them.  
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The checklists comprised a number of criteria that might enable an assessment of performance 
to be made. The individual criteria is considered to be less important than the ability to identify 
variance. Whilst some of the specific criteria chosen may be questioned, as may the exclusion 
of some criteria, the use of these KPIs enables an ongoing review of practice. Subsequent 
iterations might use different criterion.  
Participants 
All staff practicing as dissectors with the pathology department participated. The retrospective 
completion of the checklists involved recording a numerical code for each participant, to 
maintain confidentiality. Twelve different individuals were identified as dissectors at this stage, 
five BMS and seven pathologists.  
Materials 
Dissection checklists (Appendix Four – Dissection Checklists on page 210) 
Procedure 
The dissection checklists were completed against authorised reports for appendix (n=50), 
gallbladder (n=50), colon (n=50) and uterus (n=50). Confidentially and data protection was 
maintained by following NHS Information Security Policy (NHS England, 2014a). All electronic 
records were kept within the NHS computer system within a password protected system, all 
paper copies were kept within a locked cabinet within a locked office. No identifying 
characteristics for either staff or patients were carried over on to the data collection form, a 
numerical code for the case and the dissector was recorded on the form. This was the case for 
each subsequent use of the checklists.   
The checklists were completed by the Chief Investigator by reviewing the completed 
macroscopic report and determining whether a criterion had been met, not been met or was 
not applicable.  
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Study Two Part Two – The introduction of the checklist 
Introduction 
The checklists developed and used retrospectively in part one demonstrated the ability to obtain 
KPI data for individual dissectors. This showed the variation in practice occurring, on an 
individual basis, however, this showed what had already happened. In order to attempt to 
reduce the variation at the point of dissection, the checklists were introduced at the dissection 
bench. The aim of this intervention was to provide a prompt to the dissector, whilst the 
specimen was on the bench in front of them, whilst also allowing KPI data to be recorded. 
Affixing the checklists to the specimen request form placed the checklists directly in the sight of 
the dissector and their assistant, who needed to remove the checklist before dissection could 
commence.  
Method  
Design 
The checklists developed in part one (Appendix Four – Dissection Checklists, on page 210) were 
affixed to the specimen request forms for 50 appendix, 50 gallbladder, 50 colon and 50 uterus 
specimens. The specimens were placed in the usual place for routine dissection.  
Participants 
All staff practicing as dissectors with the pathology department participated (n=5 BMS, 7 
Pathologists). The dissection assistant completing the checklists involved recorded a numerical 
code for each participant, to maintain confidentiality.  
Materials 
50 Dissection checklists for each specimen type were attached to the relevant specimen request 
forms (Appendix Four – Dissection Checklists, on page 210) 
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Procedure 
The dissection checklists were introduced to the staff in a departmental meeting. Their purpose 
was explained and all staff were asked for their help in completion of the checklists. Both the 
dissector and their assistant would need to be involved in completing the checklists, and from 
the literature discussed earlier, regarding checklists and teamwork, it is clear that the checklist 
facilitates, not drives, the team dynamic.  
The dissection checklists were completed by the dissector and / or their assistant for appendix 
(n=48), gallbladder (n=50), colon (n=43) and uterus (n=48). The specific manner of completion 
was left to the discretion of the dissector and their assistant. The checklist mandated that the 
specimen number be recorded, a numerical code for the dissector and the initials of the 
assistant. In some cases the assistant would question the dissector and record their response, 
e.g. “Have you orientated the specimen?” in other cases the assistant was able to use their own 
judgement, e.g. if the dissector dictates a block key stating that one cassette contains the 
proximal margin and another contains the distal margin, the assistant knows that the dissector 
has orientated the specimen. This more informal manner of completion was favoured as the 
relationship between the dissector and their assistant was quite relaxed and informal, this 
collaborative approach to the checklist was felt to fit better into the team dynamic.  At the end 
of a dissection sessions, completed checklists were placed in a designated place within the 
dissection area, for collection by the Chief Investigator. 
Study Two Part Three – The training event plus checklist 
Introduction  
Part two showed a persistent level of variation from both the BMS and pathologists, although 
less variation was noted from the BMS group. In order to build on the advances found with the 
checklists, a training / feedback event was designed. The informal group discussions prompted 
by the use of the checklists up to this point had generated significant interest amongst the 
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dissector group, notable the BMS dissectors. The pathologists were also interested in the output 
of the checklists and saw an opportunity to engage with the BMS dissectors as a group; efforts 
to encourage the pathologist to engage with the BMS and other pathologists and a whole group 
of dissectors were less positively received.  
Method  
Design 
In order to enhance communication of expectations and needs between the BMS and the 
pathologists, and between the BMS, a group discussion format was envisaged, whereby a 
dissector would present a case, or a cohort of cases, exploring a theme or group of themes. A 
dialogue between all those present was envisaged, with challenge and response to points raised. 
Discussion of the rationale of points and a review of the SOP resulting in an agreed standardised 
approach was envisaged, which was expected to encourage buy in and uptake by all participants.  
Participants 
All BMS practicing as dissectors with the pathology department participated (n=7). Four of the 
pathologists were involved in the initial training events, this was later expanded to include all of 
the pathologists (n=13). The dissection assistant completing the checklists recorded a numerical 
code for each participant, to maintain confidentiality. 
Materials 
50 Dissection checklists for each specimen type were attached to the relevant specimen request 
form (Appendix Four – Dissection Checklists, on page 210) 
Procedure 
The dissection checklists were completed by the dissector and / or their assistant for appendix 
(n=50), gallbladder (n=50), colon (n=50) and uterus (n=50). The checklists were completed as 
detailed in study 3. 
65 
 
A training intervention was introduced, this was held each Friday at 12 o’clock – 10 minutes in 
length, in practice this was quite variable, lasting between 15 and 25 minutes. A request for a 
10 minute commitment increased agreement to participate beyond the 30 minute event 
originally suggested. There are calls to integrate this event into our monthly CPD meeting, this 
will be trailed in future and the optimal structure determined.  
Preparation 
 Select case / cases sufficient for timespan 
 Review SOP against macro and blocks provided, review blocks to determine 
accuracy of sections 
 Note any deviations from SOP 
 Return to specimen and examine remaining material 
 Consider accuracy of description and sampling 
 Take photos if desired 
Feedback 
 Give clinical and specimen details; highlight any important information 
 Discuss the macro and blocks provided – indicate if poor embedding / sectioning / 
staining 
 Compare the macro and sampling with findings on review of the specimen 
 Indicate areas of discrepancy, good or poor practice 
 Indicate areas for improvement 
After four cycles of the training event, the dissection checklists were completed against the 
pathology reports, to assess the effect of the training event.  
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Study Two Part Four – The training event only  
Introduction 
Using the training event to engage the dissector group in a dialog, combined with the checklists 
has resulted in the elimination of most of the variation seen at the baseline. In order to try and 
isolate the effects of the training event, the checklists were removed from circulation.  
The use of the checklists is not arduous or especially time consuming, however, if the effects 
were largely due to the training event and the checklists could be removed, this would be one 
less task to perform in a busy laboratory. Conversely, if the effects were due to the checklists 
and only showing now due to lag, removing them would remove the gains previously made.  
Method 
Design 
The training event was continued and the checklists were removed. The BMS dissectors were 
reporting that the training event was very useful and something that they wished to continue. 
In order to assess the effectiveness of this alone, the checklists were withdrawn for a period of 
two months.  
Participants 
All staff practicing as dissectors with the pathology department participated (BMS=5, 
Pathologist=7). At this stage there were 6 of 12 pathologists taking part in the training event.  
Materials 
50 Dissection checklists for each specimen type completed (Appendix Four – Dissection 
Checklists, on page 210) 
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Procedure 
After the two month withdrawal period the chief investigator performed a review of 
macroscopic reports on the laboratory computer system. The checklists were completed 
retrospectively by them based on these reports (n=50), gallbladder (n=50), colon (n=50) and 
uterus (n=50). 
Study Two Part Five – The use of diagrams only  
Introduction 
In part 4, the data demonstrated that those taking an active part in the training events were 
benefiting most. Removing the checklists meant that those not taking part in the training events, 
e.g. most of the pathologists, were no longer receiving any input or prompt. In order to more 
fully engage with those dissectors that the training event was not reaching, a set of guide 
diagrams were created.  
The idea behind the diagrams is that they indicate the key descriptive and sampling points in the 
SOP and RCPath guidance. This enables the dissector to concentrate on assessing the sample in 
front of them, without getting bogged down in protocol – looking at the diagram to prompt as 
needed, to ensure all the required information in recorded and all the necessary sampling is 
done.  
Method 
Design 
The training event and checklists were discontinued. Indicative guide diagrams for each 
specimen type were introduced. These were intended to highlight the significant features of 
specimen dissection and provide a guide to dissection.  
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Participants 
All staff practicing as dissectors with the pathology department participated. (BMS = 4, 
Pathologist = 7) 
Materials 
The diagrams were developed with reference to the Royal College of Pathologists tissue 
pathways and minimum datasets. Alongside these, the departmental SOPs were reviewed and 
the descriptive and sampling goals were considered. This allowed line diagrams to be drawn, 
and the diagrams were annotated with boxes to indicate sampling locations and key descriptive 
points. For dissection diagrams see Appendix Five – Dissection Guide Diagrams on page 214. 
Procedure 
The guide diagrams were introduced to the dissectors on a one to one basis. The intention and 
aim of the diagrams were explained to the individual dissector. Also, the diagrams were 
displayed and explained at the weekly departmental meeting. The diagrams were affixed to the 
wall, in direct sight of the dissector whilst working.  
The dissection checklists were retrospectively completed against completed reports for 
appendix (n=50), gallbladder (n=50), colon (n=50) and uterus (n=50). 
Study Two Part Six – The use of the training event with diagrams  
Introduction 
The previous section made use solely of guide diagrams, in an attempt to further engage those 
dissectors who had not yet shown much improvement. However, the diagrams were not well 
received, and the feedback event was missed by the BMS dissectors. Attempts were made to 
recruit more pathologists to deliver the training events, and for them to attend sessions run by 
other pathologists. Whilst enthusiastic response were given, only two further pathologists 
delivered training events, and none came to sessions delivered by another pathologist.  
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The diagrams were retained, and the training events were resumed. This was to assess the effect 
of the two interventions running concurrently.  
Method 
Design 
The training event was re-introduced without the checklists. The indicative guide diagrams for 
each specimen type remained. Checklists were completed retrospectively against completed 
reports to assess the effect of the diagrams.  
Participants 
All staff practicing as dissectors with the pathology department participated (BMS = 4, 
pathologists = 5). At this stage there were 6 of 12 pathologists taking part in the training event. 
Materials 
Dissection checklists and diagrams (see appendices one and four) 
Procedure 
The dissection checklists were completed against completed reports for appendix (n=50), 
gallbladder (n=50), colon (n=50) and uterus (n=50). 
Study Two Part Seven – The use of the checklists only  
Introduction 
In order to understand the current state of practice, and to assess the effect that the 
interventions have had, given that a number of changes in the individuals practice have been 
noted in the preceding studies, the checklists were used in isolation. This is the first time since 
their introduction that they have been used without either the training event or diagrams.  
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Method 
Design 
The training event and diagrams were discontinued. The checklists were reintroduced.  
Participants 
All staff practicing as dissectors with the pathology department participated (BMS = 5, 
pathologist = 2). 
Materials 
Dissection checklists (Appendix Four – Dissection Checklists, on page 210) 
Procedure 
The dissection checklists were completed by the dissector and / or their assistant for appendix 
(n=46), gallbladder (n=43), colon (n=39) and uterus (n=48). 
Study Two Part Eight – Return to the use of the training event with checklists  
Introduction 
This repeat session aimed to assess the changes that have occurred in dissection over the 
preceding studies. A number of changes have been noted in each preceding study, some of 
which have been sustained, whilst others have not.  
Method 
Design 
The training event was re-introduced alongside the checklists.  
Participants 
All staff practicing as dissectors with the pathology department participated (n=14). All 
pathologists (n=12) had agreed to take part in the training event.  
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Materials 
Dissection checklists (Appendix Four – Dissection Checklists, on page 210)  
Procedure 
The dissection checklists were completed by the dissector and / or their assistant for appendix 
(n=46), gallbladder (n=43), colon (n=39) and uterus (n=48). 
A pathologist facilitated a training session / discussion involving a case review. The case was 
examined on the bench to review the remaining material alongside the macroscopic description, 
the blocks taken and the slides produced. The SOP was reviewed and the manner in which the 
specimen had been described and handled was discussed. Any examples of good or poor 
practice were highlighted as learning opportunities. The dissectors were encouraged to 
challenge the pathologists requests and gain an evidence based justification for practices that 
were, or were not performed.  
Results of Study Two 
The results of study 2 highlighted substantial variation throughout histopathological dissection 
within the Royal Derby Hospital Histology laboratory. Study 2 generated a great deal of data, 
with each part informing the formation of the next part. The results for each part are presented 
and discussed briefly in sequence. After each round has been discussed, consideration is given 
to each specimen type and how practice relating to that specimen type has changed over time. 
Finally, the changes over time for all specimen types are considered as a whole. As clearly 
established in the literature review, variation in practice leads to worse patient outcomes 
(ACOG, 2012; Dhingra, 2010; Coombs, 2009; Ferran, 2008); as such, we seek to reduce 
unnecessary variation.  
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Study Two Part One – The creation of the checklists and collecting baseline data (BMS 
N=5, Pathologist, N=7) 
The checklists clearly demonstrated the ability to capture variation in practice. The retrospective 
analysis of reports for appendix specimens showed a difference in sampling practice between 
the dissectors. One group was taking a longitudinal section from the tip of the appendix and two 
transverse sections from the body, whilst the rest were taking a longitudinal section from the 
tip and one transverse section from the body. The former approach is the one suggested by the 
RCPath and the one which all dissectors should have been following. The latter approach had 
previously been the standard practice in the department, but had been changed over a year 
previously. This had been communicated at the time to all dissectors, and the SOP had been 
updated. Upon discussion with both groups, those sampling correctly were able to clearly recall 
the change in practice, whilst those still performing the older style of sampling had no 
recollection of any notification of the change.  
The gallbladder data also demonstrated variation in sampling protocols. The SOP calls for the 
fundus of the gallbladder to be sampled. This is based on the belief that the funds is the mostly 
frequent site of adenoma or dysplasia (Yamamoto, 1989; Levy, 2001), as such sampling of 
macroscopically unremarkable gallbladder wall should be from the fundus. Of course, any 
macroscopic abnormalities ought to be sampled, regardless of location. Again, a split was seen 
with two distinct groups of dissectors. One group was correctly sampling the gallbladder through 
the fundus, whilst the other group was sampling the body in transverse section. After discussion 
with the dissectors it transpired that one group, the fundus sampling group, had been trained 
by the departmental lead for GI pathology, whilst the other group had been trained a different 
pathologist.  
The colon data showed a number of variations, the most widespread was the sampling of 
background mucosa. This is something which is mandated by the RCPath minimum dataset for 
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colorectal cancers and the RCPath tissue pathway for GI pathology suggests that samples of 
macroscopically normal bowel may be informative (RCPath, 2009; RCPath, 2014a). This is a clear 
recommendation, one that involves minimal time or cost to satisfy and therefore ought to be 
met on all occasions. On discussion with the dissectors, some were unaware of this need, whilst 
some of the BMS stated that they had been asked not to sample background mucosa by 
pathologists, one of the pathologists stated that they simply did not wish to see “normal” tissue.  
The checklists demonstrated a great deal of variation for the uterine dissection. The most 
common source of variation was in relation to the cervix. The tissue pathway for gynaecological 
pathology (RCPath, 2015) calls for the cervix to be described, the local SOP reiterates this, whilst 
also requiring a transverse measurement of the cervix. Clearly, this something which is not being 
performed with any degree of reliability or regularity. A discussion with the dissectors indicated 
that some were unaware of this requirement; others, on prompting, were able to recall that this 
something they were aware of, but had forgotten.  
The various discrepancies were communicated to the dissectors in group discussion, this was a 
valuable exercise as it allowed for a two way dialogue. This discussion and feedback to the 
dissectors was greeted enthusiastically by the BMS dissectors, and formed the basis for the 
second intervention detailed in study 2, part 3. 
The completion of a large number of checklists retrospectively was time consuming. For this 
reason, when planning part 2 (introducing the checklists to routine dissection) the checklists 
were introduced intermittently, the reason for this was so that no individual dissector 
encountered a glut of checklists at any one time. As there was likely to be some resistance to 
the checklists, minimising their impact on the dissector was a reasonable step to take during 
their introduction. Also, spreading the checklists out over a wider time frame enabled greater 
exposure to the checklists – rather than a single instance of encountering many checklists, the 
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dissector was likely to encounter two or three in each dissection session, spread out over several 
weeks.  
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Figure 2- Baseline Data for Study 2 Part 1, Appendix. This figure shows the original baseline data collected by using the checklists to review the recent practice in appendix dissection. 
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Figure 2 - baseline data for Study 2 - Part 1, Appendix
Specimen orientated (e.g. tip & base) Complete measurements given External surface described
Abnormality described (if present) Appropriate blocks SOP followed
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Figure 3 - Baseline Data for Study 2 Part 1, Gallbladder. Figure 3 shows the original baseline data collected by using the checklists to review the recent practice in gallbladder dissection
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Figure 3 - baseline data for Study 2 - Part 1, Gallbladder
Specimen orientated (e.g. duct & fundus) Complete measurements given External surface described
Abnormality described (if present) SOP followed Appropriate blocks
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Figure 4 - Baseline Data for Study 2 Part 1, Colon. Figure 4 shows the original baseline data collected by using the checklists to review the recent practice in colon dissection 
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Figure 4 - baseline data for Study 2 - Part 1, Colon
Specimen orientated (e.g. Proximal & distal margins) Complete measurements given External abnormalities on surface described (if present)
Involvement of margins stated Appearance of mucosa described Presence / absence of appendix recorded (if appropriate)
Macroscopic penetration of tumour recorded (if appropriate) SOP followed Margins
Appendix, if present Background Back ground abnormalities sampled, e.g. diverticulae, polyps
Pathology sampled, e.g. inflammation, tumour Apical node (for cancer cases) At least 12 nodes (for cancer cases)
Is the minimum dataset complete (if appropriate)
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- 
Figure 5 - Baseline Data for Study 2 Part 1, Uterus. . Figure 5 shows the original baseline data collected by using the checklists to review the recent practice in uterus dissection 
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Figure 4 - baseline data for Study 2 - Part 1, Uterus
Specimen orientated Measured in three dimensions Tubes & ovaries measured (if present)
External abnormalities on surface described (if present) Cervix described Cervix measured
Polyp described (if present) Endo/myo described, endometrial thickness recorded Cervix
Endo/Myo Fundus Fibroid (if present)
Polyp (if present) Posterior reflection (if endometriosis) Is the minimum dataset complete (if appropriate)
Was SOP followed
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Study Two Part Two – Checklist Introduction (BMS N=5, Pathologist, N=7) 
The introduction of the checklists has clearly had an effect. There is a substantial change from 
the baseline data recorded before their introduction. There is a variable change across the range 
of personnel and specimens, as would be expected. Different dissectors will encounter the 
checklists with different frequencies and in different circumstances. Any change must be given 
time to take effect, and so several contacts with the checklists might be expected before a 
dissector begins to change their practice, if they change at all.  
The appendix checklists show a noticeable improvement from the BMS dissector group, 
although some variation remains. The pathologists show lot of variation, but all show some 
improvement. Most of the variation is in the area of sampling and measurement. This is similar 
to what was seen in study one and two. Whilst the checklists have had an effect on the practices 
of the dissectors, there does still remain an unnecessary level of variance. 
The gallbladder specimen checklists showed that most of the BMS were at 100%, with one BMS 
not taking appropriate blocks. The pathologists still show substantial variation, although it has 
reduced from the previous study. Pathologist one shows 100%, the variance of the other 
pathologists mostly centres on the description of the external surface and in the sampling, as 
seen in study two.  
The colon dissection checklists show reduced variation among the pathologists, although some 
variation persists; the BMS show full 100% conformance. There is no clear area of deficit in 
practice, more a number a small variations. These small areas of variation are rather harder to 
manage.  A complete failure to adhere to a KPI is most often due to a lack in knowledge, or a 
deliberate decision. In these cases, education and management can rectify this issue. However, 
when the dissector meets the KPI on some occasions, but not on others, it is more difficult to 
identify a cause and therefore a resolution.  
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The BMS and pathologists show a lot of reduction in variation for the uterine dissection. 
However, so variation does remain. The variation mostly relates to the description of the cervix 
and measurement of the endometrial thickness. The importance of this is discussed in study 
one. Whilst improvement is seen here, there is still room for improvement. 
Overall, the change is more notable in the BMS group than the pathologist group, which may 
not be surprising. The BMS are all actively engaged in training and may be more amenable to 
changing their practice. Comparison between part 1 and part 2 shows a distinct reduction in 
variation. The introduction of the checklists resulted in standardisation in practice. Having the 
checklists available at the point of dissection appears to have focused attention on the process 
of dissection and allowed dissectors to think more specifically about the specimen without 
distraction. Discussion with several of the dissectors has indicated that reading the checklists 
highlighted requirements that they had not been aware of and that some used the checklist as 
a memory prompt. The introduction of the checklist allowed dissectors to become aware of 
what information was being collected, this prompted the dissectors to ask questions and check 
the requirements of the SOP. This dialog led to the development of training and feedback 
scheme, detailed in Chapter Four – Study 3 – Participant Interviews, on page 137. 
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Figure 6 - First Use of Checklist, Study 2 Part 2 – Appendix. Figure 6 demonstrates the results gained when the checklists were first used on the dissection bench. A noticeable reduction in variation 
is seen when compared to Figure 2, page 75. 
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Figure 6 - First Use of checklists - Study 2 - Part 2, Appendix
Specimen orientated (e.g. tip & base) Complete measurements given External surface described
Abnormality described (if present) Appropriate blocks SOP followed
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Figure 7 - First Use of Checklist, Study 2 Part 2 – Gallbladder. Figure 7 shows the data gained the first time the checklists were introduced to the dissection bench. Again, a notable reduction in 
variation is seen on the previous round, Figure 3, on page 76. 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
BMS1 BMS2 BMS3 BMS4 BMS5 Path1 Path3 Path4 Path6
C
o
n
fo
rm
an
ce
 t
o
 f
e
at
u
re
Figure 7 - First Use of checklists - Study 2 - Part 2, Gallbladder
Specimen orientated (e.g. duct & fundus) Complete measurements given External surface described
Abnormality described (if present) SOP followed Appropriate blocks
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Figure 8 - First Use of Checklist, Study 2 Part 2 – Colon. Figure 8 also shows a reduction in variation, compared to the baseline, Figure 4 on page 77, although this is not quite as dramatic as that 
seen for the appendix and gallbladder.  
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Figure 8 - First Use of checklists - Study 2 - Part 2, Colon
Specimen orientated (e.g. Proximal & distal margins) Complete measurements given
External abnormalities on surface described (if present) Involvement of margins stated
Appearance of mucosa described Presence / absence of appendix recorded (if appropriate)
Macroscopic penetration of tumour recorded (if appropriate) SOP followed
Margins Appendix, if present
Background Back ground abnormalities sampled, e.g. diverticula, polyps
Pathology sampled, e.g. inflammation, tumour Apical node (for cancer cases)
At least 12 nodes (for cancer cases) Is the minimum dataset complete (if appropriate)
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Figure 9 - First Use of Checklist, Study 2 Part 2 – Uterus. Here we can see the data gathered from the introduction of the checklist to the dissection bench. At baseline, Figure 5 on page 78, some 
variation in practice was seen – comparison of with this figure shows a reduction in variation.  
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Figure 8 - First Use of checklists - Study 2 - Part 2, Colon
Specimen orientated Measured in three dimensions Tubes & ovaries measured (if present)
External abnormalities on surface described (if present) Cervix described Cervix measured
Polyp described (if present) Endo/myo described, endometrial thickness recorded Cervix sampled
Endo/Myo sampled Fundus sampled Fibroid sampled (if present)
Polyp sampled (if present) Is the minimum dataset complete (if appropriate) Was SOP followed
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Study Two Part Three – Training Event and Checklists (BMS N=5, Pathologist, N=7) 
In part 3, with the introduction of the training event, the data for the appendix dissection shows 
only a slight variation from BMS 2, the other four BMS are showing full conformance to all KPI. 
Pathologist 3 continues to show substantial variation in practice, and pathologist 4 shows slight 
variation. Pathologist 1 and 7 show full conformance to KPI, continuing the improvements seen 
in the previous studies.  
The gallbladder dissection data shows all the BMS, pathologists 1 and 3 meeting all of the KPI. 
Whilst pathologist 4 shows only slight variation and pathologist 6 shows a slightly worse 
performance than in previous round. The main discrepancies remain related to the external 
description and measurements.  
The checklists for the colon both BMS meeting all KPI, as does pathologist 4. Pathologists 1, 3, 6 
and 7 show moderate variation, whilst pathologist 5 once again shows full conformance for all 
KPI, except sampling background mucosa. As noted above, this was discovered to be a deliberate 
choice, in contrast to the RCPath guidelines. 
The uterus checklists show a small amount of variation from BMS 1 and 2 and pathologist 6, 
whilst BMS 4 and pathologist 3 show full conformance to all KPI. Pathologist 4 continues to omit 
any data relating to the cervix. The other variations are without obvious pattern and appear to 
relate to simple omissions. This is something that the checklists may be able eliminate, given 
time.  
In most areas the changes seen in the previous round, that of reduced variation and more 
concordance to SOP, was continued. Again, a variable response was seen from different 
individuals. It is noteworthy that all the BMS dissectors were attending the feedback events, 
however, only one pathologist attended a feedback event other than one that they were 
delivering. It is worth noting that the pathologists who have shown the greatest reduction in 
variation are those involved in delivering the feedback events (pathologists 1, 3 and 4).  
86 
 
As there were now two interventions running concurrently (the checklists and the training 
intervention), the checklists were removed in order to judge the effect of the training event in 
isolation.  
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Figure 10 - Training Event - Study 2 Part 3, Appendix. Figure 10 presents the data gathered from the checklists at the introduction of the training event. Comparison with Figure 2 on page 75 and 
Figure 6 on page 81 shows a continued reduction in variation.  
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Figure 10 - Introduction of Training Event, Study 2, Part 2, Appendix
Specimen orientated (e.g. tip & base) Complete measurements given External surface described
Abnormality described (if present) Appropriate blocks SOP followed
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Figure 11 - Training Event - Study 2 Part 3, Gallbladder. This figure shows the data gathered using the checklists at the introduction of the training event. Comparison with Figure 3 on page 76 
and Figure 7 on page 82 shows a continued reduction in variation.  
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Figure 11 - Introduction of Training Event, Study 2, Part 2, Gallbladder
Specimen orientated (e.g. duct & fundus) Complete measurements given External surface described
Abnormality described (if present) Appropriate blocks SOP followed
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Figure 12 - Training Event - Study 2 Part 3, Colon. Figure 12 shows the same pattern noted with the other figures in this round. The data gathered using the checklists at the introduction of the 
training event presented here, continues to show a reduction in variation when compared to Figure 4 on page 77 and Figure 8 on page 83. 
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Figure 12 - Introduction of Training Event, Study 2, Part 2, Colon
Specimen orientated (e.g. Proximal & distal margins) Complete measurements given
External abnormalities on surface described (if present) Involvement of margins stated
Appearance of mucosa described Presence / absence of appendix recorded (if appropriate)
Macroscopic penetration of tumour recorded (if appropriate) SOP followed
Margins Appendix, if present
Background Back ground abnormalities sampled, e.g. diverticula, polyps
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Figure 13 - Training Event - Study 2 Part 3, Uterus. The data collected with the checklists at the point the training event was introduced is shown here. Compared to the preceding rounds, shown 
in Figure 5 on page 78 and Figure 9 on page 84 
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Figure 13 - Introduction of Training Event, Study 2, Part 2, Uterus
Specimen orientated Measured in three dimensions Tubes & ovaries measured (if present)
External abnormalities on surface described (if present) Cervix described Cervix measured
Polyp described (if present) Endo/myo described, endometrial thickness recorded Cervix sampled
Endo/Myo sampled Fundus sampled Fibroid sanpled (if present)
Polyp sampled (if present) Posterior reflection sampled (if endometriosis) Is the minimum dataset complete (if appropriate)
SOP followed
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Study Two Part Four – Training Event only (BMS N=5, Pathologist, N=7) 
The review of macroscopic descriptions in this round revealed that in the dissection of the 
appendix all the BMS (1 – 5) were meeting all the KPI in call cases. Pathologists 1, 2 and 7 also 
showed full compliance to KPI. Pathologist 3 continued to show substantial variation, whilst 
pathologist 4 showed a small amount of variation. In both cases this again relates to the 
completeness of the measurements given and the external description.  
The gallbladder data also shows all the BMS (1 – 5) and pathologist 1 showing full conformance, 
meeting all the KPI. Pathologist 3 shows minor variation, in relation to block selection, whilst 
pathologist 4 shows slight variation in relation to the description of the external surface. 
Pathologist 6, however, shows variation over several KPI, including the measurements, the 
description of the external surface, the description of abnormalities and the taking of 
appropriate blocks.  
The dissection of the colon specimens shows the BMS (1 & 2), along with pathologists 3, 4 and 
7 demonstrating full conformance on all KPI. Pathologist 5 continues their previous practice of 
omitting to sample the background mucosa, as described previously, Pathologist 6 shows a wide 
variation, over a number of KPI, as seen in their practice with the gallbladder and uterine 
dissection in study 5. 
The uterus data continues to show variation from BMS 1 and 3, whilst BMS 3 and pathologist 3 
maintain the full conformance to KPI noted previously. Pathologists 4 and 6 both show 
substantial variation, mostly in relation to the cervix and description of the endometrium, this 
also being where BMS 1 and 3 show variation.  
After the initial large change reduction in variation seen with the checklists and training event, 
the improvements begin to plateau. Whilst the training event shows clear utility to the BMS, the 
pathologists are delivering their own feedback, but are choosing not to attend that delivered by 
others, meaning that they miss out on the opportunity to improve. However, attendance is 
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voluntary – pressure of work has been often cited to explain or justify the pathologists choice 
not to attend.  
In an attempt to widen exposure to the training material, beyond those that were able to attend 
the training events, and to provide more immediacy, i.e. placing the material at the point of 
dissection. A set of guide diagrams were created. These were drawn up with reference to the 
RCPath guidelines and the departmental SOPs.  
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Figure 14 - Training Event Only - Study 2 Part 4, Appendix. In part 4 the training event was run without the checklists on the bench, the checklists were used retrospectively to gather the data. 
The patter noted in previous rounds is seen again here. Comparison with Figure 2 on page 75, Figure 6 on page 81 and Figure 10 on page 87 shows a continued reduction in variation.  
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Figure 14 - Training Event Only, Study 2, Part 4, Appendix
Specimen orientated (e.g. tip & base) Complete measurements given External surface described
Abnormality described (if present) Appropriate blocks SOP followed
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Figure 15 - Training Event Only - Study 2 Part 4, Gallbladder. This figure shows the data gained from running the training event in isolation. The checklists were used to retrospectively collate 
data from specimens dissected during this time. Here we see continuation of the reduction in variation noted in the previous rounds, seen in Figure 3 on page 76, Figure 7 on page 82 and Figure 
11 on page 88 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
BMS1 BMS2 BMS3 BMS4 BMS5 Path1 Path3 Path4 Path6
C
o
n
fo
rm
an
ce
 t
o
 f
e
at
u
re
Figure 15 - Training Event Only, Study 2, Part 4, Gallbladder
Specimen orientated (e.g. duct & fundus) Complete measurements given External surface described Abnormality described (if present) Appropriate Blocks SOP Followed
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 Figure 16 - Training Event Only - Study 2 Part 4, Colon. This figure demonstrates the data gathered during the period where the training event was running in isolation. The checklists were 
completed retrospectively, analysing the reports of specimens dissected during this time. The chart shows that the reduction in variation obtained in previous rounds is continued, and further 
reductions are noted from other dissectors when compared to Figure 4 on page 77, Figure 8 on page 83 and Figure 12 on page 89. 
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Figure 16 - Training Event Only, Study 2, Part 4,  Colon
Specimen orientated (e.g. Proximal & distal margins) Complete measurements given External abnormalities on surface described (if present)
Involvement of margins stated Appearance of mucosa described Presence / absence of appendix recorded (if appropriate)
Macroscopic penetration of tumour recorded (if appropriate) SOP followed Margins
Appendix, if present Background Back ground abnormalities sampled, e.g. diverticula, polyps
Pathology sampled, e.g. inflammation, tumour Apical node (for cancer cases) At least 12 nodes (for cancer cases)
Is the minimum dataset complete (if appropriate)
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Figure 17 - Training Event Only - Study 2 Part 4, Uterus. In Study 2, Part 4 the reduction in variation seen in the preceding rounds, Figure 5 on page 78, Figure 9 on page 84 and Figure 13 on page 
90, is continued; while a further reduction is seen by other dissectors. In this part of the investigation, the training event was run in isolation, and the checklists used to gather data retrospectively, 
for specimens dissected during this period. 
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Figure 17 - Training Event Only, Study 2, Part 4, Uterus
Specimen orientated Measured in three dimensions Tubes & ovaries measured (if present)
External abnormalities on surface described (if present) Cervix described Cervix measured
Polyp described (if present) Endo/myo described, endometrial thickness recorded Cervix sampled
Endo/Myo sampled Fundus sampled Fibroid sampled (if present)
Polyp sampled (if present) Posterior reflction (if endometriosis) Is the minimum dataset complete (if appropriate)
SOP followed
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Study Two Part Five – Guide Diagrams (BMS N=5, Pathologist, N=7) 
The data for the appendix shows an almost unchanged picture from part 4. BMS 1, 3 – 5 show 
full conformance to KPI, although BMS 2 has shown a slight variation, with a reversion to the 
older sampling protocol on some cases. Pathologist 1 and 2 are also continuing to show full 
conformance to all KPI. Pathologist 3 and 4 continue to show the same variation noted 
previously, whilst pathologist 7 drops from their previous full conformance, showing minor 
variation in provision of full measurements.  
Gallbladder dissection continues in much the same way, with the BMS (1 – 5) and pathologist 1 
and 3 once again showing full conformance to all KPIs. Pathologists 4 and 6 continue to show 
variation on the same KPIs.  
This is the same picture for the colon dissection, where minimal change is noted from study 5. 
The uterus data shows some change, in that the BMS 1, 3 & 4 now all show full conformance to 
KPI. Pathologist 3 continues to demonstrate full conformance seen previously, pathologist 4 now 
fully fails to describe or measure the cervix, whilst pathologist 6 now shows full conformance to 
all KPI. 
Part 5 showed a continuation of the performance noted in the previous rounds, that is to say, 
continuation of practice at the newly reduced level of variation. However, some return back 
towards the previous variation was noted amongst some individuals. The diagrams were not 
well received by staff, and the discontinuation of the training event was lamented. As such, a 
further study was considered retaining the diagrams, allowing for further exposure to overcome 
the resistance to them, and reintroducing the training event. 
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Figure 18 - Diagrams Only - Study 2 Part 5, Appendix. This figure represents the use of indicative guide diagrams for the first time. The diagrams were run in isolation, and the checklists were 
used retrospectively to obtain this data from specimens dissected during this period. A slight increase in variation is noted amongst some dissectors here, compared to previous rounds (Figure 2 
on page 75, Figure 6 on page 81, Figure 10 on page 87 and Figure 14 on page 93). 
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Figure 18 - Diagrams Only, Study 2, Part 5,  Appendix
Specimen orientated (e.g. tip & base) Complete measurements given External surface described Abnormality described (if present) SOP followed Appropriate blocks
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Figure 19 - Diagrams Only - Study 2 Part 5, Gallbladder. This figure represents the use of indicative guide diagrams for the first time. The diagrams were run in isolation, and the checklists were 
used retrospectively to obtain this data from specimens dissected during this period. A slight deduction in overall variation is noted amongst here, compared to previous rounds (Figure 3 on page 
76, Figure 7 on page 82 and Figure 11 on page 88). 
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Figure 19 - Diagrams Only, Study 2, Part 5, Gallbladder
Specimen orientated (e.g. duct & fundus) Complete measurements given External surface described
Abnormality described (if present) Appropriate blocks SOP followed
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Figure 20 - Diagrams Only - Study 2 Part 5, Colon. This figure represents the use of indicative guide diagrams for the first time. The diagrams were run in isolation, and the checklists were used 
retrospectively to obtain this data from specimens dissected during this period. A slight increase in variation is noted amongst some dissectors here, compared to previous rounds (Figure 4 on 
page 77, Figure 8 on page 83, and Figure 12 on page 89). 
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Figure 20 - Diagrams Only, Study 2, Part 5, Colon
Specimen orientated (e.g. Proximal & distal margins) Complete measurements given
External abnormalities on surface described (if present) Involvement of margins stated
Appearance of mucosa described Presence / absence of appendix recorded (if appropriate)
Macroscopic penetration of tumour recorded (if appropriate) SOP followed
Margins Appendix, if present
Background Back ground abnormalities sampled, e.g. diverticula, polyps
Pathology sampled, e.g. inflammation, tumour Apical node (for cancer cases)
At least 12 nodes (for cancer cases) Is the minimum dataset complete (if appropriate)
101 
 
 
Figure 21 - Diagrams Only - Study 2 Part 5, Uterus. Comparison of figure 21 with the preceding rounds shows a reduction in variation from all dissectors, except pathologist4  - Figure 5 on page 
78, Figure 9 on page 84, Figure 13 on page 90 and Figure 17 on page 96. 
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Figure 21 - Diagrams Only, Study 2, Part 5, Uterus
Specimen orientated Measured in three dimensions Tubes & ovaries measured (if present)
External abnormalities on surface described (if present) Cervix described Cervix measured
Polyp described (if present) Endo/myo described, endometrial thickness recorded Cervix sampled
Endo/Myo sampled Fundus sampled Fibroid sampled (if present)
Polyp sampled (if present) Posterior reflection sampled (if endometriosis) Is the minimum dataset complete (if appropriate)
SOP followed
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Study Two Part Six – Training Event and Guide Diagrams (BMS N=5, Pathologist, N=5) 
Very little change is noted in study 6, in any of the specimen types. The only notable change is 
in relation to the uterus, where pathologist 4 now follows protocol and provides the mandated 
information in relation the cervix, in all cases.  
Unfortunately, part 6 occurred at a time when several of the dissectors who were previously 
practicing either moved to new posts, or were simply unable to spend time in dissection, due to 
other pressures of work. As this was unlikely to change for the foreseeable future, part 6 was 
run with fewer participants. However, those that remained in dissection found themselves, by 
necessity, performing a higher volume of dissection.  
Those dissectors showing variation in the preceding studies were largely pathologists who are 
not present in this study. The results show that the dissectors who had already reduced their 
variation were able to maintain their improved performance. Those dissectors who still 
demonstrated variation in the previous study (and were present in this study) demonstrated an 
incremental reduction in variation.  
A number of changes have been introduced during the course of this and the preceding studies. 
In order to assess the effect of the interventions a further study was designed, using the 
checklists without the training event or diagrams.   
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Figure 22- Training Event and Diagrams - Study 2 Part 6, Appendix. In this chart the variation noted in previous rounds by BMS2 persists, whilst the other dissectors sustain their newly found 
reduction in variation, compared to previous rounds (Figure 2 on page 75, Figure 6 on page 81, Figure 10 on page 87, Figure 14 on page 93 and Figure 18 on page 98) 
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Figure 22 - Training Event & Diagrams, Study 2, Part 6, Appendix
Specimen Orientated (e.g. tip and base) Complete Measurements Given External Surface Described
Abnormaility Described (if present) Appropriate blocks SOP followed
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Figure 23 - Training Event and Diagrams - Study 2 Part 6, Gallbladder. The data here reflects that seen in the other rounds – the dissectors are maintaining the lack of variation gained in previous 
rounds (Figure 3 on page 76, Figure 7 on page 82, Figure 11 on page 88, Figure 15 on page 94 and Figure 19 on page 99) 
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Figure 23 - Training Event & Diagrams, Study 2, Part 6, Gallbladder
Specimen orientated (e.g. duct & fundus) Complete measurements given External surface described
Abnormality described (if present) Appropriate blocks SOP followed
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Figure 24 - Training Event and Diagrams - Study 2 Part 6, Colon. In part 6 only pathologist 6 is not reaching 100% for all data points, the other dissectors continue the 100% found in previous 
rounds (Figure 4 on page 77, Figure 8 on page 83, Figure 12 on page 89, Figure 16 on page 95 and Figure 20 on page 100) 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
BMS1 BMS2 BMS4 Path6
C
o
n
fo
rm
an
ce
 t
o
 f
e
at
u
re
Figure 24 - Training Event & Diagrams, Study 2, Part 6, Colon
Specimen orientated (e.g. Proximal & distal margins) Complete measurements given
External abnormalities on surface described (if present) Involvement of margins stated
Appearance of mucosa described Presence / absence of appendix recorded (if appropriate)
Macroscopic penetration of tumour recorded (if appropriate) SOP followed
Margins Appendix, if present
Background Back ground abnormalities sampled, e.g. diverticulae, polyps
Pathology sampled, e.g. inflammation, tumour Apical node (for cancer cases)
At least 12 nodes (for cancer cases) Is the minimum dataset complete (if appropriate)
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Figure 25 - Training Event and Diagrams - Study 2 Part 6, Uterus. In part 6, pathologist 4 still shows some variation, but it is reduced from previous rounds, whilst the other dissectors continue 
to demonstrate 100% conformance to all points as seen in previous rounds) (Figure 5 on page 78, Figure 9 on page 84, Figure 13 on page 90, Figure 17 on page 96 and Figure 21 on page 101). 
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Figure 25 - Training Event & Diagrams, Study 2, Part 6, Uterus
Specimen orientated Measured in three dimensions Tubes & ovaries measured (if present)
External abnormalities on surface described (if present) Cervix described Cervix measured
Polyp described (if present) Endo/myo described, endometrial thickness recorded Cervix
Endo/Myo Fundus Fibroid (if present)
Polyp (if present) Is the minimum dataset complete (if appropriate) Was SOP followed
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Study Two Part Seven – Checklists only (BMS N=5, Pathologist, N=0) 
The data for part 7 remains very similar to that in part 6. Those individuals remaining in 
dissection have increased the volume of work they are performing, in response to the lack of 
pathologist involvement. Some drift is noted in performance, with the removal or the training 
event, BMS 2 has reverted to their previous sampling method for appendix specimens, and BMS 
4 is occasionally showing the same pattern. BMS 5 is beginning to omit an external description 
of the gallbladder, something which they had previously been doing for all cases. Also, BMS 3 is 
no longer describing the cervix or endometrium in call cases, something that they had previously 
been doing. Discussion with the dissectors attributed the most likely cause for this drift in 
performance to the withdrawal of the training event. The training event, it was felt, provided 
direction and the generalised feedback from the preceding studies enabled a discussion 
regarding appropriate practice.  
The lack of pathologist data in part 7 is unfortunate, however, the BMS data clearly shows that 
dissectors are maintaining the reduction in variation that was seen with the introduction of the 
checklists. The training event was again missed by the dissectors, who were keen for its 
reintroduction. They made a number of suggestions as to how the training event might be 
developed. In order to draw the investigation to a close, a further study was designed 
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Figure 26 - Training Event and Diagrams - Study 2 Part 7, Appendix. In part 7 BMS 2 continues to show variation in their practice in regard to block taking, BMS drops from their previous 100% 
conformance in part 5, whilst the other dissectors maintain the 100% conformance seen in previous rounds (Figure 2 on page 75, Figure 6 on page 81, Figure 10 on page 87, Figure 14 on page 
93, Figure 18 on page 98 and Figure 22 on page 103) 
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Figure 26 - Training Event & Diagrams, Study 2, Part 7, Appendix
Specimen orientated (e.g. tip & base) Complete measurements given External surface described
Abnormality described (if present) Appropriate blocks SOP followed
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Figure 27 - Training Event and Diagrams - Study 2 Part 7, Gallbladder. The data gained in part 7 is much the same as that gained in part 6, although BMS 5 does show a slight decrease in their 
conformance compared to previous rounds (Figure 3 on page 76, Figure 7 on page 82, Figure 11 on page 88, Figure 15 on page 94, Figure 19 on page 99 and Figure 23 on page 104) 
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Figure 27 - Training Event & Diagrams, Study 2, Part 7, Gallbladder
Specimen orientated (e.g. duct & fundus) Complete measurements given External surface described
Abnormality described (if present) SOP followed Appropriate blocks
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Figure 28 - Training Event and Diagrams - Study 2 Part 7, Colon. In part seven all dissectors reach full conformance to data points, although those dissectors showing most variation in previous 
rounds are missing from this part of the study (Figure 4 on page 77, Figure 8 on page 83, Figure 12 on page 89, Figure 16 on page 95, Figure 20 on page 100 and Figure 24 on page 105) 
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Figure 28 - Training Event & Diagrams, Study 2, Part 7, Colon
Specimen orientated (e.g. Proximal & distal margins) Complete measurements given
External abnormalities on surface described (if present) Involvement of margins stated
Appearance of mucosa described Presence / absence of appendix recorded (if appropriate)
Macroscopic penetration of tumour recorded (if appropriate) SOP followed
Margins Appendix, if present
Background Back ground abnormalities sampled, e.g. diverticulae, polyps
Pathology sampled, e.g. inflammation, tumour Apical node (for cancer cases)
At least 12 nodes (for cancer cases) Is the minimum dataset complete (if appropriate)
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Figure 29 - Training Event and Diagrams - Study 2 Part 7, Uterus. In part 7 a reduction in conformance is seen from BMS 3, compared to their previous performance. BMS 5 appears in the uterus 
dissection data for the first time, and shows full conformance to SOP (Figure 5 on page 78, Figure 9 on page 84, Figure 13 on page 90, Figure 17 on page 96, Figure 21 on page 101 and Figure 25 
on page 106) 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
BMS1 BMS3 BMS5
C
o
n
fo
rm
an
ce
 t
o
 f
e
at
u
re
Figure 29 - Training Event & Diagrams, Study 2, Part 7, Uterus
Specimen orientated Measured in three dimensions Tubes & ovaries measured (if present)
External abnormalities on surface described (if present) Cervix described Cervix measured
Polyp described (if present) Endo/myo described, endometrial thickness recorded Cervix
Endo/Myo Fundus Fibroid (if present)
Polyp (if present) Is the minimum dataset complete (if appropriate) Was SOP followed
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Study Two Part Eight – Training Event and Checklists (BMS N=6, Pathologist, N=8) 
Whilst a small amount of variation persists, the reintroduction of the training event appear to 
have reversed the drift in adherence to KPI noted in part 7. A number of dissectors are noted in 
part 7 who have not been seen previously. Some of these are established pathologists, who have 
not been practicing in dissection regularly, whilst other are new appointees.  
Figure 30 on page 113 to Figure 33 - Training Event and Checklists - Study 2 Part 8, Uteru on page 
116 show the lack of variation in practice gained over the course of this investigation. Those 
dissectors who have been a part of the investigation for several rounds all show a reduction in 
variation for all specimen types, those joining or intermittently participating show a higher level 
of variation. There are some dissectors who show full conformance at the outset, e.g. 
pathologists 8, 10 and 12, and these are considered in Chapter Three – Study 2 – The Training 
Intervention, Results of Study Two, on page 71. 
A great deal of information has been gained in the preceding studies. In order to evaluate the 
impact of the studies in a longitudinal fashion, an overview of the results is presented in 
Chapter Three – Study 2 – The Training Intervention, Results of Study Two, on page 71.
113 
 
 
Figure 30 - Training Event and Checklists – Study2 Part 8, Appendix. Figure 30 demonstrates the frequency with which individual dissectors met each requirement of the checklists, whilst the 
training event was also running. A small amount of variation is noted from BMS4, whilst Pathologist 9 fails to meet half of the requirements, 100% of the time. Most dissectors present in previous 
rounds continue to show 100% conformance, whilst BMS 4 shows a small increase in variation compared to previous rounds (Figure 2 on page 75, Figure 6 on page 81, Figure 10 on page 87, 
Figure 14 on page 93, Figure 18 on page 98, Figure 22 on page 103 and Figure 26 on page 108)  
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Figure 30 - Training Event and Checklists - Study2, Part 8, Appendix
Specimen orientated (e.g. tip & base) Complete measurements given External surface described
Abnormality described (if present) Appropriate blocks SOP followed
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Figure 31 - Training Event and Checklists - Study 2 Part 8, Gallbladder. Figure 31 demonstrates the frequency with which individual dissectors met each requirement of the checklists, whilst the 
training event was also running. A small amount of variation is noted from BMS4, whilst Pathologist 9 fails to meet many of the requirements, much of the time. BMS 1 and 2 continue the 100% 
conformance seen in previous rounds, whilst BMS 4 shows an increase in variation from previous rounds (Figure 3 on page 76, Figure 7 on page 82, Figure 11 on page 88, Figure 15 on page 94, 
Figure 19 on page 99, Figure 23 on page 104 and Figure 27 on page 109) 
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Training Event and Checklists - Study2, Part 8, Gallbladder
Specimen orientated (e.g. duct & fundus) Complete measurements given External surface described
Abnormality described (if present) SOP followed Appropriate blocks
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Figure 32 - Training Event and Checklists – Study 2 Part 8, Colon. Figure 32 demonstrates the frequency with which individual dissectors met each requirement of the checklists, whilst the training 
event was also running. A small amount of variation is noted from Pathologist 1, whilst Pathologist 4 fails to meet two of the requirements, 100% of the time and one of the requirements 50% 
of the time. Those present in previous rounds continue the reduction in variation previously noted (Figure 4 on page 77, Figure 8 on page 83, Figure 12 on page 89, Figure 16 on page 95, Figure 
20 on page 100, Figure 24 on page 105 and Figure 28 on page 110) 
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Figure 32 - Training Event and Checklists - Study2, Part 8, Colon
Specimen orientated (e.g. Proximal & distal margins) Complete measurements given External abnormalities on surface described (if present)
Involvement of margins stated Appearance of mucosa described Presence / absence of appendix recorded (if appropriate)
Macroscopic penetration of tumour recorded (if appropriate) SOP followed Margins
Appendix, if present Background Back ground abnormalities sampled, e.g. diverticulae, polyps
Pathology sampled, e.g. inflammation, tumour Apical node (for cancer cases) At least 12 nodes (for cancer cases)
Is the minimum dataset complete (if appropriate)
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Figure 33 - Training Event and Checklists - Study 2 Part 8, Uterus. Figure 33 demonstrates the frequency with which individual dissectors met each requirement of the checklists, whilst the training 
event was also running. A small amount of variation is noted from BMS4 and 6, whilst Pathologist 11 fails to meet one of the requirements, 100% of the time. This shows a reduction of the 
variation noted in previous rounds (Figure 5 on page 78, Figure 9 on page 84, Figure 13 on page 90, Figure 17 on page 96, Figure 21 on page 101, Figure 25 on page 106 and Figure 29 on page 
111)  
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Figure 33 - Training Event and Checklists - Study2, Part 8, Uterus
Specimen orientated Measured in three dimensions Tubes & ovaries measured (if present)
External abnormalities on surface described (if present) Cervix described Cervix measured
Polyp described (if present) Endo/myo described, endometrial thickness recorded Cervix
Endo/Myo Fundus Fibroid (if present)
Polyp (if present) Is the minimum dataset complete (if appropriate) Was SOP followed
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Changes over time, by tissue type 
The mean rate of adherence to SOP for each dissector is displayed in the following four graphs, 
one for each specimen type, covering all of the studies over time.  
Appendix 
Starting with study 2 part 1 (checklists completed against archive) and moving through each part 
in turn (P2 = checklists used at the dissection bench; P3 = training event and checklists; P4 = 
training event only; P5 = diagrams only; P6 = training event and checklists; P7 = checklists only) 
and ending with part 8 (training event and checklists), Figure 34 –  presents the average 
conformance to SOP for each dissector handling appendix specimens in each study. The trends 
in individual conformance are then easily seen, allowing individuals to be compared against one 
another.  
 
Figure 34 – This graph demonstrates the changes over time from each dissector when dealing with appendix 
specimens. This is a representation of their average conformance to the SOP, as measured by the checklists and report 
review. It is apparent that at S2P1 (baseline) there is much variation. A rapid, and sustained, convergence to agreed 
practice is seen from the majority of practitioners. However, some variation remains. This is discussed in detail later.  
The graph for the baseline (S2 P1) data seen here (Figure 2, on page 75) clearly demonstrates a 
great deal of variation in practice. BMS 3 and Pathologist 2 are both demonstrating full 
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concordance with all of the KPIs. BMS 1 is showing almost full compliance across the range, 
whereas BMS 2 and 4 are showing full compliance on some KPIs, and variable performance on 
the others. Pathologists 1 and 7 are fully compliant on the first few KPIs, but show zero 
conformance on the majority of the others. Pathologists 3 and 4 show a great deal of variation 
in their practice.  
The difference between the baseline (S2 P1 - Figure 2, page 75) and the first round of checklists 
(S2 P2) (Figure 6, on page 81) is clear and obvious. BMS 1-3 show 100% conformance to all KPI, 
BMS 4 showed 50% on one KPI, also meaning that the SOP was followed 50% of the time; this 
being the same as was seen at baseline. BMS 5 also failed on one KPI, having described the 
external surface 83.3% of the time, this was the only failing, meaning that they followed the SOP 
83.3% of the time; this was an improvement on the baseline where six KPIs were noted to fall 
short of the 100% mark. The pathologists also showed a marked improvement, although not as 
striking as that seen by the BMS. Pathologist 1 previously showed at 0% conformance on three 
KPI, one of those now returns at 100% and the other two are at 20%. Pathologist 2 continues to 
return 100% across the full range. Pathologist 3 shows a negative change, with them following 
the SOP 33.3% of the time at baseline compared to only 15% of the time with the checklists. 
Pathologist 4 showed a striking improvement, where only a single KPI fell short of 100%, this 
being reflected in the SOP being followed 83.3% of the time. Pathologist 7 showed minimal, if 
any, change. They failed to take appropriate blocks for all of their cases, both at baseline and 
with the checklists. 
Data collated after the introduction of the training event (S2P3) (Figure 10 on page 87) continues 
the theme noted with the introduction of the checklists. A small amount of variation is noted 
from BMS 2, with half their KPIs returned at 75%. The remaining BMS all show full 100% 
conformance for all KPIs. Pathologists 1 and 2 also show 100% conformance for all KPIs, whilst 
pathologist 3 again shows a great deal of variation. Pathologist 4 shows a small amount of 
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variation, similar to that seen in the previous round. Pathologist 7 shows a substantial 
improvement, with 100% conformance to all KPIs.  
Assessing the current state of practice was achieved by a suspension of the training event. Data 
gathered in study 2 part 4 (Figure 14 on page 93) showed 100% conformance across all KPIs for 
BMS 1, 3, 4 and 5; however, BMS 2 showed a substantial drop in their performance. BMS 2 failed 
to orientate the specimen 25% of the time and failed to describe abnormal features for 25% of 
the cases. Pathologist 1 sustained their previous improvement and again returned 100% across 
all KPIs, as did Pathologist 2. Pathologist 3 failed to measure the specimen appropriately in 70% 
of cases and did not adequately describe the specimen in many cases. Pathologist 4 showed 
similar performance to BMS 2 with a few KPIs returning in the region of 80%. Pathologist 7 
showed 100% conformance for all KPIs.  
In study 2 part 5 (Figure 22, on page 103) the picture is almost unchanged from that seen in the 
previous round (S5). BMS 1, 3, 4 & 5 along with Pathologists 1, 2 & 7, show 100% conformance 
for all KPIs. The other dissectors (BMS 2, Pathologists 3 & 4) show virtually identical performance 
to the last round with only slight variation in their non-conformances. 
All of the dissectors in study 2 part 6 (Figure 22 on page 103), except one (BMS 2), showed 100% 
conformance across all KPI. BMS 2 showed a similar level of non-conformance as in previous 
rounds. 
In study 2 part 7 (Figure 26 on page 108) there is a similar picture to that seen in the last round. 
BMS 1, 3 and 5 continue their full compliance across all KPIs. BMS 2 continues to demonstrate 
variation across a similar range of KPIs. BMS 4, who was last seen in part 3 showing 100% of all 
KPIs, shows some variability in this round. They only follow the SOP in 66.7% of cases, all of the 
variation relates to one KPI, that of taking appropriate blocks.  
Study 2 part 8 (Figure 30 on page 113) sees the introduction of new pathologists to the group of 
dissectors, this will be discussed in more detail in chapter 5. These dissectors show a distinct 
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split in their behaviour, pathologist 9 does not follow the SOP in any of their cases, whilst 
pathologist 10 shows full conformance to SOP. This is seen across other specimen types.   
The overall picture for appendix dissection shows a general trend towards the KPIs and hence 
compliance with SOP. Some individuals show less standardisation than others, and the change 
is more sustained in some than others.  
Gallbladder 
Starting with study 2 part 1 (checklists completed against archive) and moving through each 
study in turn (S2 P2 = checklists used at the dissection bench; S2 P3 = training event and 
checklists; S2 P4 = training event only; S2 P5 = diagrams only; S2 P6 = training event and 
checklists; S2 P7 = checklists only) and ending with study 2 part 8 (training event and checklists), 
Figure 35 - below, presents the average conformance to SOP for each dissector handling 
gallbladder specimens in each study. The trends in individual conformance are then easily seen, 
allowing individuals to be compared against one another.  
 
Figure 35 - This graph demonstrates the changes over time from each dissector when dealing with gallbladder 
specimens. This is a representation of their average conformance to the SOP, as measured by the checklists and report 
review. It is apparent that at Study 2 Part 1 (S2P1 (baseline)) there is much variation. A rapid, and sustained, 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Study 2
Part 1
Study 2
Part 2
Study 2
Part 3
Study 2
Part 4
Study 2
Part 5
Study 2
Part 6
Study 2
Part 7
Study 2
Part 8
O
ve
ra
ll 
co
n
fo
rm
an
ce
 t
o
 S
O
P
Figure 35 - Overal Conformance to Gallbladder SOP, all 
dissectors. Study 2, Parts 1 to 8
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convergence to agreed practice is seen from the majority of practitioners. However, some variation remains. This is 
discussed in detail later. 
The graph for the baseline data (S2P1) (Figure 3, page 76) for gallbladder shows a similar picture 
to that for the appendix. A great deal of variation is again seen. BMS 1 and 2 show similar 
variation, with 100% on a few KPI, then variation on the others. BMS 3, 4 and 5 all show 
substantial failings, with only a few KPIs reaching 100% and many being at 0%. Pathologist 1 is 
fully compliant across all KPIs, Pathologist 3 describes the external surface only 80% of the time 
but is otherwise fully compliant. Pathologist 4 fails to describe the external surface and take 
appropriate blocks every time. Pathologist 6 shows 100% for the initial KPIs, but then mirrors 
the variation seen with the other pathologists.  
With the introduction of the checklists (S2P2) (Figure 7 on page 82) the results for the 
gallbladder demonstrated some interesting data. BMS 1, 2 and 3 showed a 100% conformance 
across all KPIs, BMS 4 showed 100% two KPIs, around 80% for two and 0% for the remaining two 
KPI. BMS 5 showed near 100% conformance for all except the same two KPI, where they 
returned also returned 0%. The reason for this spilt is discussed later. Pathologist 1 continued 
to return 100% conformance across all KPI. Pathologist 3 again showed a reduced performance 
when compared to their baseline, they failed to reach 100% on 5 KPIs in comparison to failing 
to reach 100% on 2 KPIs at baseline. Pathologist 4 showed a partial improvement, whilst still 
failing to describe the external surface on a single case, they were able to take appropriate 
blocks 75% of the time, in contrast to the 0% seen at baseline. Pathologist 6 showed a slight 
change with one KPI increased and one decreased.  
In study 2 part 3 (Figure 11, on page 88), introduction of the training event, there is 100% 
standardisation from all of the BMS dissectors. The pathologists performance is also much 
improved. Pathologist 1 shows 100% conformance to all KPIs, as in the previous round. 
Pathologist 3 has much improved, with 100% conformance. Pathologist 4 shows a small amount 
of variation. Pathologist 6 shows a largely unchanged picture from the previous round.   
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A very similar picture is seen in this study 2 part 4 (Figure 15 on page 94), with all the BMS 
showing full conformance. Here the training event was suspended to obtain a view of current 
practice after the pervious changes. Pathologist 3 failed to sustain their improvement, with a 
drop in appropriate block taking to 75%. Pathologist 4 showed a slight improvement, whilst 
pathologist 6 showed improvement in block taking, but a decrease in the overall percentage of 
cases where they followed the SOP.  
As with the data for the appendix, not much change is seen in study 2 part 5 (Figure 19 on page 
99). However, there are some features of note. Whilst all the BMS (1 – 5) and pathologist 1 
remain at 100%, pathologist 3 has improved from the previous round and now also reports 100% 
for all KPI. Pathologist 4 identically, whilst pathologist 6 shows some improvement on all KPI. 
The three dissectors practicing in study 2 part 6 (Figure 23 on page 104Error! Reference source 
not found.) (BMS 1, 5, pathologist 3) all showed 100% conformance for all KPI. This was 
sustained from the previous round where they all previously returned 100%. 
A slightly diminished picture is seen in study 2 part 7 (Figure 27 on page 109), compared to the 
previous round. BMS 1, 2, 3 and 4 continue to show the full conformance they demonstrated in 
the previous round. However, BMS 5 has not followed the SOP in 33.3% of cases. In each case, 
the variation relates to describing the external surface. 
With study 2 part 8 (Figure 31 on page 114) performance remains much the same as in the 
preceding rounds. Pathologist 9 only has managed to perform appropriate dissection in only 
10% of cases. Pathologist 9 declined to make use of the checklists. The remaining dissectors 
continue to show high conformance to SOP. 
Colorectal 
Starting with study 2 part 1 (checklists completed against archive) and moving through each 
study in turn (S2 P2 = checklists used at the dissection bench; S2 P3 = training event and 
checklists; S2 P4 = training event only; S2 P5 = diagrams only; S2 P6 = training event and 
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checklists; S2 P7 = checklists only) and ending with study 2 part 8 (training event and checklists), 
Figure 36 - , below, presents the average conformance to SOP for each dissector handling 
appendix specimens in each study. The trends in individual conformance are then easily seen, 
allowing individuals to be compared against one another.  
 
Figure 36 - This graph demonstrates the changes over time from each dissector when dealing with colorectal 
specimens. This is a representation of their average conformance to the SOP, as measured by the checklists and report 
review. It is apparent that at Study 2 Part 1 (S2P1 (baseline)) there is much variation. A rapid, and sustained, 
convergence to agreed practice is seen from the majority of practitioners. However, some variation remains. This is 
discussed in detail later.  
At baseline (Study 2 part 1) (Figure 4 on page 77) across the range of BMS and Pathologists for 
the colorectal specimens, not a single individual shows 100% conformance. The BMS (1 and 2) 
both show greater concordance than the pathologists, although notable gaps are seen. 
Pathologist 1 shows an interesting picture with 100% on many items and 0% on several others, 
with three KPIs between 50 and 75%. The remaining pathologists show a similar pattern, with 
some things that they always do, some things they never do, and some things that they do some 
of the time. Pathologist 3 is perhaps closest to ideal of the pathologists, but even they only reach 
75% average conformance to SOP.  
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Figure 36 - Overal Conformance to Colorectal SOP, all 
dissectors. Study 2, Parts 1 to 8
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As with the other specimen types, the introduction of the checklists (S2P2) (Figure 8 on page 83) 
gives clear results. BMS 1 and 2 show a full conformance to SOP across all KPI. Pathologist 1 
showed a notable improvement, however, they were still fully following the SOP in only 45% of 
cases, with 4 KPIs returned at under 100%. Pathologist 3 showed a small overall increase in 
conformance to SOP, although no great change was seen. Pathologist 4, who had been 
demonstrating a very patchy conformance at baseline, demonstrated a 100% conformance to 
all KPIs with the introduction of the checklist. Pathologist 5 showed a similar improvement, with 
only one KPI below 100%, that of sampling the background mucosa, this was at 0%. Pathologists 
6 and 7 both showed a similar limited improvement.  
The improvements noted in the previous round have been sustained in study 2 part 3 (Figure 12 
on page 89), with all but two dissectors showing full adherence to SOP with 100% conformance 
to all KPIs. Pathologist 1 has shown further improvement, although not yet reaching full 100% 
conformance. Pathologist 6 has shown no change in their practice in this round, although they 
did show an initial improvement in the first round.  
The graph for study 2 part 4 ( 
125 
 
 
 Figure 16 on page 95) shows only two dissectors (Pathologists 1 and 6) that fail to meet all of 
the targets. In the preceding round there were five dissectors failing to meet all targets; clearly, 
this is a notable improvement. Pathologist 1 shows 5 KPI around the 80% mark, whilst 
pathologist 6 shows three KPI around 40% and three around 75%; the rest are at 100%.  
There is little change in study 2 part 5 (Figure 20 on page 100). Whilst BMS 1, BMS 2 pathologist 
4 and pathologist 7 maintain their 100% score, pathologist 1 remains non-compliant on the same 
KPI as seen before. Pathologist 3 does show a small negative change, with the macroscopic 
penetration of the tumour only being recorded in 80% of cases. Pathologist 5 shows no change 
at all, with all except the sampling of background mucosa being at 100%. 
The reduction in variation gained in the previous rounds are sustained in study 2 part 6 (Figure 
24 on page 105) by BMS 1, 2 and 4, with 100% concordance with all KPIs. However, pathologist 
6 continues to show a variation across a number of KPI. 
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Figure 16 - Training Event Only, Study 2, Part 4,  Colon
Specimen orientated (e.g. Proximal & distal margins) Complete measurements given
Involvement of margins stated Appearance of mucosa described
Macroscopic penetration of tumour recorded (if appropriate) SOP followed
Appendix, if present Background
Pathology sampled, e.g. inflammation, tumour Apical node (for cancer cases)
Is the minimum dataset complete (if appropriate)
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Study 2 part 7 (Figure 28 on page 110) shows a slightly diminished picture, when compared to 
the previous round. BMS 1, 2, 3 and 4 continue to show the full conformance they demonstrated 
in the previous round. However, BMS 5 has not followed the SOP in 33.3% of cases. In each case, 
the variation relates to describing the external surface. 
Study 2 part 8 (Figure 32 on page 115) shows a continuation of the high level of conformance to 
SOP reached previously. Pathologist 4, who was absent from studies 7 and 8, shows a drop in 
conformance from 100% to 84.4%. Pathologist 8 joins the dissection team here, and 
demonstrates 100% conformance at the outset. The BMS dissectors demonstrated a change to 
high or full conformance for all KPIs, whilst the pathologists showed a much more variable 
response. However, an overall trend towards conformance is noted in studies 2 to 5, with some 
drop in part 5. Unfortunately, this is where most pathologist input ends, making a longer 
assessment impossible.  
Uterus 
Starting with study 2 part 1 (checklists completed against archive) and moving through each 
study in turn (S2 P2 = checklists used at the dissection bench; S2 P3 = training event and 
checklists; S2 P4 = training event only; S2 P5 = diagrams only; S2 P6 = training event and 
checklists; S2 P7 = checklists only) and ending with study 2 part 8 (training event and checklists), 
Figure 37 - on page 127 presents the average conformance to SOP for each dissector handling 
appendix specimens in each study. The trends in individual conformance are then easily seen, 
allowing individuals to be compared against one another.  
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Figure 37 - This graph demonstrates the changes over time from each dissector when dealing with uterus specimens. 
This is a representation of their average conformance to the SOP, as measured by the checklists and report review. It 
is apparent that at S2P1 (baseline) there is much variation. A rapid, and sustained, convergence to agreed practice is 
seen from the majority of practitioners. However, some variation remains. This is discussed in detail later. 
Once again we see extensive variation across all individuals at baseline (S2P1) (Figure 5 on page 
78). BMS 1 is returning 100% for most KPIs although two of them are noted to be 75 & 80%. 
BMS 3 and 5 both show 100% on many KPI, however they both return at least one 0% and several 
ranging between 15 and 85%. Pathologist 3 returns three 0% and a number of variable 
conformances. Pathologist 4 shows 100% conformance across all KPIs. Pathologist 6 shows 100% 
across most KPIs with two 0% returns and one at 85%.  
Again, the reduction in variation is noticeable with the introduction of the checklists (S2P2) 
(Figure 9 on page 84). The variation in performance between BMS 1, 3 & 4 all relate to the cervix. 
With the checklists in place, this variation is substantially reduced for BMS 1 & 3, for BMS4 the 
variation disappears entirely, with 100% conformance for all KPIs. Again, pathologist 3 shows a 
great deal of variation, across a number of KPIs, this disappears entirely with the checklist, with 
100% conformance for all KPIs. Pathologist 4 and 6 also showed variation in regard to the cervix, 
although each showed variation in one other KPI. Pathologist 4 showed some improvement from 
the previous round, but there was no change from pathologist 6.  
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Figure 37 - Overal Conformance to Uterus SOP, all dissectors,  
Study 2. Parts 1 to 8
BMS1
BMS3
BMS4
BMS6
Path3
Path4
Path6
Path11
Path12
128 
 
In next round (S2P3) (Figure 13 on page 90) BMS 1 and 3 show near 100% conformance, with 
slight improvements over the previous round. BMS 5 and pathologist 3 continue their improved 
performance of 100% returns for all KPIs. Pathologist 4 has again demonstrated a small 
improvement in some areas, whilst pathologist 6 has shown no change. 
With the removal of the checklist and continuation of the training event (S2P4) (Figure 17 on 
page 96) BMS 1 continues to show variation in relation to the cervix and the 
endometrium/myometrium, although less than in the previous round. BMS 3 shows more 
variation in this round than in the previous round, in the same areas as BMS 1.  BMS 4 and 
pathologist 1 continue to demonstrate the 100% conformance they showed in the last round. 
Pathologist 4 shows an improvement across a number of KPI, they improve their performance 
on measuring in three dimensions, now reporting 75%, they begin to measure the cervix in all 
cases, and describe it in 30% of cases. Pathologist 6 shows a reduction in conformance, no longer 
describing or measuring the cervix, and only describing a polyp in 25% of cases where one was 
found. 
In the next dataset (S2P5) (Figure 21 on page 101) BMS 1, 3, 4, pathologist 3 and pathologist 6 
all return 100% concordance across all KPI. Pathologist 4 measures the specimen in 50% of cases, 
and omits to measure or describe the cervix for every specimen. This is a clear improvement 
from the previous round, where two out of the three BMS and two out of the three pathologist 
showed variation. Interestingly, the positive change seen in the previous round from pathologist 
4, in relation to the cervix KPI, has been entirely lost; with them returning to their previous 
practice of neither describing nor measuring the cervix.  
In Study 2 part 6 (Figure 25 on page 106) BMS 1, 3 and 5 continue their 100% conformation with 
SOP across all KPIs, as seen in previous rounds. Pathologist 4 shows some improvement from 
the last round; here we see that there is variation only on the specimen measurement and in 
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the description of the endometrium/myometrium, the previous variability in relation to the 
cervix has disappeared.  
Study 2 part 7 (Figure 29 on page 111) shows BMS 1 and 5 maintaining the 100% adherence to 
SOP seen in the preceding two rounds. However, BMS 3 showed variation on two KPIs. Most 
notably the measurement of the cervix, the reason for this is discussed later.  
Study 2 part 8 (Figure 33, on page 116) draws the dissectors to, or close to, 100% for all KPIs. 
This continues the pattern seen in previous rounds and with other specimen types. Again, more 
variation is noted from the pathologists than the BMS, but the overall trend for all dissectors is 
towards conformity and lack of variation.   
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Changes over time for all specimen types 
The mean for all SOP conformance across all specimen types is plotted below (Figure 38 on page 
131) for each dissector. The high level of variation seen in the individual graphs (Figure 34 on 
page 117 to Figure 37 on page 127) is evident. The overall trends that can be discerned show 
that the checklists have the most effect to the most people. When the checklists are withdrawn 
and other interventions run in their place, the average conformance drops. The use of diagrams 
alone saw the average conformance drop for one of the BMS and two of the pathologists. 
Reintroducing the checklists stabilises the drop, and the reintroduction of the training event 
brings most dissectors to an average of 100% for all KPIs. Participating in this investigation for 
the first time in study 2, part 8 are pathologists 8, 9, 10, 11 and 12. Pathologists 8, 10 and 12 
show 100% conformance, pathologist 11 shows an average of 83% conformance to SOP, with 
only the presence of the checklist. Pathologist 11, however, did not wish to engage with the 
checklists, and demonstrated less than 10% conformance to SOP.  
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Figure 38 – This graph plots the overall conformance to SOP for each dissector (as assessed by the checklists and report review), for each stage of study 2. Whilst a great deal of variance is seen, 
a clear trend towards 100% conformance is seen over time for the majority of practitioners over each round. Some variation returns, and for some dissectors the amount of variation is in itself 
quite variable. This is discussed in detail in chapter 5 
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Figure 38 - Overal Conformance to dissection SOP, all dissectors.  Study 2, Parts 1 to 8
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This is a complex picture, with a 17 total participants. What is immediately clear is that the BMS 
(solid lines) show a rapid response to the interventions, which is sustained. The BMS average 
conformance does not drop below 75% from study 3 onwards. The pathologist picture does 
show an overall reduction in variation, although it is somewhat less immediate and sustained. 
Each dissector finished the series of investigations with less variation than they demonstrated 
at the start. Of the five pathologists who first appear in part 8, one is showing 83% conformance 
to SOP, three are at 100%, whilst the fifth is showing a 0% conformance to SOP. This has already 
been discussed in part 8 and will be further considered in the discussion.  
When attempting to unpick the effect of each individual intervention, this is a more complex 
issue than one might initially think. As the participants change throughout it is not possible to 
fully isolate the effects of each intervention – as each builds on the last, the effects of the 
programme also become apparent to the dissectors, increasing their investment and buy in to 
the system. Therefore the effect of each intervention is not so easy to isolate. However, Figure 
39 on page 133 gives some indication of this. The chart shows the mean conformation to SOP 
for each round, by specimen type – the error bars indicating the standard deviation, illustrating 
the range in values obtained. Over each round, the variance and the standard deviation 
decrease, resulting in much greater conformation to SOP. 
133 
 
  
 
Figure 39 – Mean of Average Conformance to SOP, by specimen type, for all dissectors, Study 2 - all parts. This figure demonstrates the change in means for adherence to SOP for all dissectors 
in each round, broken down by specimen type. The error bars indicate one standard deviation, demonstrating the range of values. The chart clearly shows that conformance to SOP overall 
increases throughout each round, and a reduction in variance between dissectors is seen, by the reduction in size of the error bars.  
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Figure 39 - Mean of Average Conformance to SOP, by specimen type, for all dissectors, Study 2 -
all parts
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Whilst this does track changes over time, it still does not isolate the individual effects of each 
intervention.  As noted above, it is not possible to definitively identify exactly what changes are 
related to which interventions, as our experimental subjects are people, and the people involved 
are themselves changing; as are the particular individuals involved. However, we can make some 
statistical representation of the changes. Figure 39, above, shows the mean of the means shown 
in Figure 38. This figure demonstrates the change in means for adherence to SOP for all 
dissectors in each round, broken down by specimen type. The error bars indicate one standard 
deviation, demonstrating the range of values. The chart clearly shows that conformance to SOP 
overall increases throughout each round, and a reduction in variance between dissectors is seen, 
by the reduction in size of the error bars on page 133, adding the standard deviation of the 
means, and the mean of the standard deviations. In this table we can compare the changes in 
mean for each round against the baseline, and consider the standard deviation.  Also included 
is a column demonstrating the t-test statistic, comparing each round against the baseline data. 
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Table 7- Mean of mean conformance to SOP, Mean of SD within this data and SD of the means – all dissectors, all 
specimen types, all rounds. The table demonstrates the increase in conformance to SOP over time, and a reduction in 
SD over time. 
Stage Mean of 
means % 
Mean of SD SD of means T - test 
Study 2 Part 1 67.38 26.27 10.695  
Study 2 Part 2 79.83 25.02 14.71489 0.36674 
Study 2 Part 3 89.42 18.11 12.44693 0.089034 
Study 2 Part 4 92.52 17.91 5.95346 0.020678 
Study 2 Part 5 94.23 10.23 3.26793 0.017718 
Study 2 Part 6 96.41 6.12 4.095559 0.011818 
Study 2 Part 7 90.16 14.49 12.55288 0.07795 
Study 2 Part 8 97.38 2.38 0.373436 0.016303 
 
Table 7, above, neatly demonstrates the trends seen in the data. A consistently smaller t value 
is seen with each round (study 2 part 7 is an outlier, discussed below), compared against the 
baseline, this could be taken to indicate that study 2 part 8 was the most effective and most 
powerful. However, as noted above, this study has been cumulative with each round building 
on that which went before. In Table 7 the data for study 2 part 7 does not follow the trend seen 
in the other rounds, in that mean drops and the SD raises to near that seen in study 2 round 3. 
However, one must only note the mean of the standard deviations for the data here, to see how 
much individual variance there was in conformity. This is explained by the change in the people 
involved in these rounds. Had the specific individuals remained constant throughout the study, 
the data analysis would be much simpler and the trends clearer to see. However, even with this 
additional layer of complexity, the changes are clearly visible.  
At the end of study 2 a substantial number of changes and investigations had been introduced. 
Consequently, all of the dissectors practicing at this time (n=10) were invited to take part in a 
series of semi-structured interviews. The goal was to review the investigation so far, from the 
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point of view of the dissectors involved, to determine what they had gained from the process 
and how it might be improved.  
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Chapter Four – Study 3 – Participant Interviews  
 
 
 
 
 
 
 
  
Study 2 – The Training Intervention  
Part One – The creation of the checklists and collecting baseline data 
Part Two – Checklist Introduction (BMS N=5, Pathologist, N=7) 
Part Three – Training Event and Checklists (BMS N=5, Pathologist, N=7) 
Part Four – Training Event only (BMS N=5, Pathologist, N=7) 
Part Five – Guide Diagrams (BMS N=5, Pathologist, N=7) 
Part Six – Training Event and Guide Diagrams (BMS N=5, Pathologist, N=5) 
Part Seven – Checklists only ((BMS N=5, Pathologist, N=0) 
Part Eight – Training Event and Checklists (BMS N=6, Pathologist, N=8) 
Study 1 – Archival Review 
100 appendix, 100 gallbladder, 100 colon, 100 uterus reports reviewed 
Unknown number of participants 
Study 3 – Participant Interviews 
The dissectors were interviewed 
BMS n=6, Pathologist n=4 
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Introduction 
In order to evaluate the investigation, and understand its impact from the point of view of the 
dissectors, each dissector was invited to an interview. The interviews were semi-structured and 
designed to explore the dissectors view of the dissection process in the laboratory, their own 
abilities and how the investigation did, or did not, help them.  
The investigation so far has concentrated on the output from the dissectors, and how to monitor 
and improve upon that. In this part, consideration is given to the subjects themselves. As this is 
a process that affects people, it is important to ensure enough attention is given to the 
individuals and their reactions to the work.  
In order to investigate and explore the feelings and experiences of the participants an interview 
with each dissector was planned. A series of questions were devised prior to the interviews (see 
Appendix Six – Participant Information Pack and Question Sheet on page 218), and the 
interviews were recorded.  
Design 
After the interventions (checklist, feedback event and guide diagrams) had been introduced, 
several rounds of data collection were performed. Following this, the participants were 
interviewed. The information pack (comprising an information sheet, debriefing sheet and 
consent form) along with the question sheet (which was not disclosed in advance), can be found 
in Appendix Six – Participant Information Pack and Question Sheet on page 218.  
This study was designed to explore the attitudes of the participants to the work undertaken. As 
such, quite open ended questions were devised. A foundational work by Schuman and Presser 
(1979) sets out very well the advantages and disadvantages of open and closed questions, 
including the obvious advantages when it comes to coding and numerical data analysis. 
However, they also detail how closed questions can enhance any bias on the part of the 
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questioner or question setter. They note how open questions, whilst taking longer to ask and 
answer, and longer to process and code, result in a greater variety of answers – providing more 
insight into why people think or feel the way they do. One of the advantages of closed questions 
is that there is a higher response rate to questionnaires distributed with closed questions than 
those with open questions. As this study had a small number of participants, and the questions 
were to be asked face to face, most of the advantages of closed questions were lost. The 
advantage of easier coding and data analysis was considered to be offset by the additional 
insight that could be offered by open questions.  
Bearing in mind the lessons from Schuman and Presser (1979), the work of Braun and Clarke 
(2006) was used here. Their work details how transcripts from interviews can be analysed and 
coded for analysis (see Thematic Analysis on page 141 for more details) allows for open ended, 
exploratory questions to be used. As the questions related to perceptions of experience and 
opinion, parallels may be drawn with the techniques used in sensory science. Kleji and Musters 
(2003) noted that open questions allow full use of expressive language, which is intrinsic to the 
self-expression of the individual. They note that an analysis of the data gained from open 
questions allow the clear generation of further questions, the questions used here (see page 
223 for the questions) have been chosen to explore the thoughts, feelings and experiences of 
the participants. The goal in these interviews is to gain an insight into the participants’ 
experiences, to further refine and improve this scheme.   
Participants 
All staff members (n=10) currently involved in histopathological dissection (at the time of 
interview) at the Royal Derby Hospital (RDH) were divided into two groups:  
1) Pathologist (medically qualified, consultant or SPR grade) (n=4) 
2) Biomedical Scientist (BMS) 
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i) Expert BMS (have gained the Institute of Biomedical Science (IBMS) Diploma of 
Extended Practice in Histological Dissection) (n=3) 
ii) Advanced BMS (have gained Fellowship of the IBMS, without specific dissection 
qualification) (n=3) 
Each person was approached informally by the chief investigator, to determine their initial 
opinion regarding being interviewed. The response was positive from all individuals. A consent 
form and information sheet were given to the participants, who were asked to return the 
consent form to the chief investigator within a week. The participants were assured that the 
interviews would be confidential, and that only anonymous excerpts would be quoted. They 
were told that they would be free to withdraw at any time. 
Materials 
Interview room with digital recorder. Recorded interviews and transcripts of the interviews.  See 
Appendix Six – Participant Information Pack and Question Sheet on page 218 for interview pack.  
Ethics 
As this investigation involved human participants, the necessity for ethical approval was 
investigated. The Integrated Research Application System (IRAS) was contacted, as was the 
Research and Development department at the Derby Royal Hospitals NHS Foundation Trust. 
Both confirmed in writing that they considered that ethical approval was not required for the 
interviews. The Trust Service Evaluation and Audit lead delegated authority for approval to the 
Histopathology department manager. The Histopathology manager gave their authorisation for 
the interviews. 
Method 
A time was arranged with each individual at their convenience, and a private location agreed 
upon. For the pathologists, this was in their own office; for the BMS interviews a private office 
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space was booked. The process was explained to the interviewees and they were encouraged 
to ask questions, should they have any. The recorder was started and the interview began with 
an introduction of the interviewer and interviewee. The questions in Appendix Six – Participant 
Information Pack and Question Sheet, on page 218, were worked through and the interviewees 
were encouraged to digress as they wished and to discuss any other areas they felt relevant. At 
the end of the interview the interviewee was thanked and the recording saved to a secure 
location.  
The recordings were then transcribed on to the computer system and saved within a secure 
location on the hospitals NHS IT system.  
The interview transcripts were examined with the aim of understanding the perspective of the 
interviewees in regard to the interventions undertaken in this investigation. The interviews were 
designed to explore the opinions of the interviewees in relation to their own practice, the quality 
of dissection in the laboratory as a whole, and how they felt the interventions had, or had not, 
helped them. The interviewees were also questioned to discover their thoughts on how the 
process could be improved upon.  
Thematic Analysis of Participant Interviews 
Each of the individuals who had been practicing in dissection during the period of data 
collection, (and were still working within the department) were approached to participate in 
these interviews. Everyone gave their consent to participate. Four of these were consultant 
pathologists, three were expert BMS dissectors and three were advanced BMS dissectors. Due 
to the small number of participants, the quotes discussed below are not attributed to 
individuals, to preserve anonymity.  
Pathologist A is a highly experienced consultant pathologist, with international experience. They 
are involved with strategic governance of the Trust and setting the direction for the pathology 
laboratory within the Trust. They are enthusiastically involved with various pathology societies 
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and have been recently involved in reviewing the tissue pathways for one of the histopathology 
specialities. 
Pathologist B is a consultant pathologist of several years standing, they are involved with the 
management of the department at a senior level. Whilst they have fewer years of experience 
than pathologists A and C, they do have experience working across the country. They are 
correspondingly more recently trained, with more of a multidisciplinary, collaborative, forward-
looking approach. 
Pathologist C is the most experienced, with in the region of 40 years post qualification 
experience. They have a wealth of practical hands on knowledge, which they are often able to 
put to use in training.   
BMS A to C are Advanced BMS. Their post registration experience ranges from ten to 
approximately forty years. None have specific qualifications in dissection and none are based 
fully in dissection. They all practice a general dissection role, handling specimens in the RCPath 
categories A – C (IBMS, 2005), and each has a specific area of more specialist dissection interest.  
BMS D to F are Expert BMS. They have post registration experience ranging from ten to twenty 
five years. They all hold the IBMS Diploma of Expert Practice in Histological Dissection, and hold 
(or are working towards) the Advanced Specialist Diploma in Histological Dissection. 
The interview transcripts were examined with the aim of understanding the perspective of the 
interviewees in regard to the interventions undertaken in this investigation. The interviews were 
designed to explore the opinions of the interviewees in relation to their own practice, the quality 
of dissection in the laboratory as a whole, and how they felt the interventions had, or had not, 
helped them. The interviewees were also questioned to discover their thoughts on how the 
process could be improved upon.  
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The interviews were recorded and transcribed. Braun & Clarke (2006) provides an excellent 
stepwise guide to performing a thematic analysis, their method was followed in this case: 
1. Familiarising yourself with your data  
2. Generating initial codes  
3. Searching for themes  
4. Reviewing themes 
5. Defining and naming themes 
6. Producing the report  
The recordings were played and the transcripts read in detail, several times, and those points 
that recurred within an interview, or across different interviews, were highlighted on the 
transcripts. These coding points were then grouped into what appeared to be the most relevant 
categories, enabling themes to be identified. The interviews were replayed and transcripts read 
again, targeting each theme in turn; during this phase what was said was examined, along with 
the way in which it was said, and each remark was considered in context.  
The interviews identified four main themes, which interlink and are supported by several sub-
themes. The research supervisor reviewed the data and themes, also a Clinical Psychologist 
unconnected to the investigation was invited to review the data. Both were in broad agreement 
with the themes detailed below.   
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Knowledge – “it’s not part of our culture” 
There was much discussion of knowledge levels amongst all groups. The pathologists felt that 
their level of knowledge was a strength that they could bring to dissection, whilst the BMS 
commented on a perceived lack of knowledge. The consultants were all happy with the level of 
knowledge demonstrated by the BMS and with the training. Despite the consultants being happy 
with the levels of knowledge and performance demonstrated by the BMS, they were clear that 
their knowledge was greater. This is undoubtedly true, within this group the most experienced 
of the BMS dissectors have been performing dissection for approximately 10 years, whilst the 
least experienced pathologist has been performing dissection for approximately 20 years. 
However, the data gathered here shows that this knowledge and experience does not 
necessarily translate into higher standards. Attitudes to staff groups taking on tasks delegated 
to them by more senior groups are known to vary. One attitude often seen is a degree of 
distancing and protectionism, the delegation and control in these situations often remains with 
the more senior profession, as in this case. Scotland for Health (2011) note that providing the 
opportunity to undertake these complex activities and develop the new skills needed is 
sometimes resisted by the senior group. They note that there are number of reasons for this, 
one of the most frequently given is unrelated to perceptions of ability on the part of the 
delegate, and relates to decreased job satisfaction.  
The comments regarding knowledge were also linked into experience and standardisation. One 
consultant considered the value of knowledge and experience: 
“I think my strengths probably are experience” … “And you need to also understand the reasons 
why you are dissecting, what information you are actually trying to get out of the specimen”… 
“if it’s not a straightforward case, with a specific clinical question you might want to modify your 
approach” 
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Another pathologist noted that their experience allowed a more targeted approach to 
dissection: 
“…the recognition of a pathology macroscopically, then guides you how to take appropriate 
blocks. So, macroscopic recognition of pathology is my strength” 
Whilst all the pathologists were very keen that BMS dissectors followed a standard protocol, 
they were very much aware that they did not always do this themselves. This was largely 
considered to be of little consequence, however, as seen earlier, variation in practice leads to 
higher error rates (ACOG, 2012; Haynes et al., 2009). As there is no form of quality checking for 
this procedure, also discussed earlier, unnecessary variation should be avoided wherever 
possible. The latter quote certainly indicates an intention to make an individual judgement and 
sampling based on that judgment. That pathologist went on to indicate that one of their 
weaknesses was sometimes not taking enough blocks, indicating a deviation from normal 
practice. This is despite being well aware of the SOP and the tissue pathways. This is also seen 
in the attitudes of the other pathologists, in that there is an undercurrent indicating that they 
are sufficiently trained / educated that they can address a specimen on its individual merit, 
whereas they would expect the BMS to follow the SOP. This seems to be an example of “do as I 
say, not as I do”, the consultants feel that they are happy to introduce variation based on their 
experience, which they would not expect in practice by the BMS. This contradiction is not new, 
nor confined to doctors or medicine (Kantele et al., 2010). This option to make their own choices 
was worn almost as a badge of honour, and clearly became an aspiration of the expert BMS. 
“there’s always that stipulation that it’s guidance, and not mandatory” was a comment made 
by one, another adding “I know that we do do things a little differently…” 
One pathologist felt that one of their strengths was their ability to demonstrate and teach 
dissection principles. This, they felt, was due to their level of knowledge and experience.  
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“I’d like to think that because I was trained to do dissection very much as part of my job, I would 
very much be able to sort of apply the principles of good dissection to any specimen and what I 
also hope is a strength, is that I’m always very keen on passing on those skills in terms of 
explaining those skills to others.” 
This enthusiasm for teaching has been beneficial to both the Advanced and Expert BMS during 
their training, as this pathologist delivered a great deal of the training. However, as they 
themselves gain experience and competence, the importance of consultant led training is 
diminished as the BMS becomes a more independent practitioner, who themselves begin to 
train others. Naeger et al. (2014) demonstrate that no significant advantage is found when 
teaching is performed by a resident (registrar or Expert BMS equivalent) or an attending 
(consultant equivalent) in radiology. This is backed up by several other studies, including 
Donnelley et al. (1989) Whittaker et al. (2006). Further, performing teaching serves as an 
important learning opportunity for the more junior member of staff (Wamsley et al., 2004; Hill 
et al., 2009; Zabar et al., 2004). Wamsley et al. describe a literature review covering Residents 
and teaching. They noted that residents’ self-reported skills in teaching were increased over 
time, and in concert with teaching training programs. They also suggested that teaching skills 
may decline over time. Hill et al. make a number of good points in regard to near-peer training. 
The authors note that the resident may well be better placed to teach ancillary skills of time 
management, role constraint and appropriate practice. The competent BMS is perhaps better 
placed to train in BMS dissection, than a consultant pathologist. Zabar et al. report in detail on 
objective structured teaching exams (OSTEs), noting that the teachers reported these to have 
been an educational experience. OSTEs serve as an opportunity to observe teaching skills in a 
modelled clinical scenario and are representative of normal practice.   
There appear to be two main benefits to using Expert BMS to deliver training to more junior 
BMS; they are near-peers and they are consciously competent (Snell, 2011). As individuals much 
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closer in career standing to the trainee than the consultant, it is easier for the trainee to relate 
to the trainer. Being consciously competent means that the trainer is actively aware of the how, 
what, where and why of what they are doing; as such they are better placed to pass this on to 
the trainer. Snell (2011) goes on to note that those residents who are rated as better teachers 
tend to have higher levels of knowledge, enthusiasm and job satisfaction.   
Whilst the level of experience might be expected to correlate to higher performance, the data 
in the results section demonstrates clearly that this is not necessarily the case. However, 
knowledge is shown to correlate well with performance (Nakhelh, 2013). Nakhleh notes that 
knowledge, and knowledge of ones’ limitations, is of paramount importance when considering 
error rates and systems.  
Some of the expert BMS commented on their level of knowledge, reflecting that performing 
slide review had given them a significant insight into the application of that knowledge in 
dissection.  
“good knowledge of the microscopy aspect of the specimens I’m dissecting, … which I think helps 
when you’re looking at the whole picture, the clinical picture” 
Another was able to reflect on their own practice, and contrast their knowledge against their 
perception of the consultant level of knowledge. They felt that they had good experience of 
macroscopic pathology, but they lacked knowledge of how well that correlated to the diagnostic 
features being seen on the microscope slides: 
“I do feel that there’s a big gap and that needs to be improved. Slide review sessions, I think they 
need to be more often and more structured. So [that] we’re doing them weekly” … “And I think 
the only way to get them stronger now is by having more slide review and looking at my macro 
and discussing it” 
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This sentiment, that the microscopic knowledge was integral to the dissection process, was also 
echoed by consultants.  
“I think one of the main ways you know how to cut up, is by reporting the specimens you cut up.  
There are obviously very good guidelines and now the tissue pathways from the college are all 
useful, but I still think that the only way to know how to cut up is to report a reasonable number 
of specimens that you’ve cut up.” 
“I think it’s vitally important that we do go back to slide review, so dissectors who have dissected 
specimens, they need to have adequate time in the week for slide review. I think that is lacking 
in the department, that will enhance the way the person will approach the specimen” 
This desire for the BMS to have a greater knowledge of the microscopy aspect is explored in 
more depth later in the thesis the final theme of “Microscopy”, the final theme in this chapter 
on page 157. 
Knowledge of the wider pathological picture and of the evidence base behind the RCPath 
guidelines was lacking in the BMS when compared to the pathologists. Although this knowledge 
was not uniform across the pathologists. One pathologist was deeply involved in drafting the 
guidelines for the British Association for Gynaecological Pathology, and very well aware of the 
current literature for their specialist areas. Whilst another admitted that they were not as up to 
date as they felt they ought to be.  
“Well, I don’t know how much I’ve kept up to date, not as much as I ought to have done.” 
Overall, however, there was a reasonable awareness of, and engagement with, the literature.  
“….I’ll read through articles that are relevant to my practice, so I might not read all the articles, 
sometimes I will venture into one or two skin articles and so on, depending on the nature of the 
topic, but on the whole I tend to read through areas that are relevant to my areas of practice, 
but again, focusing on diagnostic applications rather than the raw science.” 
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The BMS showed much lower level of engagement with the literature. The expert BMS showed 
some awareness of and a small amount of engagement with the literature. 
“I haven’t looked, not really. Unless there’s something, unless it’s got some relevance to the 
specimen…” 
“I’ve read some of the gynae references “ 
The advanced BMS showed even less awareness and engagement. 
“I’m vaguely aware of it.” 
“Not really …… I haven’t looked at the evidence behind that” 
“I haven’t read any of the literature.” 
Whilst this is not necessarily a problem, obtaining knowledge from multiple sources is an integral 
part of being a practitioner, rather than a technician (Crawford et al., 2006). In the initial stages 
of training, observation is a key learning tool, however, this needs to be consolidated with an 
engagement with the appropriate literature. In the early stages of practice, the appropriate 
literature will be text books, RCPath tissue pathways and similar documents. When operating as 
a practitioner, the engagement needs to be with a deeper level of literature, that being the 
primary scientific documentation. Despite the Expert BMS previously expressing dissatisfaction 
with their level of knowledge, there is a definite lack of desire to invest time in the primary 
literature. Part of this clearly comes down to time, repeated mentions were made of time 
pressures, and the inability of the individual to complete the required tasks, even regularly 
working beyond their contracted hours.  
“that it’s in your own time and if you want to learn any of these extra things, which I don’t mind 
doing to a certain degree, but I do feel that if it’s necessary for my job, it should be part of my 
everyday as well.” 
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“when that does happen, it usually has to be in our own time” 
“I think we have definite lack of time…” 
The conflicting demands placed upon the BMS were mentioned repeatedly, with the result that 
there was insufficient time to complete the routine workload. This had the effect that many, if 
not all, of the BMS were putting their training and development on hold. The lack of progression 
in their knowledge, and lack of engagement with the wider clinical team, can be largely 
explained by a lack of suitable staffing.   
Standardisation – “there was a little bit of not everyone not doing the same thing” 
This was a topic that was mentioned by all interviewees, to some degree. The advanced BMSs 
commented that there was good theoretical standardisation, with comprehensive SOPs giving 
good guidance on dissection. However, how well the SOPs were adhered to was questioned and 
whether or not the SOP had even been read: 
“…but whether everybody follows the SOP to the letter, I don’t think they do. I think there’s 
probably a great deal of variation between staff members” 
“…have people actually read the SOP?” 
The data seen in the baseline round would indicate that these individuals were quite correct in 
thinking there was a great deal of variation. The Expert BMS commented on variation, in terms 
of the requirements of the pathologists. Despite all working to the same guidelines and 
minimum datasets, there is variation in how the pathologists interpret them, resulting in 
variation in how they wish dissection performed.  
“…at one point some of us weren’t doing it, because one pathologist told me that I didn’t need 
to do that, then I got told otherwise, so there was a little bit of everyone not doing the same 
thing.” 
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“….with Dr X I always take a background block with a cancer case, but recently Dr Y said ‘I don’t 
need to see that, you’ve just given me normal background, if you’ve said it’s unremarkable, I 
don’t expect you to take it.’” 
The second quote was in relation to colorectal cancer resection, where the RCPath guidelines 
do specifically state that representative block of the background mucosa should be taken. The 
guidelines are not obligatory, and individual pathologists / laboratories are able to determine 
their own local practice; in this case the recommendation is met, albeit incidentally, in that the 
resection margins are sampled. This provides a piece of mucosa that is, given adequate surgical 
clearance, free of the tumour and therefore constitutes background mucosa. The dataset 
document (RCPath, 2014a) gives clear guidance that this is part of the recommended minimum 
sampling, and gives the reason for sampling (for microsatellite instability or germline testing).  
This variation is reflected in many other areas of dissection, where one practice is required for 
one pathologist and another practice is required for another pathologist.  The more complex the 
individual resection is, the more variety there is from individual consultants. Simple specimens, 
e.g. appendix and gallbladder, are easier to reach a consensus on how they should be 
approached. Despite all specimen types showing a similarly high level of variation in the initial 
baseline data, a collective decision on how to handle these specimens had already been reached, 
and introducing the checklists clearly brought everyone back on target. However, the checklists 
are not able to cover every eventuality and attempting to do so would remove their 
effectiveness (Bosk, 2009; Frakes, 2007). With the colorectal cancer specimens there is great 
scope for variation in practice. The checklists were based on the minimum dataset from the 
RCPath and on their tissue pathways; as the graphs show there was clearly great variation and 
the checklists reduced that variation. However, that only measures the variables that were 
checked, there are a great many other areas of potential variance. Attempting to standardise 
the requirements of the pathologists is one step in reducing this variance, although this must be 
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combined with allowing the dissector and pathologist the freedom to act according to their 
judgment in non-standard cases.  
It is ironic, then, that after being identified as a substantial source of variation, the pathologists 
themselves identified a lack of standardisation as an issue. The consultants highlighted variation 
in practice as a weakness and a possible area of difficulty; they were also aware of their own 
variance and how that might have a negative effect on the training of other dissectors.  
“{weaknesses] I’d say for me, it’s the variance. There is a degree of variability,” ….. “if we have a 
standard approach to specimens, in terms of assessment, description as well as blocks taken I 
think that will help to improve a lot of the areas” 
“…consultants have a degree of variance in terms of how we approach specimens ….. that 
sometimes has a negative impact on the BMS, because they will then see different practices and 
then that introduces a degree of doubt or uncertainty …. if the consultants have a more agreed 
standard approach, that would help overall.” 
Knowledge and experience came in to consideration in this area also. Variance in and of itself is 
not a negative factor; the skills of the dissector must be such that when presented with a non-
standard case, they are able to employ non-standard methods in order to answer the clinical 
question fully. However, variation is something that should be employed towards a specific end, 
not due to drift in practice.  
“I think you need a degree of experience to allow you to know when you should adhere to certain 
protocols, or when you can be at slight variance to it” 
“…crucially, it’s also being aware of the impact in terms of when you’re taking blocks and so on, 
that has on the microscopy” 
One pathologist also noted that reducing variation engendered more confidence in the 
dissectors, enabling them to practice with self-assurance and know where their limits are.  
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“I think we’ve got a good training structure which gives dissectors confidence in the way they are 
operating, so they can seek advice as and when needed.” 
A comment was made from a pathologist regarding another consequence of reducing variation. 
They noted that as there was a standardisation of practice, this lead to less revisiting of 
specimens, reducing interruptions to practice and removing delays from the pathway.  
Another pathologist, when considering how we could build on this work, and how to improve 
dissection standards, felt that diagrammatic SOPs were the way forward. They had seen this 
used to great effect in other laboratories; having seen how the reference diagrams reduced 
variance in this work, they felt that there was scope to expand the range of these diagrams. 
“…practical SOPs that are easier to access, and in a picture format, I think that will enhance 
standardisation.”   
Feedback – “You’re working blindly” 
This is a topic which was discussed universally. Feedback has many times been called the “heart 
of medical education” (Branch and Pranajape, 2002; Kaul et al., 2014).  Communication is rightly 
considered to be of paramount importance in teaching and training; failures in these areas are 
associated with the Joint Commission reporting that 70% of Sentinel Events are due to 
communication failures (Dhingra, 2010). This communication must be multidirectional. The 
process of dissection may be considered a method of communicating information regarding that 
specimen to the pathologist, there must be communication back to the dissector to enable them 
to have confidence in their practice. The training in the department follows the general pattern 
in medical education, with a variety of lectures, self-directed learning, directly supervised 
practice and indirect supervision leading to practicing independently, but within a hierarchical 
framework. The theory and science behind the practice is delivered both during formal learning 
and informal conversations when viewing cases – either macroscopically or microscopically. 
Once a practitioner (either a trainee pathologist or a BMS) is working without direct supervision, 
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providing adequate feedback becomes very important. Feedback must be of sufficient depth to 
enable learning, but not so detailed that the practitioner becomes lost in the minutiae; it must 
be targeted to a specific case or specific cases, not general non-specific feedback and it must be 
timely enough to enable the practitioner to still be able to reflect on the case and apply the 
feedback to the case(s) (Branch and Paranajape, 2002; Archer, 2010). 
Advanced BMSs commented in relation to the feedback events that: 
“I thought they were very good. I learnt a lot from them. Because you’ve got the pathologist 
telling you these things and telling you why you need to do them. I did find them very helpful, 
yes.” 
“I think that any input that the pathologists can give is always good. And can also highlight, not 
exactly mistakes, just kind of maybe, assumptions.” 
Another, on being asked their opinion of the feedback event, exclaimed: 
“Bloody great! Yeah, really good.” …. “It’s a bit of recognition, it’s them saying, yes you’ve done 
this right and a few cases where they’ve said, this could have been done better. So, presumably 
better standardisation. It’s just nice to get a bit of interaction and get a bit of the history of the 
case.”  
Commenting on feedback from the pathologists generally, they went on to say: 
“the pathologists, if they don’t think you’ve given then enough information on the macro they 
should be bringing it back to you, but whether they do, or if they don’t bother….” 
One of the expert BMSs also commented on the feedback events: 
“I thought they were very good. Overall I think that they might have been more beneficial to the 
band 6s and below. From my point of view some of the specimens they dealt with were a bit 
basic” 
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These thoughts were echoed by another expert BMS: 
“I thought, to start with, as an individual I didn’t think they were good, because I thought they 
were of limited value for me. Then [thinking of training others] I had a different perspective. So 
think they could have been described a bit better to get people engaged. To say ‘look, this is one 
of the audit processes we’re going to put in place’ but we didn’t think of that until after. ‘This is 
its value, it’s not to pick fault with anyone, it’s to look at the process.’ So I think we could have 
shared it better, obviously we’ve got value in it, and we’ll try and share it that way from now on.” 
Whilst the Advanced BMS enthusiastically welcomed the training events, not all of the Expert 
BMS were as open. There was some hostility towards the event; when exploring the results and 
reduction in variation the results were questioned quite aggressively: 
“Was this with slide review?” … “So what difference did it make?” … “Are you aware of any SOP 
changes in that time though?” 
However, another expert BMS found them very useful personally, and contrasted how little 
feedback they otherwise get from the pathologists: 
[Prior to the feedback events] “…you have a few weeks or months where you don’t get any sort 
of feedback. You’re working blindly” … “I feel like I have no idea how I’m doing” … “And you wait 
to hear feedback…” 
[With the feedback events] “Brilliant. It’s been a bit infrequent. But, yes. Definitely invaluable, 
because that’s the feedback that you want constantly.” … “everything that I said seemed to 
marry what he’d seen. That was really good.” 
Those pathologists that were less actively involved in the sessions seemed to have a less positive 
view, although they could still see the value: 
“I think that’s always good, to keep the link between the dissector and the pathologist, enhance 
that and I think that will strengthen the relationship between the dissector and pathologist and 
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ensure that whatever the pathologist deem is important for them to report is fed back to the 
dissectors.“ 
Others, who were more engaged, found they got more out of the experience; the BMSs 
attending these sessions also reported getting more from the sessions with these pathologists: 
“I thought they were very useful. I thought that, again, it gave an opportunity for feedback, which 
is always a good thing. And it was also a mini teaching opportunity, in that people were able to 
ask why we do things in a certain way for a certain specimen. It wasn’t just a tick box exercise, 
in that there were sometimes issues with a specimen, in that margin wasn’t very well orientated, 
or not enough blocks had been taken from a particular area, or sometimes too many blocks taken 
from a particular type of specimen. So for that I thought it was very useful. I know that [….] 
members of staff have given that direct feedback.”  
One of the pathologists was very enthusiastic regarding feedback, and the feedback events 
specifically. They have been key in making these sessions happen and a driving force for these 
to become a routine part of departmental practice: 
“In terms of feedback, I think having the direct feedback sessions with the operators, with the 
band 6 and 7s, I think it’s useful, the more contact the 6s have with the medical staff and the 
consequences of what they do, it’s realising that it’s not just taking a block, this block is then 
going to go on and formulate a part of this patients record. So it’s having that insight and 
realising the importance of that, and I think sometimes that can be enhanced by having those 
feedback sessions with those end point users, which in this case would be the pathologists, to 
say I was able to do x, y & z because of what you’ve given me. And then explaining why they need 
to take certain blocks, so having that clinical feedback will only enhance the service. Direct 
pathologist feedback to the dissectors is a valuable part of the training.”  
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Microscopy – “The amount I learnt is amazing!” 
The advanced BMS had not considered the implications of slide review, or what might be learnt 
from doing so. The expert BMS had given this area considerable thought, and were passionate 
in their desire for more slide review. 
“I think the only way to get stronger now is by having more slide review” 
“I do feel that there’s a big gap [in knowledge] and that needs to be improved. Slide review 
sessions, I think they need to be more often and more structured.” 
“One on one slide sessions with pathologists [are not happening regularly]. And I think the fact 
that when that does happen it usually has to be in our own time, that’s definitely something that 
needs to be looked at.  
“…lack of slide review time. It is important, I don’t think you realise how important it is until you 
do the microscopy pilot. The amount I learnt [dissection applicable knowledge] is amazing.  
The expert BMS were unanimous in their desire for more slide review, and in the importance 
they placed on it. There is a newly created professional pathway for BMS – microscopic reporting 
(Liebmann, 2015). This is separate from the microscopic slide review that forms a part of 
dissection training and is outside the scope of this investigation, although it is of considerable 
interest to the dissectors.  The participant comments suggest that reviewing a number of cases 
that an individual has dissected, with the pathologist that has reported them, enables the 
dissector to better appreciate the needs of the pathologist and understand how the information 
they are communicating is being interpreted by the pathologist. It also serves as a valuable 
educational tool, topics are encountered and explored by an informal question and answer 
session, and this highlights any areas of weakness in knowledge, allowing the dissector to then 
study further in this area. This provides more than isolated pathological or clinical knowledge it 
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allows the dissector (whether junior pathologist or BMS) to understand how their dissection 
practice effects the microscopic interpretation and report. 
The pathologists had, in the main, been trained to dissect and report cases; the more recent 
transition to reporting cases without having seen them macroscopically has been undertaken 
successfully. This leaves the vast majority of dissection performed by BMS, without the 
pathologists ever seeing the specimen. The pathologists did comment that despite the BMS role 
being limited to dissection, there was great value to regular in-depth microscopic review of 
cases.  
“I think one of the main ways you know how to cut up, is by reporting the specimens you cut up.  
There are obviously very good guidelines and now the tissue pathways from the college are all 
useful, but I still think that the only way to know how to cut up is to report a reasonable number 
of specimens that you’ve cut up.” 
“I think it’s vitally important that we do go back to slide review, so dissectors who have dissected 
specimens, they need to have adequate time in the week for slide review. I think that is lacking 
in the department, that will enhance the way the person will approach the specimen.” 
Summary 
The interviews showed a clear progression in thought process, in line with the complexity of the 
dissected specimens. The advanced BMS, largely, lacked an awareness of the wider picture in 
which their practice sat; there was also no consideration of their practice on a deeper level, their 
thinking was largely confined to that of following a protocol. The expert BMS, however, showed 
clear evidence of wanting to look more deeply into their areas, they were keen to become 
involved with clinicians and to expand their areas of knowledge. The consultants had a good 
level of knowledge, appropriate to their specialism. They also had knowledge of the wider 
clinical picture, something that the BMS lacked. One way of addressing this lack has been 
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participation in microscopic slide review, something which has become increasingly ad hoc and 
time constrained within this laboratory.  
The level of knowledge required to safely practice increases in line with the complexity of the 
cases being handled. Dissectors begin with simple tissue transfer, where a simple description is 
sufficient. They progress to parts of organs and whole organs, where a deep knowledge of the 
anatomy, physiology and pathology is required to enable the specimen to be placed 
appropriately within its clinical context. Section 3.20 of the Barnes Report (2014) clearly states 
the need for an appropriate level of knowledge, with on-going updates and development. This 
is something which is the participants feel is being neglected, as a consequence of time 
pressures. Whilst the baseline and checklist data indicate that practice is currently at a safe level, 
neglecting professional responsibilities can ultimately lead to serious negative consequences as 
seen in the Francis report (2013) and the Bristol Royal Infirmary Heart Surgery Inquiry (Kennedy, 
2001).  
Feedback and microscopic slide review were keenly sought, as a route to improving knowledge 
and practice, with much of this being done in the dissectors’ own time. Time to perform the 
additional, quality enhancing, duties was felt to be in short supply, with dissectors just barely 
able to keep ahead of the practical dissection workload. The expert BMS all felt that there was 
insufficient time to complete the required paperwork, audits etc. and that slide review was a far 
lower priority than it ought to be. The strong desire for more microscopy fell outside any desires 
for reporting. Two of the expert BMS were involved in the IBMS / RCPath BMS reporting pilot, 
and were able to convey how much difference that had made to their understanding of their 
practice. However, the microscopy training that they were receiving as part of this pilot is not 
the same as case review and they both felt that case review was of vital importance to a high 
quality diagnostic service. The other strong theme was the benefit of the feedback events. The 
advanced BMS got more from these sessions than the expert BMS, this being a consequence of 
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the sessions being pitched to cover specimens that all dissectors would handle, they were a little 
simplistic for the more experienced of the expert BMS. However, they could still see the benefit 
and welcomed further sessions, with the hope that more complex cases would be included.  
Francis (2013) reports that there should be “Regular comprehensive feedback on performance”, 
whilst speaking in that instance about nursing, the point clearly applies across the professions. 
He also acknowledged the need for timely feedback, even suggesting real time feedback is 
desirable. In his conclusion he noted that “learning opportunities were denied through lack of 
feedback”, something which is clearly happening in this laboratory.  
The consultants showed a definite desire for the BMS, at all levels, to show greater 
standardisation and, during the dialog, began to realise that they were, in part, a cause of that 
lack of consistency. Their own variations in practice started to become more apparent, with an 
acknowledgement that this was not conducive to good training. The pathologists were very 
supportive of this investigation as a tool for quality control amongst the BMS, but seemed to 
feel it was somewhat beneath them. The data gathered would indicate that the checklists may 
be more relevant to their practice than to the BMS. The Expert BMS also seemed to view the 
checklists with an amount of condescension, in that that they knew what they were doing. One 
stating “I know that I’m doing it, I know. Because I do, I’m very methodical”, however, the results 
at baseline and after introducing the checklists show very clearly that no-one was working fully 
to protocol showing a lack of awareness of their own practice. The advanced BMS were the most 
enthusiastically engaged, they responded very well to the introduction of the checklists and 
embraced the new methodology. The results after the introduction of the training intervention 
demonstrate, that despite the somewhat dismissive attitude from some quarters, everyone 
showed a noticeable increase in conformance to protocol.  
The consultants were not the most resistant to monitoring and assessment, the long held 
attitude of “Doctor knows best” has translated into a desire for similar autonomy amongst some 
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of the expert BMS, with a resistance to objective assessment and standardisation. However, the 
strength of the data produced in this investigation appears to have demonstrated the value of 
a standard approach to both the consultants and the expert BMS. This is acknowledged in the 
report into pathology quality assurance by Barnes (2014). He report that there was too much 
variation in pathology practices, which was unacceptable to patients and service users. Further, 
he called for the relevant professional bodies to produce national standards and protocols to 
reduce variation and increase standardisation. 
The overarching desires were for regular, structured feedback sessions and slide review; it was 
thought that this would enhance knowledge and further standardisation. The desire for the 
feedback sessions was such that, despite the previously stated time pressures, each session was 
very well attended.  
At the end of study 3, three interventions had been trailed (checklists, training intervention and 
guide diagrams), with a series of conversations to allow for adaptation during the investigation, 
and the interviews. The investigation was brought to a close by formally thanking the 
participants for their contribution and providing an overview of the results achieved. 
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Chapter Five – Discussion 
Summary  
The thesis this far has covered a lot of ground. From concerns about patient welfare leading to 
reviews into quality in pathology, to the concept of KPIs backed up by evidence based practice 
and how to ameliorate poor performance. A comprehensive assessment of the scientific 
literature around specimen dissection and the importance of standard practice has been 
performed in the literature review. The importance of evidence based practice has been 
discussed, along with the utility of Key Performance Indicators. How to use this information in 
order assess practice has been investigated in the studies performed, revealing a great deal of 
variation in practice. This variation was then addressed by three interventions (the checklists, 
the training event and the diagrams). The interventions have been developed after careful 
consideration of the areas discussed in the literature review, namely learning theory and change 
management. The interventions are constructed in such a way as to encourage a team approach 
and to foster a collaborative atmosphere to the development of the dissectors. The effect of 
each of these interventions and combinations of interventions, and also the absence of the 
interventions, has been assessed in the studies forming this research.  
The results 
The results from the data collection, indicating the starting point, show considerable variation 
in the way that individuals handle and describe specimens. The appendix analysis demonstrated 
a clear split in the BMS group, with different sampling practices between the two groups. The 
differences did not have any appreciable outcome on diagnosis or workload, but do highlight 
variation in practice, which, as established in the literature review, leads to greater error rates 
and worse patient outcomes (NHS England, 2014b; Shia, 2012; Ludeman & Shepherd, 2006; 
Verrill, 2004). The data from the pathologists demonstrated a broad conformity; one pathologist 
was noted to show the same variance in sampling seen in one BMS group. Investigation into the 
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discrepancy revealed that the difference was due to a change in the SOP, which some people 
were unaware of. The change had been made over a year previously, to bring the sampling in 
line with the RCPath guidelines; however, these staff members were somehow unaware of the 
change.  The results from the gallbladder show a similar split in sampling and description across 
two groups. This variance with the dissectors revealed a difference in training of the BMS staff. 
BMS 1, 2 & 5 had been trained by one consultant and BMS 3 & 4 had been trained by a different 
consultant. The difference related to the site of sampling – the fundus is the area that should be 
sampled, BMS 1, 2 & 5 had been doing this, however, BMS 3 & 4 had been taking a transverse 
section through the body of the gallbladder. The fundus should be sampled as this is considered 
by the lead GI pathologist as the most likely site of any incidental pathology. This triggered a 
review of the SOP and the underlying reason for the preferred sampling was stated in the SOP. 
The updated SOP was communicated to the dissectors in a group meeting and the reason for 
this explained.   
The colorectal data clearly demonstrates the application of the checklist and feedback sessions. 
There are far more data points for the colorectal than in the other specimen types, indicating 
the higher level of complexity in these specimens; the wide variation in data seen from the first 
round of data collection shows how much variation in practice there is. All dissectors should be 
working in the same way, yet the data clearly shows that this is not the case. Even amongst the 
BMS dissectors that have been trained by the same people, there is still a variation. This variation 
completely disappeared from the BMS group with the introduction of the checklists and this 
change persisted with the introduction of the training intervention. Two of the pathologists 
showed the same response, the others showed a more variable response. The two BMS are both 
in training and working towards an advanced level dissection examination, as such, they are 
both invested in their training and professional development. The pathologists are used to 
working under their own direction and making their own individual judgements, rather than 
following a protocol. As such, it is perhaps unsurprising that their data output is more variable. 
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Whilst there is no direct indication that these variations have had an impact on diagnosis, it does 
show unnecessary variation in practice.  
The variations are clear to see, as are the improvements with the introduction of the checklists 
(Figure 6 on page 81 to Figure 9 on page 84). Comparison between the baseline and first round 
shows a distinct reduction in variation. The introduction of the checklists resulted in 
standardisation in practice. Having the checklists available at the point of dissection appears to 
have focused attention on the process of dissection and allowed dissectors to think more 
specifically about the specimen without distraction. Discussion with several of the dissectors has 
indicated that reading the checklists highlighted requirements that they had not been aware of 
and that some used the checklist as a memory prompt. The introduction of the checklist allowed 
dissectors to become aware of what information was being collected, this prompted dissectors 
to ask questions and check the requirements of the SOP. One of the pathologists felt that the 
presence of the checklists enabled the dissector to focus on the specific requirements of the 
complexities of the individual specimen, whilst using the checklist to ensure they were 
performing all of the mandatory operations and satisfying the demands of protocol.  
The introduction of the training feedback intervention (Figure 10 on page 87 to Figure 13 on 
page 90) continues the trend of standardisation of practice between the BMS dissectors. 
However, the pathologist dissectors, after showing an initial improvement, do not respond as 
well. Part of the reason for this is that whilst there has been a full and enthusiastic engagement 
from the BMS dissectors, the engagement by the pathologists has been more variable. Some 
pathologists appear to have taken the view that this is a worthwhile and important exercise for 
the BMS, but that they are above such assessment. It is these pathologists that show the highest 
variation in practice. Those that have keenly engaged and are open to assessing their work are 
those that have shown the greatest change. This links in with some of the points noted in the 
literature review, in relation to attitudes. The attitudes of medical doctors have come 
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increasingly under focus in recent years, this is not the large headline hitting activities of a rogue 
doctor, such as Shipman, but the routine, day to day attitudes of the profession and how that 
reflects on the best patient outcomes. The historic approach of “doctor knows best” (Kennedy, 
2001) must continue to change, with more collaborative working and a more developed team 
dynamic. Each successive report into the NHS, and there have been many, Walshe (2001) details 
10 major inquires leading up to 2001. Only the earliest study referenced in this work (Kennedy, 
2001) is included, Francis (2013), King’s Mill (RCPath, 2013) and Barnes (2014) have all occurred 
since then, showing that whilst changes have been made, there is still work to be done. As noted 
in the literature review, Dixon-Woods (2011) provides an in depth commentary on the changes 
in the public perception and status of medical doctors. As such, it behoves the pathologists to 
accept that their own status has changed. Clearly, they are highly skilled, knowledgeable and 
extremely important to the patient pathway; what they are not, is beyond question. The 
pathologists and BMS must work more closely as a team, with the goal of the best patient 
outcome and a shared responsibility for that. In aviation a catastrophic error in flight is likely to 
result in the death of all on board, who is responsible for this is something of a moot point if 
everyone has died. As such, a more collaborative approach is seen in the cockpit, with far less 
hierarchy and rigid deference to rank. Ornato and Peberdy (2013) particularly noted the 
difference in attitudes between pilots and surgeons. They, along with Sexton et al. (2000) 
reinforced the importance of open communication, flat structure and shared goals in high risk 
environments. This is something which we have seen develop over the course of this 
investigation, with the increased communication leading to greater regard for the skills of the 
BMS by the pathologist; however, this appears in some cases to have fostered the attitudes 
previously seen in the pathologist in the newly competent BMS dissector. Clearly, this is not the 
flattening of structure that is desired. More work in this area, by continuing the Feedback Event 
and extending its scope and utility is hoped to address this. 
166 
 
I stated above that the data is almost overwhelming in scale, Figure 2 on page 75 to Figure 33 
on page 116 all detail variation through the different studies, with different specimen types. 
Thirty two graphs is a great deal of data, the key graphs are Figure 34 on page 117 to Figure 38 
on page 131. Figure 34 to Figure 37 each show the trends over time for each individual, 
separated by specimen type. Figure 34 shows a near immediate transformation in appendix 
dissection practice by all the BMS dissectors, whilst some improvement is also noted from the 
pathologists, it is not as pronounced. Figure 35 portrays a similar picture, this time for 
gallbladder dissection. A more chaotic pattern is seen from the pathologists, whereas the BMS 
dissectors converge towards 100% conformance very quickly. I note below that the colorectal 
cases are more complex, despite this, Figure 36 shows the BMS dissectors immediately moving 
to 100% conformance, and staying there. The pathologists also move towards 100%, although 
with less speed. Figure 37 shows a less clear cut response, but again, the trend is towards 100% 
conformance, that is to say, lack of variation. In Figure 37 almost all the dissectors move towards 
100%; pathologist 4 shows a rather erratic pattern of practice. The most important graph 
though, is the final one. Figure 38 on page 131Figure 37 shows the average conformance to SOP 
for all individual dissectors over all studies. The solid lines are BMS dissectors and the dashed 
lines are pathologist dissectors. The solids lines almost immediately reach over 75% 
conformance, and remain there. By the final round, all the BMS dissectors are returning an 
average conformance of at least 90%. The pathologists also show a reduction in variation, those 
who remain in the programme throughout all converge towards 100% by the final rounds, those 
who drop out in study 2, part 5 are at least now showing over 50% conformance. Figure 38 very 
clearly demonstrates that this programme works, it has achieved its main goal.  
The checklists & training event 
The first intervention was the introduction of the checklist. The literature review discussed the 
use of checklists extensively. They have been used to great effect in aviation, with a more limited 
use in medicine, despite their clear potential. Part of the reason for this discrepancy, as was 
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noted in the literature review, was the team approach seen in aviation, in contrast to the 
individualistic autocratic approach more traditionally seen in medicine. This intervention was 
seen to reduce variation in practice (study 3), although there was still variation noted. 
Study 2, part 2 led to the second intervention, which was the introduction of the Training Event. 
The aim of this intervention was to enable a structured feedback forum, where all dissectors 
could engage in an open dialogue. This enabled a conversation regarding how to describe and 
sample specimens, where BMS dissectors could speak with each other and with pathologists to 
reach an agreed approach. Whilst a uniform approach should have been in place, as there are 
SOPs based on RCPath guidance, the data clearly shows that this was not occurring. The 
intervention allowed engagement from the dissectors as a team, rather than an instruction 
directing how they must act. This further reduced variation (study 2, part 3). 
The third intervention was introduced in study 2, part 5, this was the use of guide diagrams 
(appendix 4). The aim of this intervention was to reduce variation in those who had not engaged 
with the feedback event, notably several of the pathologists. The diagrams were not well 
received, and did not appreciably alter the level of variation in practice and so were removed 
after two rounds of data collections (study2, parts 5 & 6).  
The combination of the checklists running with the training event appears to be the most 
effective, both in terms of the level of reduction in variation and in terms of the level of 
engagement from the dissectors. Using the checklists to generate anonymous data to 
demonstrate what is occurring, rather than working from assumptions, but actually being able 
to demonstrate hard evidence, provides an intellectual “hook” upon which the individual can 
hang the new ideas and practices. The training event satisfies the BMS desire for feedback, and 
creates a closer working relationship with the pathologists. As the pathologists seldom attend 
the training sessions run by another pathologist, this provides an opportunity for the BMS to 
make the pathologist aware of conflicting requirements – e.g. they have indicated that a 
168 
 
procedure should be performed in a certain way, whilst their colleague has indicated it must not 
be done this way. This has sparked discussion between the pathologists, leading to discussion 
of their intent and motivation behind those decisions, ultimately resulting in a standard 
approach from the pathologists. There remains some hope that some of the pathologists will 
attend at least some of the sessions run by another pathologist.  
One of the aims at the outset of this research was to investigate the use of KPI in dissection and 
see if they could be applied to create a dataset indicating performance standards. This has been 
achieved, the dissection checklists are based on the recommendations of the RCPath and local 
protocols, with best practice in surgery guidance used as a starting point. The specific data points 
on the checklist are less important that the checklist itself. As demonstrated in the Pronovost 
study (2006) checklists can be modified to suit the specific requirements of the individual 
environment, whilst still remaining a powerful tool for regional or national data collection. The 
checklists used here (Appendix Four – Dissection Checklists, on page 210) are discussed in detail 
later in this chapter, but it is worth noting at this point how customisable they are. If this work 
forms the basis of a national framework to address the deficiencies highlighted by Barnes (2014), 
a consensus on a set of key data points would need to be reached. Once these were agreed, the 
checklist might contain some optional points, and space for local protocol to add points that 
were important to that specific laboratory or region. As Bosk et al. (2009) takes great pains to 
point out, there was not one single checklist for the Keystone study (Pronovost, 2006), there 
were in fact over 100 versions. The checklists used in their study covered one procedure, the 
insertion of a central line catheter, and contained five key items. The ICU departments taking 
part in the study were each encouraged to customise and develop the checklist to address the 
issues and culture within their own environment. In this study four distinct checklists have been 
used for four clearly differentiated specimen types, clearly, there is room for further 
development of the dissection checklists, enabling users in other laboratories to customise them 
according to their own needs is a feature which has been considered from the outset.  
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Another aim was to use the KPI data to demonstrate variation and use this data to reduce that 
variation. This has clearly been achieved, with an abundance of graphs showing variation from 
all practitioners across all specimen types. The data is almost overwhelming in its scale, 
however, what is clear is that substantial variation in practice occurs at the beginning of this 
research, and the level of variation is reduced with the intervention of the checklists and the 
training event. The data gathered from the checklists enables demonstration of the variation, 
and demonstrating this to the dissectors at the training event is sufficient in many cases to 
eliminate that variation entirely. For others it is the dialogue at the training event, with the data 
to back it up, that engenders the change. For those that do not change, the checklist data then 
enables the final aim to be met, that of remedial and preventative action. Whilst the training 
event is sufficient to provoke a sustained change from most, some dissectors make a deliberate 
choice not to conform. Whilst there is an argument to be made for allowing autonomy in 
practice and allowing the dissector to use their judgement, this must be within the confines of 
good professional practice and the guidance given by the appropriate professional body (e.g. 
the RCPath and IBMS). This investigation has developed the training event, which has had a 
powerful remedial and preventative effect when the issue was a lack of knowledge or training, 
but where the issue has been a deliberate departure from recommended procedure, there are 
no sanctions in place for addressing deliberate variation. This lack of sanctions for poor 
performance is something which was highlighted in the Barnes report (2014), and something 
that would need to be included if this work is to be developed further.  
The pathologists have largely been keen to be involved in the delivery of the training event, 
however, less keen to participate. Very few of the pathologists have attended an event delivered 
by another pathologist, reinforcing the isolation and self-view of being “above” the BMS. Whilst 
clearly the consultant pathologists are more highly trained than the BMS dissectors, this attitude 
of being more important is reinforcing the “doctor knows best” isolationist issue. Most of the 
pathologists in post at the beginning of this investigation had considerable experience and a 
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certain way of working. Those that join the investigation in the final studies are more recently 
qualified and are perhaps more engaged with the most recent literature. They are, at any rate, 
more open to suggestions and changing their working practice. The traditional workflow within 
histopathology would see a pathologist dissect cases, and the perform the microscopic reporting 
some days later once the laboratory had processed the tissue samples on to slides. More 
recently, with BMS led dissection, the pathologists would report cases that were dissected in a 
specific manner (a single approach was agreed for the BMS dissectors, regardless of which 
pathologist would be reporting the case) by any suitably trained and qualified individual. In cases 
of staff shortage, e.g. sickness or annual leave, pathologists are asked to assist by providing 
cover in the dissection room. With current workflow practices, the pathologist may now not 
report the cases that they have dissected, meaning that it is equally important that they follow 
the designated protocols. This was the situation during study 2, part 8, the practice of 
pathologist 9 is clearly deviant from the standard protocol – as can be clearly see in Figure 30 
on page 113 and Figure 31 on page 114). They neither provide complete measurements nor take 
appropriate blocks for any cases of Appendix for the Gallbladder there is more variation, less 
than 10% of cases receive compete measurements, 55% receive a description of the external 
surface, 72% of cases have a known abnormality described, meaning that in less than 10% is the 
SOP followed. If all of the cases dissected by pathologist 9 were reported by them, and they 
possessed a prodigious memory, capable of holding all the information that they omitted from 
the macroscopic report, this may not be an issue. However, as the majority of these cases were 
reported by a different pathologist, this does become an issue. It is noteworthy that the 
microscopic reports of these cases were substantially longer than would normally be expected. 
As the specimens had received a cursory macroscopic description, which in some cases was 
contradictory, the microscopic report was, by necessity, very detailed. In some cases the 
reporting pathologist needed to view the remaining tissue from the specimen for themselves to 
clarify an issue / omission with the macroscopic description. 
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Having mentioned that (in this institution) consultant pathologists are largely called to the 
dissection room to cover shortages in BMS dissectors, we ought to consider the effect that this 
may have on their skills. As consultant pathologists, of many years of experience, they have a 
wealth of knowledge and skills in this area, however, by not practicing these skills they become 
deskilled. Their knowledge is unlikely to diminish, but some degree of practical skill will be lost. 
As noted in the study by Shaw (2008), specialist surgeons, specialist histopathologist and 
specialist BMS perform better, with significantly better patient related outcomes than 
generalists. By removing this activity from the routine practice of our consultant pathologists, 
this risks that the consultants will become generalists, performing at a lower level of quality than 
the BMS dissectors. This is not necessarily a negative of BMS dissection, as consultant dissection 
can be a routine event, it need not be of a high frequency in order to maintain proficiency – use 
of the systems developed here would enable an assessment of performance to ensure that 
practice was being undertaken with sufficient regularity. An additional area of practice being 
undertaken by the BMS now is histopathological reporting. Again, this raises the question of the 
scope of BMS practice, and how that relates to the practice of the medically qualified 
pathologists. Whilst beyond the scope of this work, some consideration might be given to how 
far the role of the BMS might be extended, and the impact that might have on the role of the 
consultant pathologist. It is the opinion of the author that there is no single area of practice that 
the BMS could not take on, however, the BMS (having undergone a very different training route) 
would not be able to take on the full breadth of all the duties of the consultant pathologist. The 
ever advancing BMS role can be considered to be akin to that of the registrar in histopathology 
and the advanced practitioner in cytology. Both are able to function with a degree of autonomy 
and take responsibility for their own cases, but work within a more restricted framework than 
the consultant pathologist.  
It is worth giving some consideration to the construction of the checklists, and how they might 
be developed to cover other specimen types. A common theme to all four specimen types is a 
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requirement to orientate the specimen, this may be proximal / distal, anterior / posterior, base 
/ tip etc, it is important to be able to consider the specimen in relation to its surrounding 
anatomy. This is especially true in the context of a pathology that may involve adjacent organs 
e.g. colitis involving one resection margin or colorectal cancer involving one of the 
circumferential resection margins. However, it may not be possible to orientate all specimens. 
A ragged, distorted and ruptured appendix may be so effected that the base cannot be clearly 
seen and the tip may not be recognisable; a gallbladder may have been cut into several times 
by the surgeon, it may be distorted by stones, rendering the cystic duct hidden and the fundus 
unrecognisable. A uterine corpus may be so distorted by fibroids that the relative positions of 
the anterior and posterior reflections may not be used to orientate the specimen. There are a 
number of possible situations in which orientation of the specimen may not be possible, 
however, these situations are not encountered particularly frequently and ought to be 
encountered with a roughly similar frequency by all dissectors. If any individual dissector is 
noted to deviate substantially from the mean rate, they may need further training, or be able to 
provide training to others.  
Orientation is also important in regard to benign conditions. For example in cases of ischemic 
bowel, the surgical margins may not be viable, which could lead to a failure of the surgical 
anastomosis. A requirement for complete measurements is also a part of the checklists. 
Depending on the point of view of the dissector, this may be considered obvious or unnecessary. 
Most dissectors would provide full dimensions for the organ unprompted, whilst some feel it 
necessary to only supply a largest dimension. Clearly an appendix 70 mm in length and 4 mm in 
diameter is different to one that is 12 mm in diameter, something that would not be 
communicated by some of the dissectors who fail to record full dimensions. The same applies 
to a gallbladder specimen, where both length and maximum diameter should be recorded. 
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An external description of the specimen ought to be attempted, this may be as simple as 
“congested appendix” or “intact gallbladder”, or may be an in depth description of some unusual 
external feature. An appendix that appears unremarkable microscopically, which was been 
described as such, may be considered to correlate; however, an appendix that that appears 
unremarkable microscopically, which lacks an external description, may not convince the 
pathologist of its unremarkable nature, necessitating revisiting the specimen. As with a 
gallbladder, if gallstones are suspected and none are found, but the specimen is described as 
having been received open, the stones may be presumed to have been removed in theatre and 
their absence noted on the report. If the macro does not record whether the gallbladder is 
received open or closed, then consideration must be given to the possibility that the stones are 
lodged further in the bile duct, which would necessitate further surgery.  
 The checklists for the uterine resections indicate the requirement for a description of the 
endometrium and myometrium, in the case of a macroscopically benign resection the 
expectation would be that the endometrial thickness would be recorded and a simple 
description of the myometrium would made, e.g. the myometrium contains intramural fibroids, 
the myometrium shows features of adenomyosis, the myometrium appears unremarkable etc. 
In cases of known or suspected malignancy the maximum macroscopic dimension of the tumour 
should be recorded, this being a specific requirement of the minimum dataset (RCPath, 2014b). 
A minimum requirement of the microscopic report is to indicate whether the tumour shows no 
myometrial invasion, myometrial invasion of less than 50% of the thickness of the myometrium 
or myometrial invasion of more than 50% of the thickness of the myometrium. Whilst this is an 
RCPath minimum requirement of the microscopic report, it is a local requirement of the 
macroscopic report. This absence is noted in a number of the reports in studies 2 and 3, whilst 
study 4 shows all dissectors providing this information. Study 5 and 7 each show a slight variation 
in the provision of this information, in all other cases the dissectors now provide this 
information. This is echoed in the colon checklists, where a description of the macroscopic 
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penetration of the tumour is requested by local protocol. The minimum dataset (RCPath, 2014a) 
simply calls for a microscopic measurement of invasion of the tumour beyond the muscularis 
propria (if applicable), however, this macroscopic description is mandated in local protocol, and 
should therefore always be provided. In study 2 we can see variation in who provides this 
information, in study 3, with the introduction of the checklists, this variation is reduced. By study 
5 all variation in relation to this KPI is lost, with all dissectors recording this information in all 
cases. Again this is an important feature to note macroscopically, and speaks of more than 
simply whether the tumour does, or does not reach the fat. If a dissector is stating that the 
tumour is not breaching the bowel wall macroscopically, yet clear unequivocal evidence is seen 
microscopically, one may consider that this was perhaps not visible macroscopically. However, 
if this was happening regularly, one may consider that the dissector is either unable to recognise 
when tumour is penetrating the bowel wall, or is perhaps not examining the specimen with an 
adequate degree of thoroughness. Alternatively, the dissector may be mistaking other features 
for tumour penetration and over calling the stage of the tumour. In any case, the discrepancy 
might be identified by an audit correlation between the macroscopic and microscopic report – 
something that is only possible if the information is recorded in the macroscopic report in the 
first instance.  
The colonic checklists also call for a description of the background mucosa. The third edition of 
the RCPath dataset for colorectal cancers (2014a) states a need to describe any background 
abnormalities, this is also stated in the local SOP for dissection of benign or malignant colorectal 
resections. The local protocol also calls for a description of the background mucosa in the 
absence of any background abnormalities, therefore there should always be some description 
of the background mucosa, even if that description is as simple as “the background mucosa is 
unremarkable”. The reason this is important is that if, for example, a tumour is noted on a 
background of diverticular disease, the pathologist is aware of the presence of diverticula 
elsewhere and will then be aware of the possibility that an area of tumour that appears directly 
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adjacent to fat, may not represent true breach of the muscularis propria, in that it may have 
breached the muscularis mucosae in the region of a diverticulum. Other features of note may 
be that the bowel wall is thickened away from the tumour, this could indicate that the tumour 
is stenotic, leading to hypertrophy of the bowel wall due to the increased resistance. If the 
received specimen has a thickened wall and incudes an obvious polypoid lesion and no other 
abnormality, consideration must be given to the possibility that a further stenosis exists distally, 
whether that be a further tumour or a diverticular stricture caused by fibrosis. Either of these 
circumstances may lead to more surgery. In the case of a further tumour, a resection to remove 
the tumour is quite likely, in the case of a fibrotic stricture, the thickened bowel wall indicates 
increased intraluminal pressure and that the bowel wall is under greater strain in trying to pass 
faecal matter. This places additional strain on the new surgical join, the anastomosis, which may 
then leak, leading to possible peritonitis, septicaemia or death. It is the wider picture 
surrounding the main pathology that is omitted by failing to record this information. The 
provision of the background description shows some variation early on, however, by study 5 
only pathologist 6 continues to omit this data.  
Knowing what needs to be sampled from each specimen type, and why, is also important. As 
previously noted, there was a discrepancy in sampling protocol for the gallbladder. This was 
brought to light in the course of this investigation, and prompted a review of the protocol. Whilst 
in this case (fundal vs corpus sampling) there is no strong evidence in favour of either approach, 
the decision taken by the lead pathologist for GI pathology in the department was for a single 
section to be taken through the fundus, and a section of the cystic duct. As such, this is what 
should have been occurring, and any deviation from this e.g. when working with a disrupted 
specimen where the fundus was damaged, should be noted on the specimen description. This 
was echoed with the sampling of the appendix. At a departmental meeting of the pathologists 
involved in gastrointestinal pathology reporting, a consensus was reached that we should 
change our sampling protocol from the current practice (two representative transverse sections 
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from the body and one longitudinal section from the tip) and take a single transverse section 
from the body and one longitudinal section from the tip. This was communicated to the 
dissectors, most of whom changed their practice, however this is the source of most of the 
variation on the “appropriate blocks” KPI for pathologists. Subsequently, a review of the RCPath 
guidelines indicated that a longitudinal block of tip should be taken and one transverse section 
from the body, along with a transverse section of the base. Again, the BMS showed a quick and 
sustained change to the new protocol, whilst the pathologists were slower to respond - in Study 
2 part 2; the BMS practice hits, and maintains, 100%. This only drops for BMS 2, whilst the 
pathologists practice shows more variance. Part of this may be due to familiarity in dissection. 
As the BMS dissectors are predominantly based in the dissection room, any changes are quickly 
put into practice and are established as routine, whereas the pathologists are infrequent visitors 
to the dissection room. This means that changes to practice may have been made some time 
before they next perform dissection, at which time they continue with their established practice 
– in the absence of any form of prompt. The checklists demonstrated their ability to serve as a 
prompt, although they were deliberately constructed in a simple non-directive manner. If the 
checklists were to state outright what constituted “appropriate blocks”, perhaps a greater level 
of conformance would have been seen. An attempt to be more communicative in terms of what 
was required was attempted with the use of diagrams. However, the diagrams did not have 
much impact. 
The concept of acceptable / expected frequency could be expanded on. Uterine polyps are not 
an unusual incidental finding at dissection, Goldstein (2002) indicates a frequency of 16.6% 
within a representative asymptomatic population.  Many of these polyps are benign and are of 
no consequence to the patient, however, they may be the focus of malignant disease, being 
both a potential source (Childs, 2005) of malignant cancer and a potential site of metastatic 
cancer (Hooker, 2011). If the checklists were amended to require that the presence or absence 
of a polyp is recorded then it would be possible to chart the frequency with which individual 
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dissectors recognise the presence of a polyp, and compare this against the mean for that group. 
The accuracy of description and macroscopic assessment may become even more important in 
the future; with increasing calls to reduce waiting times, the 62 and 31 day treatment targets 
(Department of Health, 2013), and reductions in funding, there are more and more pressures 
on the diagnostic histopathology department. These pressures are part of the drive for the 
increase in BMS led dissection, and are likely to have further effects. Salmon et al. (2012) calls 
for apparently unremarkable hysterectomy specimens to receive only a macroscopic 
description. They concluded that performing microscopic assessment of macroscopically normal 
hysterectomy specimens did not contribute to patient management. This is a radical suggestion, 
and one that is unlikely to be universally welcomed, however, it does open a dialogue and 
encourage consideration of how much utility and value is created by some of the practices in 
pathology. An ongoing discussion regarding the value of examining macroscopically 
unremarkable specimens continues with some advocating that some specimens, e.g. appendix 
and gallbladder, should not be submitted to the laboratory (Taylor, 1998) and others 
recommending that the laboratory should examine all resections of this type (RCPath, 2005). A 
possible third route would be to do as Salmon et al. suggest, and have a BMS perform a 
macroscopic assessment only; performing sampling for microscopy only where deemed 
necessary. Clearly, this is a radical step. In their study, only those cases examined by a consultant 
grade pathologist were eligible to be reported on the macroscopic description only. Further 
training, assessment, regulation and indemnity would need to be put in place to enable BMS 
dissectors to do this, however, it is certainly an avenue that the current work could help to 
achieve. If the frequency with which various pathological features were encountered were to 
be recorded and plotted, for an individual dissector against a local group mean, this would 
enable the individual practice to be assessed. Any individual showing notable deviation could 
then receive closer scrutiny to ensure full competence. This form of ongoing audit would provide 
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an excellent form of individualised quality data, as called for by both Barnes and the Royal 
College (Barnes, 2013; RCPath, 2013).  
The lymph node yield achieved is another area where an average rolling plot could be generated 
from a modified version of the audit sheets. We saw in the literature review just how extensive 
the evidence for sampling all the lymph nodes was, and that a minimum average of 12 nodes 
was expected. Using the audit sheets or an electronic system to log the number nodes retrieved 
per case would allow the individual to compare their data against a departmental mean. In the 
right team, the use of the leader board as noted by Ludeman and Shepard (2006) could serve to 
motivate diligent examination and provide a motivational “target” to aim for. In the wrong team 
it could act as a divisive factor, causing disharmony, therefore careful consideration would need 
to be given to its introduction. The lymph node yields within this department show that at 
baseline the BMS mean yield was 16.75 lymph nodes per cancer resection, and the pathologist 
mean yield was 16.77 lymph nodes per cancer resection. The BMS and pathologist dissectors 
show a near identical average yield, however, the range is interesting. The range of means for 
the BMS dissectors is 15 – 18, showing that none of the BMS have a mean below the 
recommended minimum, whilst the range for the pathologist dissectors is 11 – 23. One of the 
pathologist dissectors shows a mean yield below the recommended mean, whilst one of the 
pathologist dissectors shows a mean far in excess of the others, at 23 lymph nodes per cancer 
resection. This level of information would fit with the calls for individual quality data noted 
above and also provides a training opportunity. The pathologist dissector returning a mean of 
23 lymph nodes per cancer resection has since been asked to lead one of the BMS feedback 
events, specifically into colorectal cancers and lymph node yields. This, it is hoped, will lead to 
an improvement in BMS harvest from all those who attend. However, based on the attendance 
at previous BMS feedback sessions those who might benefit most are unlikely to attend, e.g. the 
pathologist returning a mean yield of 11 lymph nodes per cancer resection. 
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Diagrams 
The guide diagrams (appendix 4) were not received well by the dissectors. When compared to 
the diagrams in published text books, these are perhaps somewhat amateurish. They were the 
best that could be obtained at the time, with no talented artists to hand and no suitable 
diagrams that might have been adapted from elsewhere. However, the diagrams did contain all 
the important information, with lines to indicate the measurements that should be supplied and 
markers indicating what sections should be taken. The diagrams were annotated with additional 
information, indicating what features should be considered for the macroscopic description.  
No-one openly criticised the diagrams, yet one BMS dissector disliked them so much they 
removed the diagrams from the wall on the first day they were introduced. After a conversation 
with that dissector, the diagrams were replaced on the wall, but there was little enthusiasm for 
them from any of the dissectors. In the interviews with the dissectors, two the pathologists 
specifically indicated their enthusiasm for using guide diagrams, but did not recall encountering 
these in the dissection room. Unfortunately, there were no specific objections to the diagrams, 
making it difficult to understand the resistance to them and the reluctance to engage with them.  
The diagrams are all, like the checklists, based on the RCPath guidance and local protocol. The 
appendix diagram indicated the need to measure the length and diameter, indicated serially 
sectioning through the body to examine the cut surface and taking a longitudinal section 
through the tip. It also notes some macroscopic features to look out for. The same is true for the 
gallbladder, colon and uterus. The diagrams were envisaged as a simple graphical equivalent to 
the checklists, however, despite allowing time for the dissectors to get used to the diagrams, 
the dislike and disdain persisted, so they were removed.  
Attitudes, responsibility & change management 
One item noted in the results section was that pathologist 5 always failed to sample the 
background mucosa. This was highlighted in a discussion between the pathologist and the lead 
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BMS for colorectal dissection. The pathologist determined that there was no point in sampling 
normal mucosa on the premise that it is normal and therefore does not need to be sampled. 
However, the 2nd edition of RCPath dataset for Colorectal Cancer (RCPath, 2007) specifically 
states the requirement for a block of normal background mucosa, the 3rd edition (RCPath, 2014) 
repeats this statement, with the explanatory note that this is for microsatellite instability testing 
or germline testing. Despite this, pathologist 5 continues in their practice of not sampling the 
background mucosa. Clearly, this is a deliberate choice, not an error or accidental omission – 
something that will not be changed by a checklist or training event. However, as this work has 
highlighted, standardisation in practice and reduction in variation is in itself a worthy goal. The 
aim of this work is to reduce variation wherever possible, whilst allowing for professional 
autonomy and judgement; a further discussion with pathologist 5, presenting the data gathered 
here, might be hoped to engender a more positive outcome. Barnes (2014) calls for sanctions 
where standards fall below an acceptable level, clearly there is an opportunity here for a 
discussion to determine what constitutes an acceptable level. Perhaps failing to follow the 
explicit recommendations of one’s own professional body may be considered to be below the 
acceptable level; in which case a further discussion regarding what sanctions might reasonably 
be considered is order. In the case of deliberate failure to follow recommendations a 
conversation between the individual and their clinical lead might be in order, highlighting the 
omission and stressing why this is unacceptable. A lack of conformance after this might then be 
considered a management issue, and the local capability / disciplinary procedure invoked. 
Clearly, this would be a last step and a more collaborative, team led approach with shared goals 
and agreed standards would render this unnecessary.  
Continuing on the theme of deliberately departing from standard practice, pathologist 9 appears 
for the first time in study 2, part 8 (training event and checklists). They had been asked to help 
cover staffing shortages and, as discussed briefly above, their performance is clearly deviant 
from standard protocol. They made a choice to ignore the checklists, indicating in strong terms 
181 
 
that they did not have time for such things and that they knew what they were doing without 
bits of paper. However, whilst they may well know what they are doing, they clearly are not 
doing what they should be doing. Their deviation from protocol is a deliberate act, and one that 
checklists and training events will not be able to rectify. Again, an individual meeting presenting 
the appropriate evidence may be more influential. Both of these cases are of an individual 
determining that their own desire to do as they wish is more important than working to the 
recommendations of their own professional body, and the agreed standard protocol within the 
department. This, clearly, does not fit with the modern NHS ethos of collaborative working, and 
echoes back to the “doctor knows best” days of the old health service.  
This links into the area discussed in the literature review, that of change management, and also 
touches on the points raised by Frances (2013) and Barnes (2014), on the subject of adequate 
sanctions for dealing with poor performance. The use of the checklists in this investigation have 
shown clearly that this is a viable method for demonstrating variation in practice, the feedback 
events then provide an effective method of communication to correct variance. However, in the 
event that this variation persists, due to either an unwillingness or inability to change, we are 
no further forward than the situation Frances noted with Mid Staffordshire Trust where he 
called for “standards and measures of compliance ….. with rigorous and clear means of 
enforcement”. Thanks to the RCPath and their minimum datasets and tissue pathways there are 
standards, but until now there has been no method of measuring compliance. The work 
presented here demonstrates that whilst a measure of compliance is now available, a means of 
enforcement is still required, although if this were addressed as a management issue, the 
standard NHS capability or behavioural procedures could be invoked. The tone of the Francis 
(2013) and Barnes (2014) reports indicate that something more powerful, with powers to apply 
professional censure, is desired. Simply removing a poor practitioner from their post appears to 
be insufficient, the tone of the reports and the current patient–doctor dynamic calls for a more 
powerful and authoritative oversight. As this work was a trail to establish proof of concept for 
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the checklists and to explore a method of corrective action, such a structure was outside its 
scope. However, the political and social tone is ready for such a structure, the GMC, the RCPath, 
the Royal College of Nursing (RCN) the HCPC all hold the capacity to remove the right of an 
individual to practice within that profession, in the event of malpractice. Should, then, failure to 
act in accordance to the best professional guidance be considered as such? It clearly constitutes 
a failure to provide the best possible service to our patients, and the level of censure that invokes 
is best left to a wider discussion. As Dixon-Woods (2011) noted, the collegiate model of 
regulation is open to abuse and is unable to adequately protect the profession from this abuse. 
This has led to a slow diminishing of the self-regulatory powers previously possessed by the 
professions, and led to more formal legislated regulation. As such, pressing the professional 
bodies in to service to be the authoritative voice called for above, is unlikely to be successful, 
indeed such may be contradictory to our goals, as public trust has been sorely abused by 
scandals like Mid Staffs (Francis, 2013) The public may now not be receptive to being told that 
the professional bodies, made up of members of the professions, now has additional powers to 
censure its own members. An independent body with the will to enforce legal sanction may be 
the most appropriate method of dealing issues of deliberate or wilful poor performance. The 
demonstration of KPI data will engender greater trust in the abilities and practices of the medical 
team, whilst the formal oversight of an independent body will foster greater confidence in the 
organisation providing medical care.  
The preferred method of ensuring compliance must be not be authoritative, but must be 
education and discussion. In this study the feedback event provided this opportunity; however, 
if a non-compliant individual chooses not to attend or participate in the feedback event one can 
follow up the individual with a specific discussion regarding their deviation from recommended 
practice, however, in the event of no change little more can currently be done. If, as Ludeman 
& Shepherd (2006) suggest, we accept that the accuracy of the diagnosis relies on the quality of 
the dissection, we must accept the requirement for some form of standard or quality check. 
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Considering that Foy (2002) reported that changes that could be implemented on a trial basis 
were most likely to be adopted long term, any structured intervention such as the one detailed 
here ought to be introduced with collaboration and discussion with the team. The need for this 
team approach is very strongly highlighted by the work of Pronovost (2006) and Bosk et al. 
(2009), and builds on the information discussed in the literature review in relation to parallels 
with airline safety, particularly that of Kao and Thomas (2008).  
In Barnes (2014) recommendation 4.13 he encouraged training and education of the pathology 
workforce in quality management. If such a system is to be developed, it is worth giving serious 
consideration at the initial stages to the inclusion of change management within this system. 
Surely one goal of a quality management system to address deficiencies or identify areas for 
improvement, which would be expected to require some form of change. If we are to train our 
pathology staff in the management of quality, it seems logical that we should also train them in 
how to address the changes that may be needed.  
New knowledge 
This thesis contains a great deal of new knowledge. The data in study 1, indicating the relative 
frequencies of various pathological features, is information that has never previously been 
collated. Whilst this is a limited initial study, at a single site, it clearly sets a benchmark for the 
frequency for the presence of exudate, perforation or diverticula in an appendix; mucin, 
perforation or cholesterolosis in gallbladder; mean staging of colorectal tumours at point of 
resection, mean lymph node yields, perforation, diverticula and polyps in colorectal resections; 
the presence of fibroids and adenomyosis in uterine resections. This is limited data, and should 
not be used to state with confidence that x% of colorectal resections will contain background 
polyps. However, this new knowledge is a foundation that can link up with data from other 
centres and further data from this centre, such as that gain in the other studies.  
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Study 2, parts 1 to 8, all generated new knowledge, there were three main areas of new 
knowledge; KPI can be used to demonstrate good and poor practice, there is substantial 
variation in practice by and between individuals, an appropriate feedback system can reduce or 
eliminate this variation. Selecting the KPI has been done with reference to the RCPath guidance, 
and the evidence on which they are based, reference to local SOP has also been made in the 
selection of the KPI. If this work were to be expanded to a larger scale, the selection of the KPI 
would have to be discussed by an oversight group and a consensus reached before new 
checklists were developed. The graphs from study 2, parts 1 to 8 all show a progressive reduction 
in variation, something which is clearly highlighted in Figure 6 on page 81. There has never 
before been a structured assessment of variation in the practice of histological dissection, the 
numerous papers in the literature review that refer to variation in practice all indicate that 
variation in practice leads to more errors and, in those relating to patients, worse patient 
outcomes. The feedback and training event has a clear and sustained effect, demonstrated in 
the graphs presented in the results section. In most cases the amount of variation by individuals 
shows a rapid reduction, with the remaining variation being more slowly eliminated, Those few 
cases that do not show this pattern have been discussed previously and these relate to 
deliberate choice, where some form of management action or censure may be required to 
compel the change, something which is clearly outside the scope of this investigation. A more 
structured system, either locally or nationally, with the full support of the department and 
directorate may create an opportunity for those individuals who do make a deliberate choice 
not follow the protocol to engage in a constructive conversation with the programme leader. 
Chisholm (2012) noted a reluctance for some medical professionals to engage in behaviour 
change conversations, citing a desire to prioritise the doctor-patient relationship. This is 
undoubtedly true in other areas, where difficult conversations are delayed or ignored from a 
desire to maintain professional relationships. However, this concern can be contained by 
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working within a more structured framework, where an agreement to work to certain standards 
has already been made. 
Limitations 
As with all research, this study does have its limitations. The first, and largest, limitation is that 
this was an individual led, single centre study. The more this study developed, the more 
important the team aspect became and the more apparent it became that it was too large for 
an individual to implement without the enthusiastic support of the rest of the department. The 
introduction of the training event opened the study up tremendously, after the first four of these 
events the BMS dissection team was very enthused and keen to be part of the team, making 
suggestions on how to develop and what should come next. However, the involvement of the 
pathologists was more limited than would have been ideal, and this is something that should be 
considered before developing this work further or elsewhere.  
The study took place over a number of years, as such the dissectors taking part changed over 
time, as well as the participants changing in their levels of knowledge, skill and experience.  As 
such there is a development of ideas, awareness and confidence that is due to the individuals 
own professional development, and not due to the checklists or training event, it is not possible 
to separate for these effects. As this was an exploratory work, one that developed during its 
execution, the timeline is perhaps longer than would have otherwise have been the case. Also, 
the rather fluid make-up of the dissection team may have exacerbated this. If being trialled or 
developed elsewhere, a more condensed timeline would be possible, as the exploratory work 
has been performed. Additionally, as well as taking a more team led approach at the outset as 
mentioned above, selecting a core team of dissectors would simplify the approach and enable a 
more streamlined trial. However, once the development work is complete, extending the 
scheme to cover all dissector staff would ensure a full complement of data.  
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The checklists themselves proved to be very adaptable. They were deliberately constructed to 
be as simple as possible, however, it is possible that more explicit statements would have 
produced a greater changed. For example, instead of a checklist point indicating “Appropriate 
blocks”, the checklist could state was is meant by appropriate blocks, the appendix checklist 
could state “1 x LS from tip, 1 x TS from Base, 1 x TS from Body”. A space might be left for the 
dissector to state their justification in the event they felt it necessary to deviate from this 
standard sampling. Balancing the conflicting aims of a simple checklist, with a specific checklist 
is a difficult process and would be refined over successive iterations.  
Further work 
I was privileged to be invited to speak at the 2015 annual conference of the Academy of Clinical 
and Medical Laboratory Scientists, in Kilkenny. Whilst there I attended a presentation by Richard 
Crocker, Head of Medicines Optimisation for the NHS Clinical Commissioning Group (CCG) in 
Northern, Eastern and Western Devon. Crocker detailed the approach taken within his CCG, 
where the pharmacy had become far more involved in primary care. The pharmacists are far 
better placed to keep abreast of current developments in medicines, to know what the most 
appropriate drug is, when a generic drug will perform as well, at a fraction of the cost, to know 
the long terms side effects etc.  He detailed a number of cases where a suboptimal medicine 
had been prescribed simply because the general practitioner was unaware that one of the 
myriad of alternatives was now the preferred choice. They provided an electronic formulary, 
whereby the GP entered the condition they wished to treat, or the drug they wished to 
prescribe, and the system would indicate the preferred choice, and the reasons why that was 
the preferred choice. The GP was still free to make a different choice, but had to record their 
reason for their choice. This clearly enhances clinical decision making, utilising the skills of the 
professionals within the group to the best advantage of the patient and saves money. One 
challenge in all areas of the NHS is saving money, if we can perform our specimen dissection to 
the upmost clinical and cost effectiveness, that will provide time and cost savings which we are 
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then able to use to benefit out patients elsewhere. This has clear utility elsewhere in pathology, 
notably in the blood sciences. Clinicians often take the approach of simply ticking each test 
request box on the request form, rather than giving a true evaluation to what is needed. A trial 
run by Crocker saw the clinicians stating the clinical question, and leaving the repertoire of tests 
to be selected by the laboratory, who then provided clinical advice to the clinician. In essence, 
this is what we already do in histopathology. We receive an organ with the clinical information 
of “Crohn’s” or “tumour” and we investigate that specimen in the most appropriate way. This 
then puts us in a position of leading the clinical integration of the pathology service.  
However, there is further work to be done. The Joint Working Group on Quality Assurance in 
Pathology is currently following up on the Barnes Report, and this work may be of interest to 
them. The calls from Barnes and Francis for individualised, transparent quality data are clearly 
met in this work; however, this is a single site study and needs to be replicated. A further 
multicentre study, where core items for the checklists are agreed across all centres, would 
validate the data gained here and form the basis for a stepwise introduction of a national quality 
framework. This work can go further, the calls from Barnes apply to all of pathology, not simply 
to histopathological dissection. The concept of KPI can be extended further into the 
histopathology laboratory, covering areas such as section cutting, immunocytochemistry, etc. 
Collating these KPI may require a different approach to using checklists, and may be generated 
directly from the Laboratory Information Management System (LIMS), this again can provide the 
individualised, transparent quality data, but would also allow the automated collation of 
accurate workload statistics. Moving to other areas of pathology, perhaps in microbiology one 
might have a rolling count of contaminated cultures, the frequency of repeat tests, and 
adherence to the Standards for Microbiological Investigations (SMI) etc. In blood sciences the 
practices are somewhat clearer cut, and so the KPI may need to translate to errors e.g. errors in 
centrifugation, refrigeration, pipetting etc. It must be stressed that errors are expected and an 
individual making occasional errors is acceptable, the point here would be to enable trends by 
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and between individuals to be identified on a local, regional and national scale. This would 
provide the individual and transparent quality data that is being called for.  
Chapter Six – Conclusions 
The checklists are very clearly an effective intervention, audit and management tool. In the 
current climate of “More for Less” and the requirements for more accountability, and the 
needed change in ethos towards the team dynamic seen in the aviation industry, this shows a 
great deal of promise. The checklist is highly adaptable and can be modified to suit local 
practices, although it might be hoped that the checklist might be picked up by the Joint Working 
Group on Quality Assurance. A national framework incorporating the checklists as a method of 
providing QA in histopathological dissection is entirely feasible. 
The training intervention was very popular, takes minimal organisation, occupies a small amount 
of time and uses virtually no resources other than time. It increases communication between 
the BMS and pathologists; and between the BMS dissectors. The only real lack in the training 
event is that they are delivered by pathologists, to BMS; meaning that the needed increase in 
communication between pathologists is missed. It is hoped that in future more pathologists will 
attend sessions delivered by other pathologists and the BMS will deliver sessions to other BMS 
and to the pathologists. 
The combination of checklists and training intervention has produced a noticeable and sustained 
reduction in variation. It has enabled the identification of both inadvertent poor practice (low 
lymph node yield) and deliberate deviation from agreed practice (pathologists 5 and 9). Prior to 
this study there was no reason to suspect poor performance, and there was no evidence of 
deviation. This then allows these issues to be tackled, increasing standards in the department 
and improving patient outcomes. 
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This work has relied heavily on the identification of substandard performance by Barnes (2014). 
It is fitting then to consider how this work seeks to meet some of his recommendations.  
2.22. Overall the quality assurance framework in pathology lacks several 
key factors without which we cannot say the best interests of the patient 
are being served: transparency, integration, key assurance indicators, 
oversight and effective triggers for sanction and reward. 
This work focuses extensively on demonstrating the use of KPIs, demonstrates the facility for 
transparency and oversight. All that remains is for a decision on thresholds for sanction and 
reward. 
4.28. “Further consideration must be given to the ways in which individual 
performance can be assessed, monitored and competence-assured. The 
National Medical Director will ask the professional bodies, led by RCPath, to 
review these issues and report back within twelve months on their 
findings.” 
Individual performance is monitored clearly here, and can be compared against other 
individuals, local or national means. Competence assurance is currently based on gateway 
qualifications, the data here could easily be used to demonstrate ongoing competency in any, 
or all, areas.  
4.32. The professional bodies, led by RCPath, should develop methodologies 
for assessing the performance of individuals in EQA schemes that will give a 
fair and accurate picture of their competency to practice. 
This work could integrate with LIMS and allow automatic data collection for KPIs. This could be 
collated, analysed and reported by an EQA scheme, allowing for independent analysis and 
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reporting, based against a local, regional or national standard. The power for sanction and 
reward could rest with the CQC, NHS England or the Professional Standards Authority.  
4.44. “The quality and governance systems of pathology providers must be 
integrated with trust governance and quality structures. This should include 
the measurement of appropriate quality assurance indicators and the 
identification of an accountable board member within the organisation. 
CQC and the Chief Inspector of Hospitals have indicated that robust 
information on the quality of pathology services could contribute to the 
overall assessment of quality under the new hospital inspection model.” 
Clearly, there is plentiful scope for this work to develop further. The Joint Working Group on 
Quality Assurance is currently determining how to address the recommendations of Barnes, in 
the background of changes being made in response to Frances. The author hopes that this 
investigation may demonstrate the gap in knowledge currently, the potential risk to patients it 
presents and the feasibility of this method to address it.  
1.7. The current pathology quality assurance framework lacks several key 
factors: transparency, integration, scrutiny, oversight and effective triggers 
for reward and sanction, without which we cannot say the best interests of 
patients and healthcare generally are truly being served. 
This work sets out the framework to provide just such a system, and proof that it works.  
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Appendix One – Tissue Pathways and Minimum Datasets 
 
The range of RCPath tissue pathways and minimum dataset documents is listed below: 
 General Introduction to cancer datasets 
 Breast 
 Bone and Soft Tissue 
 Cardiovascular System 
 Cytopathology 
 Central Nervous System 
 Endocrine System 
 Eye 
 Gastrointestinal Tract 
 Gynaecological Tract 
 Head and Neck 
 Lung 
 Paediatric 
 Lymph Nodes & Bone Marrow Lymphomas 
 Skin 
 Urinary Tract and Testis 
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Appendix Two – IBMS & RCPath Dissection Categories 
Taken from IBMS, 2005. 
Specimen Categories 
Specimen dissection – guidelines for categorisation of specimens according to 
complexity. 
These are intended to be broad guidelines definitions to act as a base line, which 
departments and individual consultants may see fit to modify. The review system will 
permit the recognition of situations in which clinical or anatomical circumstances 
indicate the category as per protocol is inappropriate. 
Basic definitions: 
A Specimens only requiring transfer from container to tissue cassette. 
B Specimens requiring transfer but with standard sampling, counting, weighing or 
slicing. 
C Simple dissection required with sampling needing a low level of diagnostic assessment 
and/ or preparation. 
D Dissection and sampling required needing a moderate level of assessment 
E Specimens requiring complex dissection and sampling methods  
Category A 
All small biopsies (endoscopic, synovial etc.), uterine curettings, simple products of 
conception, bone marrow trephines, testicular biopsies, cervical punch biopsies, needle 
biopsies (excluding those requiring special procedures e.g. renal, muscle), skin 
curettings and skin biopsies not requiring dissection. 
Category B 
Vasa deferentia, temporal arteries, sebaceous cysts, Small lipomas, unremarkable 
tonsils, unremarkable nasal polyps, thyroglossal cysts, fallopian tubes, molar pregnancy, 
prostatic chippings, transcervical endometrial resection, lymph nodes. 
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Category C 
Placenta, uterus – routine hysterectomy, diverticular disease, femoral head, 
parathyroidectomy, ischaemic bowel, small soft tissue tumours, meckel’s diverticulum, 
thyroid – non-tumour, muscle and cardiac biopsy, large gastrointestinal polyps, renal 
biopsy, appendix, skin biopsies – benign – requiring dissection, gallbladder, simple small 
benign breast biopsies, salivary gland – non-tumour. 
Category D 
Orchidectomy – non-neoplastic, gastrectomy – benign ulcer, simple small ovarian cysts 
& tumours, salivary gland – tumours, pigmented skin lesions, thyroid – tumours, 
complex (non-neo-plastic) gastrointestinal resections. 
Category E 
Uterine carcinoma, gastro-intestinal carcinomas, oesophagectomy, bladder resections, 
renal resections, vulvectomy, penile carcinoma, mastectomy, localised wide lump breast 
excisions, neck dissection, bone tumours, prostatectomy, orchidectomy – neoplastic, 
ovarian tumours, mandibulectomy. 
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Appendix Three – Baseline Data Collection Sheets 
Appendix  
Specimen Number: 
 
Time from receipt to dissection (working days, mean)  
Need for extra investigations (e.g. levels, ICC)  
The number of blocks (mean)  
The need for and number of extra blocks  
A record of any errors in the macroscopic description  
Whether the manner of dissection and macroscopic description allows the 
minimum dataset to be completed. 
 
Whether the following are described in the macro:  
Length  
Diameter  
Serosa  
Exudate  
Perforation  
Mucin  
Fibrosis  
Appearance suggestive of malignancy  
Faecolith  
Pus  
Diverticula  
Normal / unremarkable appendix  
If there is agreement between the macroscopic description and the 
microscopic report. 
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Gallbladder  
Specimen Number: 
 
Time from receipt to dissection (working days, mean)  
Need for extra investigations (e.g. levels, ICC)  
The number of blocks (mean)  
The need for and number of extra blocks  
A record of any errors in the macroscopic description  
Can the minimum dataset be completed.  
Whether the following are described in the macro:  
Length  
Width  
Depth  
Received open / unopened  
Serosal surface  
Lumenal contents  
Presence or absence of stones  
Type of stones (if present)  
Exudate  
Perforation / incision  
Fibrosis  
Mucin  
Wall thickness  
Polyps  
Appearance suggestive of cholesterolosis   
Empyema  
Rokitansky-Aschoff sinuses  
Cystic duct lymph node  
Suspicious of malignancy  
Mucosa  
Agreement between the macroscopic description and the microscopic report.  
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Colon 
Specimen Number: 
 
Time from receipt to dissection (working days, mean)  
Need for extra investigations (e.g. levels, ICC)  
The number of blocks  
Pathological staging under the TNM classification  
The number of lymph nodes recovered  
The incidence of requests for extra blocks  
A record of any errors in the macroscopic description  
Whether the manner of dissection and macroscopic description allows the 
minimum dataset to be completed. 
 
Whether the following are described in the macro:  
Full measurements   
Background mucosa  
Polyps  
Diverticula   
Ulceration  
Fissuring   
Loss of fold pattern  
Thickening / thinning of wall  
Oedema   
Perforation  
Serosal puckering  
Exudate  
Agreement between the macroscopic description and the microscopic report 
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Uterus 
Specimen number: 
 
Time from receipt to dissection (working days, mean)  
Need for extra investigations (e.g. levels, ICC)  
The number of blocks  
The need for and number of extra blocks  
A record of any errors in the macroscopic description  
Whether the manner of dissection and macroscopic description allows the 
minimum dataset to be completed. 
 
Whether the following are described in the macro:  
The presence of fibroids  
The appearance of the serosal surface  
The thickness of the endometrium  
The appearance of the myometrium  
The presence of adenomyosis  
The presence of endometriosis  
If there is agreement between the macroscopic description and the 
microscopic report. 
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Appendix Four – Dissection Checklists 
Dissection Checklist – Uterus, benign and malignant 
Case number_________________ Dissector__________ Assistant______________ 
 
  Yes No N/A 
1 Clean / tidy work area and instruments    
2 Specimen number and name checked    
3 Cassette numbers checked    
4 Specimen orientated    
5 Measured in three dimensions    
6 Tubes & ovaries measured (if present)    
7 External abnormalities on surface described (if present)    
8 Cervix described    
9 Cervix measured    
10 Polyp described (if present)    
11 Endo/myo described, endometrial thickness recorded    
12 Blocks of:    
Cervix    
Endo/Myo    
Fundus    
Fibroid (if present)    
Polyp (if present)    
Posterior reflection (if endometriosis)     
13 Is the minimum dataset complete (if appropriate)    
14 Was SOP followed    
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Dissection Checklist – Colorectal, benign and malignant 
Case number_________________ Dissector_____________
 Assistant______________ 
  Yes No N/A 
1 Clean / tidy work area and instruments    
2 Specimen number and name checked    
3 Cassette numbers checked    
4 Specimen orientated (e.g. Proximal & distal margins)    
5 Complete measurements given    
6 External abnormalities on surface described (if present)    
7 Involvement of margins stated    
8 Appearance of mucosa described     
9 Presence / absence of appendix recorded (if appropriate)    
10 Macroscopic penetration of tumour recorded (if appropriate)    
11 SOP followed    
12 Blocks of:    
Margins    
Appendix, if present    
Background    
Back ground abnormalities sampled, e.g. diverticulae, 
polyps 
   
Pathology sampled, e.g. inflammation, tumour    
Apical node (for cancer cases)    
At least 12 nodes (for cancer cases)    
13 Is the minimum dataset complete (if appropriate)    
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Dissection Checklist – Appendix 
Case number_________________ Dissector_____________
 Assistant______________ 
  Yes No N/A 
1 Clean / tidy work area and instruments    
2 Specimen number and name checked    
3 Cassette numbers checked    
4 Specimen orientated (e.g. tip & base)    
5 Complete measurements given    
6 External surface described     
7 Abnormality described (if present)    
8 SOP followed    
9 Appropriate blocks    
10 Is the minimum dataset complete (if appropriate)    
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Dissection Checklist – Gall Bladder 
Case number_________________ Dissector_____________
 Assistant______________ 
  Yes No N/A 
1 Clean / tidy work area and instruments    
2 Specimen number and name checked    
3 Cassette numbers checked    
4 Specimen orientated (e.g. duct & fundus)    
5 Complete measurements given    
6 External surface described     
7 Abnormality described (if present)    
8 SOP followed    
9 Appropriate blocks    
10 Is the minimum dataset complete (if appropriate)    
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Appendix Five – Dissection Guide Diagrams 
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Appendix Six – Participant Information Pack and Question Sheet 
The following pages show the sheets provided to the participants in the interviews, and also 
show the questions asked – the questions (page 223) were not disclosed in advance to the 
participants.  
The questions were developed in conjunction with the project supervisor, a chartered 
psychologist. The intent was to explore the attitudes and opinions of the participants to 
dissection within the department and their views on the work undertaken. The work thus far 
had appeared promising, and with the requirement for personally identifiable quality data from 
the Barnes report (2014) and the King’s Mill enquiry (RCPath, 2013), this scheme might be able 
to be extended to other hospitals – as such, views on how the scheme might be improved and 
introduced in an improved fashion elsewhere were sought. The work of Braun and Clarke (2006) 
was instrumental in considering the type of question, and how they might be structured. As 
these were face to face interviews, rather than a questionnaire, the questions could be further 
explored after an initial answer. 
The questions were designed to be open ended, and as discussed on page 138, participants were 
encouraged to digress and explore their attitudes and experiences in this area.  
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Information Sheet 
  
Study Title:  The use of key performance indicators as quality assurance in 
histological dissection. 
  
  
What is the purpose of the service evaluation? 
  
The aim of this service evaluation is: 
 To examine the histological dissection standards following the introduction of 
the feedback and training intervention. 
  
Do I have to take part? 
  
Data generated within the department from dissectors is anonymously used. Your 
participation in the interview portion of this study is entirely voluntary. 
  
What if I change my mind? 
  
If you do decide to take part you are still free to leave the study at any time and 
without giving reason. If you decide to withdraw, please contact me through the 
details given below and I will remove your information from the study. 
  
What will I have to do if I take part? 
  
This study involves firstly filling out and returning a consent form. We will then 
have a semi structured conversation regarding the aims of the study. The 
conversations can be as long or short as you feel appropriate, with as much detail 
as you feel comfortable giving. The conversations will be carried out through a 
recorded informal interview. Additional information can be added if you later 
think of other points. 
  
Will my participation in this study be kept confidential? 
  
All information which is collected from you during the course of the study will be 
kept strictly confidential. Any names that you may mention in your personal 
account including your own will be changed and not used in the write up of the 
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study. Direct quotes may be used; however no one will be able to link the 
information to you personally. The e-mail address that you provide will only be 
available to me and no printed copies will be generated.  
  
Contact Details: 
Mr Matthew Griffiths 
Dept of Histopthology 
Royal Derby Hospital 
Uttoxter Road 
Derby 
DE22 3NE 
  
E-mail: matthew.griffiths4@nhs.net 
 
Director of Studies: Rachel.Gillibrand@uwe.ac.uk Tel: 0117 328 3385  
  
  
  
Thank you for taking the time to read the information above and if you are interested in 
taking part in the study please complete and return the consent form, which you will 
find attached. 
  
  
Many Thanks 
  
  
Matthew Griffiths 
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Consent Form 
 The use of key performance indicators as quality assurance in histological 
dissection. 
  
Please read the following list of statements and enter yes (Y) or no (N) 
in the boxes.                
  
  
 I have read and understood the nature of the service 
evaluation as outlined in the participant information 
sheet.  
 I feel as though I have received enough information 
about the service evaluation.  
 I feel as though I have had sufficient time to come to 
my decision. 
 I understand that I am free to withdraw from the 
interviews at any time without reason. 
 I agree to participate in the service evaluation.   
 
 
 
Sign/Print name: 
  
  
Date: 
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Debriefing Form 
 The use of key performance indicators as quality assurance in histological 
dissection. 
 
The service evaluation so far has demonstrated a great deal of variation in practice, 
when working to the same SOPs. The amount of variation was tremendous, and after 
the introduction of the checklists and then the feedback event, the variation dropped to 
almost nothing.  Standardisation in practice allows us to be certain we are working to a 
high standard, review of the SOPs allows us to know we are working to the latest 
RCPath datasets and tissue pathways. 
The current data allows us to visualise anonymous individual practice in comparison to 
their peers. We hope to structure this so that the individual will be able to see their own 
data and compare this to the mean data for the laboratory. This can be used to audit 
their dissection, allowing them to identify areas where they could improve their own 
practice. 
  
If you have any queries about the service evaluation or have any further questions 
please do not hesitate to contact me on the details below. 
  
  
I would like to take this opportunity to say thank you for your contribution to the 
service evaluation. Your help is invaluable to enabling this service evaluation to 
take place. All participants will be able to access a copy of final write up, should 
they wish to.  
  
  
  
Contact Details: 
Mr Matthew Griffiths 
Dept of Histopthology 
Royal Derby Hospital 
Uttoxter Road 
Derby 
DE22 3NE 
  
E-mail: matthew.griffiths4@nhs.net 
Or Rachel.Gillibrand@uwe.ac.uk 
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Interview Questions 
  
1.  What do you think the dissection standards are within the department? 
2. Are there any specific weaknesses in the department? 
a. Do you feel you have any specific areas of weakness?  
3. Are there any specific strengths in the department? 
a. Do you feel you have any specific areas of strength? 
4. How do you know how to dissect specimens?  
5. What was your opinion of the checklists? What do you think they achieved? 
6. What is your opinion of the feedback meetings? What do you think they 
achieved? 
7. What else should we be doing? 
8. We want to introduce this programme at another hospital, what can we do 
better? 
 
 
